Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3024139	s-igg3	g/l (g/l)	3434	4690	0.00%
3024139	s-igg3	— (—)	1508	2031	100.00%	Distribution not available
3024139	s-immunoglobuliinig,alaluokka3	g/l (g/l)	117	153	0.00%
3024139	s-igg3	g/l_______ (g/l)	61	67	0.00%
3024139	s-igg3	G/L (g/l)	22	43	0.00%
3024139	s-igg3	g/L (g/l)	21	26	0.00%
3024139	immunoglobuliinig3	g/l_______ (g/l)	17	17	0.00%	Distribution not available
3024139	s-immunoglobuliinig,alaluokka3	g/l_______ (g/l)	14	15	0.00%
3024139	immunoglobuliinig3	g/l (g/l)	11	13	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other systemic involvement of connective tissue (FG)

565

937

6.13

316.93

1.8

1.3

0.39

0.40

g/l

0.34

426

659

Inflammatory bowel disease treatment related agents

2260

2283

5.63

307.65

1.5

1.2

0.39

0.41

g/l

0.76

1663

1596

1464

1993

4.38

307.65

1.4

0.39

0.42

g/l

1.31

1098

1376

Undetermined asthma

374

252

15.63

307.65

1.7

1.2

0.34

0.44

g/l

2.95

285

171

Asthma-related infections

1339

2544

5.29

307.65

1.5

1.3

0.36

0.43

g/l

6.56

1031

1806

Asthma

1398

1042

7.08

307.65

1.5

1.3

0.36

0.41

g/l

2.82

1060

677

Asthma (only as main-diagnosis)

1431

1042

7.88

307.65

1.5

1.3

0.36

0.41

g/l

2.46

1084

677

Certain disorders involving the immune mechanism

676

817

8.88

307.65

1.9

1.3

0.35

0.41

g/l

1.50

509

580

All pneumoniae

1628

3183

3.38

307.65

1.4

0.39

0.41

g/l

0.46

1215

2259

Immunodeficiencies

404

174

29.10

307.65

2.0

1.3

0.27

0.41

g/l

4.22

324

130

Asthma, including avohilmo

1730

3109

3.11

307.65

1.5

1.3

0.37

0.42

g/l

5.69

1314

2174

ILD medications: prednisolone, methylprednisolone, prednisone

2167

1988

6.21

307.65

1.5

1.2

0.39

0.42

g/l

1.45

1600

1385

Asthma/COPD (KELA code 203)

1476

2914

3.44

307.65

1.5

1.3

0.37

0.42

g/l

1.98

1135

2030

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

341

134

18.89

307.65

1.5

1.2

0.49

0.45

g/l

0.36

240

Bronchiectasis

328

198

18.27

307.65

1.5

1.3

0.41

0.45

g/l

0.48

259

146

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1212

2539

4.25

307.65

1.5

1.4

0.43

0.40

g/l

1.29

882

1831

Fever of other and unknown origin

1084

1999

4.81

307.65

1.4

1.3

0.39

0.42

g/l

1.72

786

1435

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1587

3211

3.35

307.65

1.4

0.39

0.41

g/l

0.52

1189

2278

Acute pancreatitis

585

698

8.86

307.65

1.6

1.3

0.39

0.44

g/l

0.80

294

516

ILD medications: immunosuppressive drugs

1299

1889

6.40

307.65

1.6

1.2

0.42

0.41

g/l

0.24

942

1315

Second line medication for Crohn's disease

1067

2859

3.82

307.65

1.7

1.3

0.43

0.40

g/l

0.77

771

2078

Asthma-related pneumonia or sepsis

839

1401

6.18

307.65

1.5

1.3

0.37

0.44

g/l

4.87

645

987

L04AX Other immunosuppressants

1039

2780

3.83

307.65

1.6

1.3

0.43

0.40

g/l

0.78

754

2021

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1621

3142

3.54

307.65

1.6

1.3

0.39

0.41

g/l

0.69

1181

2280

Asthma-related pneumonia

838

1398

6.19

307.65

1.5

1.3

0.37

0.44

g/l

4.89

644

985

Immunodeficiency with predominantly antibody defects

317

49.88

307.65

2.2

1.3

0.26

0.38

g/l

2.69

263

Asthma, unspecified (mode)

917

983

6.89

307.65

1.5

1.3

0.38

0.42

g/l

1.11

653

645

Abnormal findings on diagnostic imaging of lung

923

1794

5.01

307.65

1.4

0.44

0.41

g/l

0.69

694

1276

First line medication for Crohn's disease

2012

2027

5.46

307.65

1.5

1.2

0.38

0.42

g/l

1.85

1475

1422

Undetermined asthma, excluding more controls

374

250

15.76

307.65

1.7

1.2

0.34

0.43

g/l

2.64

285

168

Asthma (mode)

1354

1048

6.94

307.65

1.5

1.3

0.37

0.41

g/l

1.85

1029

681

Pneumonias (Asthma/COPD co-morbidities)

1623

3184

3.39

307.65

1.4

0.40

0.41

g/l

0.40

1212

2263

Chronic lower respiratory diseases

1825

2923

3.34

307.65

1.5

1.3

0.39

0.42

g/l

1.27

1384

2036

Influenza and pneumonia

1674

3097

3.39

307.65

1.4

0.39

0.41

g/l

0.72

1252

2195

Asthma, hospital admissions 3, pneumonia

839

1401

6.18

307.65

1.5

1.3

0.37

0.44

g/l

4.87

645

987

ILD medications

2168

2032

5.89

307.65

1.5

1.2

0.39

0.41

g/l

0.95

1595

1417

Asthma, excluding more controls

1360

984

7.27

307.65

1.5

1.3

0.36

0.40

g/l

2.21

1029

640

Systemic connective tissue disorders

805

1518

5.50

307.65

1.7

1.3

0.39

0.41

g/l

0.52

597

1083

Asthma (only as main-diagnosis), excluding more controls

1407

984

8.12

307.65

1.5

1.3

0.36

0.40

g/l

1.84

1070

640

1109

1951

5.84

307.65

1.5

1.3

0.35

0.42

g/l

5.51

864

1397

Pneumonia, organism unspecified

1501

2928

3.58

307.65

1.4

0.39

0.41

g/l

0.63

1123

2072

Asthma, hospital admission 2, infections

1339

2544

5.29

307.65

1.5

1.3

0.36

0.43

g/l

6.56

1031

1806

Asthma (diagnoses ohter than nonallergic)

1608

3323

3.99

307.65

1.5

1.3

0.36

0.43

g/l

5.04

1215

2366

Oral corticosteroids

2248

2182

6.20

307.65

1.6

1.2

0.40

0.42

g/l

0.77

1662

1520

Chronic sinusitis

920

1776

5.34

307.65

1.6

1.4

0.37

0.43

g/l

2.20

730

1226

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1464

1993

4.38

307.65

1.4

0.39

0.42

g/l

1.31

1098

1376

Asthma, hospital admissions , main diagnosis only

1512

3382

3.97

307.65

1.5

1.3

0.36

0.42

g/l

4.14

1147

2391

Acute pancreatitis (for exclusion)

585

804

7.68

307.65

1.6

1.3

0.39

0.44

g/l

0.78

294

602

Asthma, unspecified (mode), excluding more controls

907

928

7.16

307.65

1.5

1.3

0.38

0.40

g/l

0.69

648

611

Autoimmune diseases related-to ILD

1289

3397

3.22

304.88

1.4

0.39

0.40

g/l

0.18

908

2473

Asthma and opportunity respiratory infection

234

123

21.67

304.52

1.5

1.3

0.38

0.46

g/l

0.84

183

Cough

720

1463

4.70

297.95

1.5

1.4

0.37

0.43

g/l

2.85

562

1021

Other pulmonary diagnosis

934

1053

4.50

289.69

1.4

1.3

0.40

0.41

g/l

0.14

680

685

Other systemic involvement of connective tissue

581

1114

5.40

286.68

1.9

1.3

0.39

0.41

g/l

0.59

438

797

Abnormalities of breathing

1265

2174

3.38

286.25

1.4

0.39

0.42

g/l

1.45

941

1505

Non-allergic asthma (mode), excluding more controls

344

378

9.29

281.13

1.5

1.2

0.38

0.42

g/l

0.81

270

254

Disorders of gallbladder, biliary tract and pancreas

1422

2964

3.03

279.19

1.5

1.4

0.41

g/l

0.15

901

2272

Allergic asthma (mode), excluding more controls

398

516

7.72

278.51

1.5

1.3

0.35

0.40

g/l

1.81

331

340

Acute sinusitis

911

2251

3.76

278.39

1.5

1.4

0.37

0.42

g/l

2.86

703

1579

Other respiratory diseases principally affecting the interstitium

427

630

7.09

276.15

1.4

1.3

0.47

0.42

g/l

1.14

298

455

Excluding asthma or asthma-COPD overlap

913

1053

4.40

276.08

1.4

1.3

0.41

g/l

0.08

661

685

Non-allergic asthma (mode)

344

390

9.00

274.40

1.5

1.2

0.38

0.43

g/l

1.15

270

265

COPD differential diagnosis

908

1049

4.39

274.08

1.4

1.3

0.41

g/l

0.09

657

681

Allergic asthma (mode)

398

526

7.57

273.94

1.5

1.3

0.35

0.40

g/l

2.12

331

347

ILD differential diagnosis

906

1048

4.39

273.06

1.4

1.3

0.41

g/l

0.09

656

681

ILD, hospital admission 2, with pulmonary infections

275

237

12.29

271.09

1.4

0.45

0.47

g/l

0.27

193

170

COPD/asthma related infections

1297

1993

3.30

270.51

1.4

0.39

0.42

g/l

1.59

959

1376

COPD/asthma/ILD related infections

1297

1993

3.30

270.51

1.4

0.39

0.42

g/l

1.59

959

1376

Other and unspecified immunodeficiencies with predominantly antibody defects

160

54.85

268.15

2.2

1.3

0.24

0.34

g/l

1.36

136

Other interstitial pulmonary diseases

382

520

7.72

266.07

1.4

1.3

0.50

0.42

g/l

2.30

266

378

Interstitial lung disease

382

525

7.64

263.83

1.4

1.3

0.50

0.41

g/l

2.44

266

380

Interstitial lung disease endpoints

382

525

7.64

263.83

1.4

1.3

0.50

0.41

g/l

2.44

266

380

ILD medications: azathioprine

342

413

8.64

263.21

1.8

1.2

0.44

0.42

g/l

0.32

257

297

ILD, hospital admissions

378

519

7.65

261.33

1.4

1.3

0.49

0.41

g/l

2.37

262

375

Obesity related asthma

628

1448

4.46

247.83

1.4

1.3

0.37

0.44

g/l

1.65

465

1020

1445

2555

2.90

246.82

1.5

1.4

0.40

0.43

g/l

1.06

1082

1778

Reimbursement for rheumatic diseases

922

2764

3.38

246.36

1.5

1.4

0.44

0.40

g/l

0.89

673

2007

Azathioprine

342

448

7.96

245.92

1.8

1.2

0.44

0.41

g/l

0.71

257

320

Any gastric operation

957

1273

3.82

244.22

1.4

1.3

0.38

g/l

0.01

650

1045

GASTRO-related operations

957

1273

3.82

244.22

1.4

1.3

0.38

g/l

0.01

650

1045

ILD, hospital admissions 3, with pneumonia sepsis

243

208

12.41

240.75

1.3

1.4

0.46

0.45

g/l

0.06

168

151

Bacterial pneumonia (organism specified)

712

1639

4.02

238.94

1.4

0.39

0.44

g/l

1.98

521

1168

ILD, hospital admissions 1, main diag only

339

465

7.67

234.68

1.4

1.3

0.50

0.41

g/l

2.28

237

335

Bacterial pneumoniae

645

1351

4.28

233.33

1.4

0.39

0.44

g/l

1.86

479

952

Chronic rhinitis, nasopharyngitis and pharyngitis

587

1347

4.47

232.92

1.5

1.4

0.37

0.42

g/l

2.98

479

938

Autoimmune diseases excluding thyroid diseases

1391

2722

2.80

229.15

1.4

0.43

0.39

g/l

1.48

1002

1977

General symptoms and signs

1337

2352

2.88

224.89

1.5

1.3

0.39

0.41

g/l

0.57

969

1673

Autoimmune diseases excluding thyroid diseases, strict definition

1338

2628

2.80

220.65

1.4

0.43

0.40

g/l

1.48

970

1917

Bacterial pneumonia, not elsewhere classified

600

1254

4.29

217.75

1.4

0.39

0.45

g/l

1.83

443

880

Dyspnoea

1239

3301

2.75

213.95

1.4

0.41

g/l

0.02

913

2389

Other acute lower respiratory infections

842

2537

3.22

205.82

1.5

1.4

0.40

0.41

g/l

0.23

643

1813

Bronchitis

1421

3358

2.57

205.02

1.4

0.39

0.42

g/l

1.22

1072

2373

Nonhereditary hypogammaglobulinemia

123

49.67

203.06

2.3

1.4

0.23

0.36

g/l

2.18

Chronic pancreatitis

295

411

7.52

201.31

2.0

1.2

0.40

0.41

g/l

0.11

163

312

Symptoms and signs involving the circulatory and respiratory systems

1217

2176

2.83

199.23

1.4

0.38

0.42

g/l

2.40

893

1505

Asthma and allergy, excluding more controls

246

283

8.84

193.26

1.5

1.4

0.34

0.38

g/l

0.90

209

190

Acute upper respiratory infections

1307

3068

2.58

190.76

1.5

1.4

0.38

0.43

g/l

3.12

988

2159

Asthma and allergy

246

288

8.69

190.49

1.5

1.4

0.34

0.39

g/l

1.25

209

190

Pain in joint

772

1403

3.43

183.71

1.4

0.39

0.42

g/l

1.69

584

982

Bacterial infection, other or unspecified

759

2005

3.25

182.85

1.4

0.40

0.42

g/l

0.66

547

1447

Kela reimbursement Agammaglobulinemia (D80-84)

106

57.53

180.53

2.2

1.4

0.25

0.38

g/l

1.42

Anaemias

395

440

5.89

179.74

1.4

1.3

0.39

0.43

g/l

0.53

279

330

Other bacterial diseases

1224

3222

2.55

178.65

1.4

0.41

g/l

0.01

893

2317

Bacterial infection, other or unspecified, including avohilmo

811

2187

3.09

178.35

1.4

0.40

0.41

g/l

0.21

590

1575

Acute bronchitis

643

1883

3.41

174.24

1.5

1.4

0.38

0.42

g/l

1.63

492

1347

Examination and observation for other reasons

769

1300

3.38

174.19

1.5

1.3

0.42

g/l

0.04

658

798

Other diseases of biliary tract

217

251

9.09

173.29

2.2

1.3

0.44

0.42

g/l

0.25

133

189

Tramadol

994

2138

2.83

172.42

1.4

0.39

0.42

g/l

0.75

730

1527

Other diseases of pleura

628

1590

3.50

171.08

1.5

1.4

0.40

0.44

g/l

1.29

444

1131

Suggestive for eosinophilic asthma

234

306

8.06

169.05

1.9

1.3

0.30

0.42

g/l

5.07

193

218

Acute upper respiratory infections of multiple and unspecified sites

993

2716

2.70

167.01

1.4

1.3

0.37

0.43

g/l

3.95

754

1918

Diseases of the respiratory system

655

875

3.79

166.16

1.4

1.3

0.39

0.42

g/l

0.95

473

566

Other bacterial diseases, including avohilmo

1269

3315

2.42

163.58

1.4

0.40

g/l

0.05

933

2380

Used for control exclusion in common control thyroid runs

1224

2465

2.53

162.88

1.4

0.41

0.40

g/l

0.30

856

1810

Autoimmune diseases

1305

2735

2.45

162.64

1.4

0.42

0.39

g/l

1.07

937

1986

Enlarged lymph nodes

314

577

5.62

162.51

1.6

1.3

0.43

0.42

g/l

0.27

229

420

Cholangitis (primary sclerosing, PSC)

178

175

10.81

160.77

2.0

1.2

0.44

0.41

g/l

0.24

106

136

Diseases of oesophagus, stomach and duodenum

1301

3280

2.37

158.03

1.4

0.40

0.41

g/l

0.21

953

2356

FESS (DNB20)

302

558

5.66

156.02

1.8

1.4

0.41

g/l

0.01

233

402

Ethmoidectomy

307

577

5.56

155.62

1.8

1.3

0.40

0.41

g/l

0.01

237

415

Headache

811

2212

2.87

155.02

1.5

1.3

0.38

0.41

g/l

1.17

623

1581

Pain in throat and chest

957

2115

2.71

152.72

1.4

0.38

0.42

g/l

1.94

721

1459

Other necrotizing vasculopathies

191

223

9.09

151.73

1.4

0.37

0.40

g/l

0.42

136

173

Other specified/unspecified systemic involvement of connective tissue

178

192

9.94

150.60

2.5

1.4

0.40

0.39

g/l

0.05

147

143

Abnormal findings on examination of blood, without diagnosis

661

1966

3.10

149.83

1.6

1.4

0.43

g/l

0.09

470

1412

Other diseases of upper respiratory tract

1220

2668

2.40

148.15

1.4

1.3

0.39

0.43

g/l

1.23

919

1833

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

671

2188

3.00

146.71

1.5

1.4

0.37

0.43

g/l

3.80

484

1507

Other necrotizing vasculopathies (FG)

164

166

10.49

145.11

1.5

1.3

0.36

0.42

g/l

0.91

117

126

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

190

233

8.58

144.85

1.7

1.4

0.47

0.42

g/l

0.61

126

169

Early onset COPD, excluding more controls

246

399

6.28

144.34

1.6

1.3

0.40

0.44

g/l

0.82

182

272

Finngen Rheumatological endpoints

1129

2674

2.42

142.58

1.5

1.3

0.39

0.40

g/l

0.30

823

1888

Diseases of liver

532

1609

3.38

142.29

1.3

1.4

0.50

0.41

g/l

1.91

360

1175

Any reimbursement code in KELA

651

979

3.37

140.65

1.4

1.3

0.38

0.40

g/l

0.52

474

720

Bacterial Sepsis

623

1686

3.10

138.78

1.4

0.41

0.44

g/l

0.65

445

1207

Other specific joint derangements/joint disorders

934

2288

2.57

137.25

1.4

0.39

0.40

g/l

0.54

699

1633

Vasomotor and allergic rhinitis

525

1567

3.33

137.07

1.5

1.4

0.35

0.42

g/l

3.89

431

1073

Other diseases of pancreas

187

242

8.10

136.20

1.7

1.2

0.39

g/l

0.00

101

184

Polyarthropathies

840

2029

2.69

135.78

1.4

0.43

0.41

g/l

0.57

626

1447

Septicaemia

554

1609

3.19

132.61

1.4

0.42

0.43

g/l

0.21

389

1166

Other soft tissue disorders, not elsewhere classified

1105

2696

2.35

131.63

1.4

0.38

0.40

g/l

1.25

832

1907

L04AA Selective immunosuppressants

405

1080

3.86

131.63

1.5

1.3

0.39

0.40

g/l

0.12

305

765

Gastrointestinal diseases

626

961

3.30

131.22

1.4

1.3

0.39

0.40

g/l

0.20

444

740

Codeine

1039

2341

2.42

129.59

1.4

0.37

0.42

g/l

2.70

746

1679

Opioids

1078

2381

2.36

125.53

1.4

0.37

0.42

g/l

2.84

771

1706

Explicit Sepsis

581

1804

2.98

123.73

1.4

0.42

0.43

g/l

0.24

412

1298

Explicit Sepsis, including avohilmo

593

1855

2.94

123.43

1.4

0.42

0.43

g/l

0.25

423

1333

Malaise and fatigue

604

1625

2.96

123.16

1.4

1.3

0.37

0.42

g/l

1.99

438

1174

Infections, IBD-co-morbidities

227

240

6.79

122.99

1.5

1.2

0.41

0.39

g/l

0.25

162

168

Other immunodeficiencies

28.09

121.38

2.4

1.3

0.32

0.36

g/l

0.47

Implicit bacterial Sepsis

527

1461

3.14

121.13

1.5

1.4

0.41

0.44

g/l

0.58

379

1045

Primary Sclerosing Cholangitis, IBD and UDCA required

101

17.96

120.84

1.5

1.3

0.48

0.36

g/l

1.13

Gastro-oesophageal reflux disease

827

2866

2.46

119.88

1.4

0.37

0.41

g/l

1.89

592

2068

Dermatitis

792

3183

2.46

118.51

1.5

1.4

0.40

0.41

g/l

0.50

586

2301

Implicit viral Sepsis, including avohilmo

436

1304

3.40

118.22

1.4

0.40

0.43

g/l

0.64

321

944

Medical observation and evaluation for suspected diseases and conditions

713

1300

2.83

117.92

1.5

1.3

0.38

0.42

g/l

1.77

558

798

Other septicaemia, including avohilmo

491

1480

3.16

116.89

1.5

1.4

0.43

g/l

0.13

351

1067

Implicit bacterial Sepsis, including avohilmo

566

1613

2.96

116.79

1.4

0.41

0.44

g/l

0.61

412

1155

Certain infectious and parasitic diseases

1034

2243

2.33

116.11

1.4

0.38

0.42

g/l

1.80

742

1593

Symptoms and signs involving the digestive system and abdomen

1061

2331

2.30

115.96

1.4

0.41

g/l

0.17

739

1709

Abdominal and pelvic pain

1059

2331

2.30

115.85

1.5

1.4

0.40

0.41

g/l

0.19

736

1709

Other septicaemia

480

1448

3.17

115.16

1.5

1.4

0.43

g/l

0.09

342

1043

Other and unspecified dermatitis

688

2691

2.59

115.02

1.6

1.4

0.40

0.42

g/l

0.76

513

1954

Sicca syndrome [Sjögren]

189

304

6.51

112.88

1.6

1.4

0.39

0.40

g/l

0.10

129

228

Other diseases of intestines

1204

3183

2.12

112.45

1.4

0.39

0.40

g/l

0.30

880

2286

Implicit Sepsis

882

2796

2.35

111.87

1.4

0.40

0.41

g/l

0.28

627

2026

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

335

356

4.77

111.30

1.3

0.36

0.41

g/l

1.20

238

246

Low back pain

896

2605

2.34

110.96

1.5

1.4

0.38

0.42

g/l

1.70

664

1838

Vocal cord dysfunction

200

289

6.22

110.57

1.6

1.2

0.37

0.46

g/l

0.85

141

201

Viral Sepsis

328

862

3.89

108.72

1.4

0.39

0.42

g/l

0.54

243

632

Nasal polyp

293

711

4.22

108.46

1.7

1.3

0.39

0.45

g/l

0.61

251

490

Implicit viral Sepsis

327

859

3.89

108.46

1.4

0.39

0.42

g/l

0.58

242

630

Haemorrhage from respiratory passages

399

1051

3.41

105.84

1.4

0.42

0.45

g/l

0.42

284

722

Noninfective enteritis and colitis

627

2450

2.59

104.87

1.4

0.38

0.41

g/l

0.92

436

1793

Primary_lymphoid and hematopoietic malignant neoplasms

351

997

3.60

103.81

1.4

0.35

0.43

g/l

2.55

248

712

Disorders of other endocrine glands

585

2255

2.59

97.38

1.5

1.4

0.37

0.41

g/l

1.66

350

1664

Pain, not elsewhere classified

358

1073

3.39

97.15

1.7

1.3

0.36

0.41

g/l

2.44

295

773

Exclusions for E4_PCOS_BROAD

315

873

3.71

96.80

1.6

1.4

0.36

0.39

g/l

0.66

164

648

Other disorders of adrenal gland

135

179

8.04

96.80

1.8

1.3

0.39

g/l

0.01

135

All influenza

344

1009

3.47

96.62

1.5

1.4

0.37

0.45

g/l

2.48

259

723

Cholelithiasis, broad definition with cholecystitis

893

2711

2.21

96.44

1.5

1.4

0.43

0.41

g/l

0.33

599

2082

Other diseases of blood and blood-forming organs, wide

345

1020

3.46

96.05

1.4

0.46

0.40

g/l

0.43

236

730

Adrenocortical insufficiency

120

140

9.24

95.80

1.8

1.3

0.39

0.41

g/l

0.12

107

Codeine or tramadol medication

1199

3276

2.00

95.52

1.4

0.37

0.42

g/l

4.19

858

2350

Disorders of lacrimal system

567

2173

2.60

95.41

1.5

1.4

0.39

0.41

g/l

0.34

416

1559

Dorsalgia

1056

2684

2.10

94.78

1.5

1.4

0.37

0.42

g/l

3.26

783

1893

Idiopathic pulmonary fibrosis

141

201

7.29

94.27

1.5

1.2

0.52

0.40

g/l

2.41

104

150

Diagnoses used for exclusion with ILD

358

1095

3.33

94.24

1.4

0.44

0.43

g/l

0.04

247

796

Pain in limb

899

2627

2.19

94.13

1.4

0.40

g/l

0.03

671

1860

Liquid cancers

396

1210

3.15

93.90

1.4

0.36

0.43

g/l

1.98

278

875

Provisional assignment of new diseases of uncertain etiology

660

2766

2.40

93.24

1.5

1.4

0.40

0.41

g/l

0.18

501

1980

Other special examinations and investigations of persons without complaint or reported diagnosis

660

1300

2.59

93.04

1.4

1.3

0.43

0.42

g/l

0.05

491

798

Codes for special purposes

660

2769

2.39

92.99

1.5

1.4

0.40

0.41

g/l

0.17

501

1983

Budesonide

198

397

5.10

92.93

1.4

1.2

0.41

g/l

0.03

140

278

Implicit Sepsis, including avohilmo

904

3028

2.15

92.82

1.4

0.40

0.41

g/l

0.21

638

2207

Other heart diseases

579

1427

2.67

92.78

1.5

1.4

0.38

0.40

g/l

0.29

417

1046

Drug-induced adrenocortical insufficiency

15.48

92.70

2.0

1.4

0.36

g/l

0.00

Nausea and vomiting

347

1029

3.34

91.44

1.4

1.3

0.38

0.42

g/l

1.50

256

769

Eosinophilic disease (BM)

23.05

91.23

1.6

1.2

0.68

0.49

g/l

0.34

Other disorders of lacrimal gland

486

1802

2.74

90.79

1.6

1.4

0.39

0.40

g/l

0.12

356

1288

Covid-19 confirmed case

474

1734

2.77

90.56

1.6

1.4

0.39

0.43

g/l

0.86

335

1233

Other arthritis (FG)

395

1314

3.05

90.14

1.5

1.3

0.43

0.42

g/l

0.14

291

932

Parasetamol

732

1539

2.42

90.09

1.4

1.3

0.39

0.41

g/l

0.58

526

1069

Unspecified acute lower respiratory infection

256

646

4.07

90.04

1.5

1.4

0.45

0.42

g/l

0.20

193

467

General examination and investigation of persons without complaint and reported diagnosis

640

1300

2.58

89.93

1.5

1.3

0.36

0.42

g/l

3.14

532

798

Cardiovascular diseases

705

1542

2.45

89.92

1.4

1.3

0.37

0.40

g/l

0.99

500

1144

Dermatitis and eczema

1207

3711

1.94

89.88

1.5

1.4

0.39

0.41

g/l

0.77

890

2658

Pneumonia due to other infectious organisms, not elsewhere classified

11.15

89.31

1.4

1.3

0.41

0.43

g/l

0.10

Respiratory disorders in diseases classified elsewhere

18.71

88.16

1.8

1.4

0.34

0.41

g/l

0.41

Cholelithiasis

842

2666

2.17

87.86

1.4

0.43

0.41

g/l

0.33

561

2048

Other disorders of white blood cells

133

193

7.27

87.83

1.5

1.4

0.55

0.39

g/l

0.57

142

Oedema, not elsewhere classified

372

1181

3.12

87.74

1.6

1.3

0.42

0.43

g/l

0.11

288

849

Biological medicines for asthma

11.95

87.36

1.4

1.3

0.31

0.33

g/l

0.22

Osteoporosis

336

939

3.35

87.28

1.6

1.4

0.39

0.42

g/l

0.63

238

675

Heart failure, not strict

802

2457

2.22

87.19

1.5

1.4

0.45

0.40

g/l

1.17

588

1754

Irritable bowel syndrome

384

1283

3.05

87.06

1.5

1.4

0.33

0.40

g/l

4.07

287

925

Other disorders involving the immune mechanism, not elsewhere classified

102

110

10.00

86.49

2.8

1.3

0.39

g/l

0.00

Viral pneumonia

206

455

4.65

86.24

1.4

1.3

0.37

0.41

g/l

0.42

146

328

Lower back pain or/and sciatica

1153

3746

1.93

85.27

1.5

1.4

0.39

0.41

g/l

0.41

861

2665

Complications of surgical and medical care, not elsewhere classified

1071

3663

1.97

85.20

1.4

0.40

0.41

g/l

0.28

790

2636

Other heart diseases, wide

1017

3077

2.02

84.87

1.4

0.41

0.39

g/l

0.46

731

2229

Oxycodone

442

1357

2.82

84.50

1.5

1.4

0.38

0.44

g/l

1.88

315

973

Sulfasalazine

294

850

3.51

84.43

1.4

1.2

0.40

0.42

g/l

0.59

210

589

Other diseases of the respiratory system

282

795

3.62

84.42

1.5

1.4

0.35

0.43

g/l

2.38

201

579

Other respiratory disorders and diseases

282

795

3.62

84.42

1.5

1.4

0.35

0.43

g/l

2.38

201

579

Cardiovascular diseases (excluding rheumatic etc)

730

1827

2.31

83.72

1.4

1.3

0.38

0.39

g/l

0.50

512

1345

Pain (limb, back, neck, head abdominally)

687

1444

2.40

82.88

1.4

0.38

0.42

g/l

2.30

493

1011

Defects in the complement system

29.45

82.71

2.7

1.4

0.31

0.39

g/l

0.61

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

960

3240

2.02

82.16

1.3

1.4

0.40

0.41

g/l

0.15

684

2341

Disorders of eyelid, lacrimal system and orbit

945

3468

2.01

82.03

1.5

1.4

0.39

0.41

g/l

0.42

697

2515

Diseases of salivary glands

441

1655

2.71

80.59

1.5

1.4

0.42

0.40

g/l

0.26

324

1184

Allergic rhinitis

437

1614

2.72

80.10

1.5

1.4

0.34

0.39

g/l

3.04

367

1139

Other specified/unspecified arthritis

351

1171

3.05

79.81

1.4

1.5

0.42

0.41

g/l

0.14

255

841

Condition for Implicit Sepsis (Organ dysfunction codes)

903

3100

2.03

79.72

1.4

0.41

g/l

0.10

636

2257

Autoimmune hepatitis, wide definition

108

138

8.22

79.68

1.4

0.58

0.37

g/l

3.79

102

Cholangitis (primary sclerosing, PSC), with reimbursement 202

12.88

79.52

2.1

1.3

0.43

0.35

g/l

0.60

COPD (mode)

244

478

4.02

79.51

1.3

1.2

0.48

0.43

g/l

0.77

179

318

Other inflammatory liver diseases

139

234

6.20

79.38

1.3

1.4

0.53

0.36

g/l

3.99

173

Disorders of thyroid, IBD co-morbidities

194

265

5.08

79.25

1.4

1.3

0.32

0.40

g/l

2.31

148

186

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

100

10.01

79.02

2.9

1.3

0.39

0.40

g/l

0.07

Dental caries

331

1006

3.15

78.80

1.5

1.3

0.40

0.42

g/l

0.21

248

704

Childhood asthma (age<16), excluding more controls

165

235

5.58

78.32

1.4

1.3

0.37

g/l

0.00

126

150

Hernia of abdominal wall, postoperative

192

428

4.52

78.32

1.5

1.3

0.53

0.41

g/l

0.66

138

363

Candidiasis, including avohilmo

414

1528

2.75

78.18

1.4

0.39

g/l

0.02

314

1096

Wegener granulomatosis

17.62

78.11

1.8

1.4

0.34

0.39

g/l

0.27

Simple and mucopurulent chronic bronchitis

9.91

77.08

1.3

0.43

0.48

g/l

0.36

Childhood asthma (age<16)

165

239

5.48

76.99

1.4

1.3

0.37

g/l

0.00

126

152

5-aminosalicylic acid

244

664

3.73

76.89

1.4

1.2

0.40

g/l

0.01

163

460

13.82

76.75

1.5

1.3

0.42

0.45

g/l

0.10

Other functional intestinal disorders

522

1955

2.45

76.65

1.5

1.4

0.36

0.41

g/l

3.20

382

1418

Intestinal infectious diseases

1017

3981

1.91

76.64

1.5

1.4

0.38

0.41

g/l

2.24

742

2872

Neurological diseases, wide definition

310

427

3.69

76.27

1.4

1.2

0.39

0.38

g/l

0.23

219

304

Osteopathies and chondropathies

646

2678

2.23

76.18

1.5

1.4

0.38

0.42

g/l

1.50

459

1946

Spondylopathies

787

2196

2.14

76.05

1.4

0.39

0.43

g/l

1.82

563

1538

COPD

419

1251

2.75

75.68

1.4

1.3

0.45

g/l

0.03

310

874

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1065

3638

1.89

75.08

1.4

0.38

0.41

g/l

2.32

775

2609

Diseases of the skin and subcutaneous tissue

967

2447

2.00

75.03

1.5

1.3

0.41

0.40

g/l

0.27

703

1714

Diarrhoea and gastroenteritis of presumed infectious origin

784

3443

2.05

74.50

1.4

0.38

0.41

g/l

1.94

568

2481

Aplastic and other anaemias

495

1871

2.45

72.54

1.4

0.43

g/l

0.00

321

1362

Symptoms and signs involving the skin and subcutaneous tissue

793

3749

2.01

72.52

1.5

1.4

0.37

0.41

g/l

2.91

612

2704

Other headache syndromes

488

2013

2.44

72.50

1.4

0.37

0.43

g/l

2.05

363

1477

Episodal and paroxysmal disorders

1095

2967

1.88

72.27

1.4

0.38

0.42

g/l

2.55

780

2171

Soft tissue disorders

1017

2717

1.93

72.19

1.4

0.39

0.40

g/l

0.21

743

1921

Caries of dentine

298

921

3.17

72.00

1.5

1.3

0.40

0.42

g/l

0.39

224

644

Eosinophilia

14.30

71.94

1.6

1.3

0.68

0.46

g/l

0.40

Rheumatoid arthritis

368

1165

2.83

71.69

1.5

1.4

0.42

g/l

0.03

283

836

Implicit fungal Sepsis, including avohilmo

134

240

5.79

71.67

1.4

0.39

0.40

g/l

0.12

182

Liquid cancers, including Hilmo

425

1445

2.63

71.47

1.4

0.37

0.43

g/l

1.50

301

1057

Other dorsopathies, not elsewhere classified

996

2695

1.93

71.25

1.4

0.38

0.42

g/l

2.42

735

1901

Other chronic obstructive pulmonary disease

399

1212

2.72

70.95

1.4

1.3

0.45

g/l

0.03

295

847

Respiratory insufficiency

119

8.13

70.58

1.4

1.3

0.38

0.48

g/l

1.38

Sleep apnoea

979

3261

1.91

70.52

1.4

0.38

0.42

g/l

1.06

676

2367

Other joint disorders

886

2327

2.00

69.82

1.4

0.39

0.40

g/l

0.13

654

1659

Sarcoidosis

210

553

3.90

69.79

1.4

1.3

0.48

0.41

g/l

0.33

141

408

Certain infectious and parasitic diseases, including avohilmo

668

1502

2.24

69.54

1.4

0.39

0.42

g/l

0.85

491

1049

L04AD Calcineurin inhibitors

205

533

3.98

69.53

1.4

0.43

0.39

g/l

0.67

144

390

Mycoses

372

1384

2.73

69.26

1.5

1.4

0.43

0.42

g/l

0.12

260

994

Neurological diseases

852

2125

2.03

69.00

1.4

0.37

0.43

g/l

3.19

602

1551

Other noninfective gastroenteritis and colitis

330

1156

2.90

68.76

1.5

1.3

0.36

0.40

g/l

1.46

241

843

Migraine

580

2017

2.26

68.60

1.4

0.35

0.41

g/l

3.85

434

1496

Cardiac arrhythmias

658

1950

2.18

68.45

1.3

1.4

0.42

0.39

g/l

0.51

471

1445

Other and unspecified anaemias

454

1745

2.47

68.23

1.4

0.43

g/l

0.04

296

1268

Intestinal infectious diseases, including avohilmo, including avohilmo

1157

3596

1.80

68.18

1.4

0.38

0.41

g/l

1.96

849

2574

Sciatica+with lumbago

550

2170

2.27

67.32

1.4

0.39

0.43

g/l

0.69

419

1530

Other anaemias

455

1756

2.45

67.30

1.4

0.43

g/l

0.02

297

1278

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

964

4074

1.86

66.82

1.5

1.4

0.40

g/l

0.02

717

2928

Dorsopathies

1008

2724

1.89

66.76

1.4

0.37

0.42

g/l

3.27

731

1926

All kidney diseases

1013

3708

1.84

66.70

1.5

1.4

0.43

0.40

g/l

1.00

712

2712

Diseases of the eye and adnexa

807

1995

2.04

66.55

1.4

1.3

0.39

0.41

g/l

0.29

595

1417

Symptoms and signs concerning food and fluid intake

160

355

4.61

66.48

1.5

1.3

0.43

0.42

g/l

0.13

117

272

Fibrosis and cirrhosis of liver

139

276

5.22

66.38

1.2

1.4

0.73

0.40

g/l

2.66

104

204

Fibromyalgia

154

333

4.75

66.35

1.6

1.3

0.33

0.38

g/l

1.23

119

234

Diseases of the musculoskeletal system and connective tissue

519

1065

2.46

66.14

1.4

1.3

0.38

0.39

g/l

0.24

372

752

Hypertensive diseases (excluding secondary)

553

1391

2.33

65.63

1.5

1.3

0.38

0.40

g/l

0.59

383

1015

Hypothyroidism, levothyroxine purchases

272

439

3.51

65.52

1.4

1.3

0.36

0.43

g/l

0.95

182

326

Hypothyroidism and >3 levothyroxin purchases

272

439

3.51

65.52

1.4

1.3

0.36

0.43

g/l

0.95

182

326

Pleural effusion

192

496

3.95

65.40

1.6

1.4

0.44

g/l

0.08

127

365

Complications of medical and surgical care

772

3569

1.96

64.80

1.4

0.37

0.42

g/l

2.45

567

2589

ILD-related respiratory insufficiency

9.39

64.60

1.2

0.42

0.41

g/l

0.03

Hypothyroidism (congenital or acquired)

272

443

3.48

64.56

1.5

1.3

0.36

0.43

g/l

1.09

182

330

Pneumocystosis

11.49

63.96

1.6

1.4

0.43

0.47

g/l

0.21

Pneumocystosis, including avohilmo

11.49

63.96

1.6

1.4

0.43

0.47

g/l

0.21

Complications of procedures, not elsewhere classified

835

3546

1.91

63.85

1.4

0.41

g/l

0.02

621

2549

Methotrexate

159

363

4.46

63.84

1.6

1.2

0.37

0.42

g/l

0.92

119

261

Persons encountering health services in other circumstances

480

2068

2.32

63.56

1.4

0.34

0.43

g/l

6.04

304

1457

Diseases of the digestive system

491

2151

2.29

62.97

1.6

1.4

0.42

0.43

g/l

0.18

345

1538

Sleep apnoea, including avohilmo

1006

3354

1.83

62.97

1.4

0.36

0.42

g/l

4.07

694

2435

Abnormalities of heart beat

349

1273

2.69

62.96

1.3

1.4

0.39

0.43

g/l

0.40

247

886

Protozoal diseases, including avohilmo

109

8.32

62.78

1.5

1.4

0.44

g/l

0.01

Inflammatory bowel disease

401

1629

2.50

62.36

1.3

1.4

0.39

0.40

g/l

0.23

271

1167

Viral infections characterized by skin and mucous membrane lesions

498

2224

2.26

62.17

1.5

1.4

0.35

0.41

g/l

2.86

376

1607

Arthropathies

884

2338

1.92

62.05

1.3

1.4

0.40

g/l

0.01

656

1670

Infection due to other mycobacteria

15.77

62.04

1.4

0.45

0.41

g/l

0.14

Sleep disorders (combined)

1073

3146

1.79

61.18

1.4

0.36

0.42

g/l

5.09

756

2291

Cholecystectomy

720

3124

1.97

61.09

1.4

0.40

0.42

g/l

0.53

479

2298

Protozoal diseases

107

8.29

61.06

1.5

1.4

0.45

0.44

g/l

0.04

Urticaria and erythema

446

1924

2.35

60.59

1.5

1.4

0.36

0.40

g/l

1.97

344

1396

Chronic laryngitis and laryngotracheitis

186

497

3.82

60.46

1.4

1.3

0.35

0.44

g/l

2.83

140

342

Other intervertebral disc disorders

787

2417

1.95

60.39

1.4

0.40

0.42

g/l

0.39

578

1696

Colitis, primary sclerosing

12.13

60.08

1.4

1.3

0.50

0.34

g/l

1.62

Hypopituitarism

150

345

4.51

60.07

1.6

1.3

0.39

0.38

g/l

0.08

259

Biological medication for rheuma

275

943

2.98

59.91

1.3

1.4

0.41

0.39

g/l

0.41

189

673

Fungal Sepsis

136

7.08

59.72

1.5

1.3

0.41

0.38

g/l

0.24

102

Implicit fungal Sepsis

121

7.54

59.70

1.5

1.3

0.40

0.39

g/l

0.06

Other diseases of liver

254

836

3.10

59.44

1.3

0.43

0.38

g/l

1.11

172

610

Other general symptoms and signs

105

177

6.09

59.08

1.7

1.3

0.34

0.41

g/l

0.96

139

Persons encountering health services in other circumstances, wide

1103

3251

1.75

58.34

1.5

1.4

0.37

0.42

g/l

3.23

825

2301

Persons encountering health services for specific procedures and health care

1077

3659

1.75

58.08

1.4

0.40

g/l

0.02

784

2644

Voice disturbances

331

1272

2.64

57.89

1.5

1.4

0.39

0.40

g/l

0.19

249

913

Depression medications

291

467

3.16

57.82

1.3

0.37

0.43

g/l

0.84

206

349

Primary biliary cholangitis, wide definition

11.60

57.80

1.3

1.5

0.92

0.32

g/l

1.94

Dysphagia

266

913

2.95

57.62

1.4

1.3

0.36

0.44

g/l

3.25

188

673

Myalgia

292

1059

2.80

57.17

1.5

1.3

0.35

0.41

g/l

2.86

214

737

Coagulation defects, purpura and other haemorrhagic conditions

267

924

2.94

57.16

1.6

1.4

0.38

0.40

g/l

0.22

202

664

Anxiety disorders, excluding more controls

846

2928

1.86

56.82

1.5

1.4

0.36

0.42

g/l

3.94

643

2094

Persons encountering health services for examination and investigation

567

1300

2.20

56.70

1.4

1.3

0.40

0.42

g/l

0.71

440

798

Functional dyspepsia

310

1165

2.70

56.63

1.5

1.4

0.35

0.42

g/l

2.64

229

827

Rheumatoid arthritis, including avohilmo

420

1826

2.33

56.11

1.5

1.4

0.42

0.41

g/l

0.13

316

1297

Constipation

893

3367

1.81

55.71

1.4

0.38

0.41

g/l

0.79

628

2480

Disorders of conjunctiva

874

3776

1.81

55.63

1.5

1.4

0.38

0.41

g/l

0.75

670

2705

Seropositive rheumatoid arthritis

263

910

2.91

55.54

1.5

1.3

0.42

0.41

g/l

0.16

207

639

Endocrine, nutritional and metabolic diseases

776

2042

1.93

55.21

1.4

1.3

0.39

0.41

g/l

0.41

529

1518

Antihypertensive medication - note that there are other indications

635

1619

2.06

54.73

1.4

1.3

0.34

0.41

g/l

3.69

453

1188

Infection due to other mycobacteria, including avohilmo

12.64

54.71

1.4

0.45

0.40

g/l

0.26

All chronic kidney diseases

557

2153

2.08

54.11

1.5

1.4

0.45

0.42

g/l

0.81

395

1558

Ulcerative colitis

310

1194

2.64

54.01

1.3

0.41

g/l

0.02

210

858

Chronic kidney disease

325

1226

2.58

54.00

1.5

1.4

0.48

0.44

g/l

0.66

221

888

Renal failure

464

1795

2.22

53.99

1.5

1.4

0.50

0.43

g/l

1.63

313

1281

Bleeding

813

3120

1.84

53.96

1.4

0.42

0.40

g/l

0.51

585

2249

Symptoms and signs involving the nervous and musculoskeletal systems

605

3075

1.98

53.77

1.6

1.4

0.37

0.41

g/l

1.84

448

2230

Primary biliary cholangitis (PBC)

11.44

53.54

1.2

1.00

0.32

g/l

2.24

Atypical mycobacterium lung infection

21.38

53.45

1.4

1.3

0.43

0.46

g/l

0.08

Intestinal malabsorption

156

6.21

53.40

1.5

1.3

0.40

0.38

g/l

0.17

119

Other disorders of fluid, electrolyte and acid-base balance

338

1278

2.52

53.23

1.5

1.4

0.41

0.45

g/l

0.80

228

915

Rheumatism, unspecified

177

501

3.61

52.93

1.8

1.4

0.47

0.41

g/l

0.34

134

356

Purpura and other haemorrhagic conditions

197

598

3.37

52.87

1.6

1.4

0.42

0.41

g/l

0.13

145

432

Other pleural conditions

127

284

4.57

52.49

1.5

1.4

0.46

0.43

g/l

0.22

210

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

143

6.40

52.13

1.7

1.4

0.47

0.40

g/l

0.40

108

COPD, hospital admission 2, with asthma infections

322

1091

2.57

51.84

1.5

1.4

0.43

0.44

g/l

0.29

239

774

Symptoms and signs involving speech and voice

375

1611

2.36

51.58

1.4

0.38

0.41

g/l

0.67

280

1150

Renal tubulo-interstitial diseases

853

3536

1.78

51.21

1.5

1.4

0.43

0.40

g/l

0.87

595

2582

Other diseases of pericardium

140

6.38

50.86

1.5

1.2

0.37

0.39

g/l

0.16

100

Osteoporosis with pathological fracture (FG)

184

5.52

50.85

1.6

1.2

0.32

0.44

g/l

2.37

139

Lumbar disc prolapse

613

2320

1.97

50.72

1.4

0.41

0.42

g/l

0.11

448

1627

Other disorders of skin and subcutaneous tissue

720

3309

1.85

50.42

1.4

0.40

0.42

g/l

0.64

539

2390

Atrial fibrillation and flutter

312

766

2.66

49.90

1.3

0.41

0.42

g/l

0.22

226

546

COPD, hospital admissions 3, with asthma pneumonia sepsis

271

854

2.75

49.89

1.5

1.4

0.42

0.43

g/l

0.28

207

612

Nerve, nerve root and plexus disorders

1014

3610

1.70

49.56

1.4

0.39

0.41

g/l

1.12

724

2598

Drug-induced osteoporosis with pathological fracture

12.57

49.53

1.8

1.3

0.35

0.39

g/l

0.29

Spondylosis

506

1912

2.08

49.33

1.5

1.4

0.36

0.44

g/l

4.15

341

1344

Non-Hodgkin lymphoma, all, including Hilmo

174

512

3.47

49.08

1.5

1.4

0.32

0.41

g/l

3.01

124

378

Polymyalgia rheumatica

152

409

3.79

48.98

1.5

1.3

0.42

g/l

0.03

113

301

Mycoses, including avohilmo

916

4087

1.72

48.96

1.4

0.39

0.41

g/l

0.66

669

2940

Other symptoms and signs involving the nervous and musculoskeletal systems

457

2176

2.12

48.79

1.6

1.4

0.37

0.42

g/l

1.58

331

1563

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

604

3108

1.92

48.73

1.4

0.38

0.42

g/l

1.68

446

2244

Ulcerative colitis, NAS

202

655

3.15

48.65

1.4

0.40

0.39

g/l

0.20

141

475

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1030

3251

1.69

48.58

1.5

1.4

0.37

0.42

g/l

4.44

816

2301

Neoplasms

751

2132

1.86

48.37

1.4

0.40

g/l

0.01

522

1569

Abnormal results of function studies

136

342

4.08

48.35

1.5

1.3

0.44

0.41

g/l

0.43

250

Erysipelas, including avohilmo

664

2626

1.89

48.28

1.5

1.4

0.41

g/l

0.10

489

1876

Anxiety disorders

903

3612

1.73

48.24

1.5

1.4

0.36

0.41

g/l

3.24

688

2570

Nutritional anaemias

500

2349

2.05

48.18

1.5

1.4

0.38

0.42

g/l

1.50

368

1691

Conjunctivitis

787

3585

1.78

48.15

1.5

1.4

0.37

0.41

g/l

0.86

610

2569

Later onset COPD, excluding more controls

145

274

4.08

47.95

1.2

0.54

0.45

g/l

1.08

108

184

Other and unspecified iron deficiency

370

1627

2.30

47.95

1.4

0.38

0.42

g/l

1.50

267

1168

Abnormal findings on diagnostic imaging of other body structures

179

546

3.34

47.66

1.5

1.3

0.42

0.39

g/l

0.36

120

397

Pneumonia due to Streptococcus pneumoniae

123

6.58

47.58

1.4

1.2

0.36

0.42

g/l

0.60

Metabolic disorders

912

3187

1.73

47.53

1.5

1.4

0.39

0.41

g/l

0.63

654

2309

Chronic hepatitis, not elsewhere classified

114

6.90

47.51

1.5

1.4

0.50

0.30

g/l

3.70

Neurotic, stress-related and somatoform disorders

894

3597

1.72

47.51

1.5

1.4

0.36

0.41

g/l

3.20

683

2556

Diaphragmatic hernia

366

1622

2.28

46.83

1.4

0.38

0.42

g/l

1.09

285

1165

Pulmonary heart disease, diseases of pulmonary circulation

326

1378

2.39

46.53

1.4

0.39

0.45

g/l

1.54

244

985

Migraine without aura

245

907

2.74

46.21

1.4

0.34

0.39

g/l

2.51

185

676

Iron deficiency anaemia

440

2068

2.11

46.04

1.5

1.4

0.38

0.43

g/l

1.82

319

1489

Abnormal serum enzyme levels

309

1236

2.44

45.77

1.5

1.4

0.41

0.44

g/l

0.56

234

900

Tumor necrosis factor alpha inhibitors

233

851

2.79

45.30

1.3

1.4

0.40

0.39

g/l

0.26

161

597

Giant cell arteritis

104

6.99

45.19

1.2

1.5

0.38

0.42

g/l

0.19

Aspergillosis, including avohilmo

15.42

44.98

1.4

1.3

0.38

0.41

g/l

0.11

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

428

1243

2.19

44.96

1.5

1.3

0.40

0.41

g/l

0.05

289

900

Explicit bacterial Sepsis, including avohilmo

141

383

3.75

44.87

1.4

0.40

g/l

0.01

288

Syncope and collapse

383

1449

2.22

44.68

1.4

0.40

0.43

g/l

0.53

273

1044

Benign neoplasm of colon, rectum, anus and anal canal

591

2658

1.89

44.64

1.5

1.4

0.41

0.42

g/l

0.30

457

1884

Acute renal failure

242

907

2.71

44.61

1.5

1.4

0.49

0.44

g/l

0.55

152

657

Explicit bacterial Sepsis

138

371

3.79

44.59

1.4

0.39

0.41

g/l

0.19

282

Other chronic obstructive pulmonary disease, including avohilmo

490

2013

2.02

44.09

1.5

1.4

0.43

0.42

g/l

0.18

360

1442

Early onset COPD

246

940

2.66

43.68

1.6

1.4

0.40

0.42

g/l

0.32

182

663

Colitis, primary sclerosing, strict definition

10.97

43.57

1.4

1.3

0.48

0.29

g/l

2.04

Inflammatory diseases of the central nervous system

129

337

3.93

43.56

1.4

0.35

0.38

g/l

0.54

101

239

Diverticular disease of intestine

628

2098

1.88

43.36

1.6

1.4

0.41

0.42

g/l

0.11

481

1507

Mood disorders, excluding more controls

879

3053

1.70

43.35

1.4

0.38

0.42

g/l

1.85

635

2178

Aspergillosis

15.05

43.28

1.4

1.3

0.39

0.41

g/l

0.06

Other/unspecified dorsalgia

367

1660

2.20

43.20

1.3

1.4

0.35

0.43

g/l

4.13

269

1181

Urticaria

353

1595

2.24

43.18

1.5

1.4

0.35

0.39

g/l

1.83

275

1157

Chronic diseases of tonsils and adenoids

675

2344

1.83

43.09

1.3

0.39

0.42

g/l

1.63

523

1613

Candidiasis

190

641

3.02

42.76

1.5

1.3

0.41

g/l

0.05

137

460

Heart failure,strict

456

1551

2.07

42.59

1.4

0.50

0.42

g/l

1.36

321

1091

Diseases of middle ear and mastoid

597

2638

1.86

42.56

1.4

0.38

0.40

g/l

0.49

433

1894

Polyarthrosis

218

706

2.82

42.47

1.6

1.5

0.40

0.42

g/l

0.21

154

514

Depression

924

3749

1.66

42.40

1.4

0.38

0.41

g/l

1.52

673

2690

Heart failure and antihypertensive medication

251

606

2.72

42.18

1.5

1.3

0.50

0.44

g/l

0.37

181

442

Other antidepressants

941

2894

1.67

41.85

1.4

0.36

0.42

g/l

4.92

664

2093

Spondyloarthritis

200

704

2.88

41.58

1.4

1.3

0.39

0.40

g/l

0.09

138

508

Benign neoplasms

913

2988

1.67

41.51

1.4

0.37

0.42

g/l

4.06

649

2139

Other specified/unspecified necrotizing vasculopathies

13.01

41.51

1.4

0.41

0.35

g/l

0.26

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

932

3595

1.65

41.32

1.4

0.39

0.41

g/l

0.83

665

2658

Noninfectious colitis NAS

181

608

3.03

41.06

1.5

1.3

0.36

0.40

g/l

0.91

139

449

Migraine with aura

273

1128

2.45

41.05

1.4

0.35

0.39

g/l

1.57

210

826

Diseases of arteries, arterioles and capillaries (FINNGEN)

230

577

2.78

40.95

1.4

0.48

0.44

g/l

0.39

170

412

Hypothyroidism, drug reimbursement

142

267

3.76

40.91

1.8

1.3

0.39

0.46

g/l

0.50

105

201

COPD, hospital admissions

396

1591

2.11

40.82

1.4

0.45

0.43

g/l

0.45

293

1123

Benign neoplasm: Colon

501

2457

1.93

40.78

1.5

1.4

0.41

0.43

g/l

0.29

388

1747

Ischemic heart diseases

761

2620

1.74

40.77

1.4

0.42

0.40

g/l

0.23

547

1889

Drug-induced cataract

7.94

40.72

1.5

1.3

0.38

g/l

0.03

Recurrent or chronic depression

415

1378

2.11

40.66

1.3

1.4

0.34

0.43

g/l

4.28

304

1000

Hypermobility syndrome

216

4.64

40.58

1.7

1.4

0.32

0.38

g/l

1.03

163

COPD, early/later onset

399

1606

2.10

40.51

1.4

0.45

0.43

g/l

0.49

295

1134

Pulmonary eosinophilia, not elsewhere classified

14.23

40.45

1.7

1.4

0.33

0.39

g/l

0.31

IBD patients in KELA-register

274

1146

2.42

40.24

1.2

1.4

0.41

g/l

0.04

178

828

Personal history of allergy to drugs, medicaments and biological substances

11.18

40.13

1.6

1.1

0.33

0.39

g/l

0.44

Disorders of orbit

153

5.42

40.03

1.7

1.4

0.32

0.39

g/l

1.05

113

Non-invasive ventilation

230

754

2.66

39.91

1.3

1.4

0.34

0.42

g/l

2.03

103

557

Visual disturbances and blindness

521

2788

1.88

39.79

1.5

1.4

0.35

0.42

g/l

4.24

398

2005

Ulcerative colitis (strict) with PSC

14.86

39.79

1.3

0.46

0.27

g/l

1.18

Visual disturbances

493

2596

1.92

39.74

1.6

1.4

0.35

0.41

g/l

3.77

377

1867

Disorders of sclera, cornea, iris and ciliary body

549

2993

1.85

39.67

1.5

1.4

0.38

0.41

g/l

1.23

394

2166

Atopic dermatitis, strict definition with reimbursement

338

1488

2.21

39.65

1.4

1.3

0.35

0.40

g/l

1.63

261

1070

Hypertension, essential

720

2328

1.76

39.61

1.4

0.38

0.40

g/l

0.51

511

1674

Erysipelas

485

2172

1.94

39.56

1.5

1.4

0.42

0.41

g/l

0.17

361

1546

IBD (strict) with PSC

12.28

39.53

1.3

0.49

0.30

g/l

1.37

Herpesviral [herpes simplex] infections

165

538

3.13

39.49

1.5

1.4

0.37

0.41

g/l

0.60

127

390

Infections of the skin and subcutaneous tissue

594

3265

1.80

39.44

1.4

0.41

0.40

g/l

0.13

450

2333

Spondylopathies (FG)

166

543

3.11

39.43

1.5

1.3

0.39

g/l

0.09

117

375

Multiple myeloma, including Hilmo

127

5.86

39.26

1.4

0.32

0.39

g/l

0.28

Care involving use of rehabilitation procedures

620

3145

1.78

39.24

1.4

0.42

0.41

g/l

0.14

444

2285

Hypertensive diseases

745

2434

1.74

39.23

1.4

0.39

0.40

g/l

0.22

530

1758

Other gastritis (incl. Duodenitis)

224

862

2.63

39.22

1.5

1.4

0.42

0.46

g/l

0.55

173

614

Percutaneous Coronary Intervention

715

2502

1.75

39.20

1.4

0.42

0.41

g/l

0.32

533

1807

Unspecified jaundice

127

5.83

39.20

2.0

1.2

0.44

0.42

g/l

0.13

103

Shoulder lesions

651

2181

1.80

39.17

1.4

0.42

0.41

g/l

0.24

485

1528

Nonsuppurative otitis media

274

994

2.42

39.06

1.5

1.3

0.38

0.39

g/l

0.17

207

719

Crohn disease

181

628

2.94

38.82

1.2

1.3

0.37

0.39

g/l

0.25

124

457

Streptococcal septicaemia, including avohilmo

119

319

3.81

38.71

1.5

1.3

0.41

0.40

g/l

0.13

247

Pulmonary embolism

290

1264

2.32

38.70

1.5

1.4

0.38

0.44

g/l

1.96

213

909

Hypertension

742

2432

1.73

38.62

1.4

0.39

0.40

g/l

0.26

527

1757

Gout

239

807

2.57

38.62

1.4

1.5

0.42

0.43

g/l

0.03

165

568

Suppurative and unspecified otitis media

403

1759

2.05

38.52

1.4

0.38

0.39

g/l

0.12

299

1261

Mood disorders

959

3841

1.60

38.48

1.4

0.38

0.41

g/l

1.67

695

2766

Pollen allergy

250

1009

2.48

38.44

1.5

1.4

0.34

0.37

g/l

0.80

216

719

Concussion

458

1816

1.97

38.33

1.5

1.4

0.39

0.42

g/l

1.04

334

1321

Unspecified chronic bronchitis

7.56

38.30

1.3

0.33

0.45

g/l

1.04

Pulmonary heart disease

290

1271

2.31

38.21

1.5

1.4

0.38

0.44

g/l

2.03

213

917

Mood [affective] disorders

956

3840

1.60

38.20

1.4

0.38

0.41

g/l

1.64

693

2765

Intracranial trauma

515

1836

1.91

38.16

1.5

1.4

0.39

0.42

g/l

0.85

372

1337

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

369

1783

2.09

38.11

1.7

1.3

0.33

0.41

g/l

3.74

224

1292

Spinal stenosis

428

1574

2.02

38.02

1.4

0.39

0.45

g/l

1.84

320

1108

Streptococcal septicaemia

116

310

3.82

37.91

1.5

1.3

0.39

0.40

g/l

0.06

241

Hypothyroidism, strict autoimmune

580

2090

1.83

37.76

1.4

0.41

g/l

0.04

414

1540

Temporomandibular joint disorders, including avohilmo

474

2424

1.91

37.70

1.5

1.4

0.36

0.39

g/l

1.14

347

1776

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

551

2919

1.82

37.69

1.6

1.3

0.34

0.40

g/l

2.99

433

2096

Depression or dysthymia

614

1852

1.82

37.66

1.4

0.39

0.43

g/l

1.16

436

1335

Emergency coronary revascularization (for ACS)

751

2676

1.70

37.57

1.4

0.42

0.41

g/l

0.26

558

1915

Glomerular diseases

210

802

2.66

37.46

1.7

1.3

0.45

0.43

g/l

0.17

146

579

Coronary revascularization (ANGIO or CABG)

709

2506

1.73

37.40

1.4

0.42

0.41

g/l

0.29

529

1809

Zoster [herpes zoster], including avohilmo

487

2509

1.89

37.38

1.5

1.4

0.37

0.42

g/l

1.62

372

1788

Hard cardiovascular diseases

760

2661

1.70

37.31

1.4

0.42

0.40

g/l

0.33

563

1898

Inflammatory bowel disease, strict (require KELA)

274

1186

2.34

37.28

1.2

1.4

0.41

0.40

g/l

0.06

178

860

Disturbances of skin sensation

311

1420

2.22

37.19

1.3

0.36

0.41

g/l

1.76

230

1007

Multiple myeloma and malignant plasma cell neoplasms

141

5.42

37.16

1.4

1.3

0.34

0.47

g/l

0.67

103

Acute suppurative otitis media

315

1341

2.21

37.12

1.4

0.39

g/l

0.09

235

961

Dialysis, with operation codes

161

537

3.06

37.07

1.4

0.44

0.39

g/l

0.60

114

393

All influenza (not pneumonia)

168

575

2.97

36.85

1.4

1.3

0.35

0.42

g/l

2.38

121

408

Benign neoplasm of other and ill-defined parts of digestive system

202

763

2.69

36.84

1.5

1.3

0.37

0.40

g/l

0.58

152

541

Nephropathy related operations

157

520

3.08

36.62

1.5

1.4

0.45

0.40

g/l

0.55

111

384

Benzodiazepine use

927

3946

1.59

36.56

1.4

0.36

0.42

g/l

3.96

665

2848

Nonsuppurative otitis media, including avohilmo

353

1458

2.11

36.55

1.5

1.3

0.43

0.39

g/l

0.37

273

1043

Other nutritional deficiencies

661

3548

1.71

36.34

1.4

0.39

0.41

g/l

0.29

485

2587

SLE (Finngen)

6.39

36.24

1.5

1.4

0.52

0.37

g/l

0.95

Alcohol-induced acute pancreatitis

134

5.52

36.14

1.3

0.42

0.40

g/l

0.19

Collagenous colitis

127

374

3.47

35.96

1.4

0.35

0.40

g/l

0.77

271

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

536

2985

1.80

35.83

1.4

0.37

0.42

g/l

2.70

393

2149

Major coronary heart disease event

741

2641

1.69

35.78

1.4

0.42

0.41

g/l

0.25

546

1892

Polyarteritis nodosa and related conditions

10.72

35.78

1.6

1.3

0.38

g/l

0.00

Other bacterial intestinal infections

199

758

2.66

35.66

1.4

1.3

0.39

0.42

g/l

0.53

148

543

Transplanted organ and tissue status

138

431

3.27

35.57

1.5

1.4

0.45

0.42

g/l

0.29

330

Cholecystitis

140

440

3.23

35.56

2.1

1.2

0.46

0.42

g/l

0.48

324

Urinary track infection

565

1541

1.85

35.54

1.5

1.4

0.38

0.40

g/l

0.69

421

1128

Personal history of allergy to analgesic agent

15.86

35.45

1.4

1.1

0.27

0.34

g/l

0.61

Anxiety (asthma-related co-morbidities)

611

2666

1.75

35.44

1.4

0.38

0.40

g/l

0.79

475

1925

Corticotropin deficiency

12.16

35.28

2.0

1.4

0.47

0.32

g/l

0.75

Pneumonia derived septicemia

106

6.07

34.98

1.5

1.3

0.39

0.44

g/l

0.39

Diseases of the ear and mastoid process

1032

3334

1.56

34.85

1.4

0.39

0.41

g/l

0.76

741

2423

Other and unspecified disorders of white blood cells

131

5.46

34.84

1.4

1.3

0.68

0.41

g/l

0.42

COPD related to multimorbidity

335

1349

2.12

34.76

1.4

0.44

g/l

0.02

243

947

Other reaction to severe stress, and adjustment disorders

382

1932

1.99

34.69

1.6

1.4

0.35

0.41

g/l

2.76

287

1383

Heart failure, strict

482

1792

1.88

34.61

1.4

0.50

0.42

g/l

1.34

340

1280

Abnormal weight loss

122

359

3.47

34.59

1.4

0.43

0.41

g/l

0.28

269

Disorders of synovium and tendon

481

2212

1.86

34.42

1.5

1.4

0.38

0.41

g/l

1.18

348

1560

DVT of lower extremities and pulmonary embolism

375

1883

2.00

34.36

1.4

0.39

0.44

g/l

1.70

270

1353

Other complications of surgical and medical care, not elsewhere classified

130

400

3.32

34.33

1.3

1.4

0.40

0.41

g/l

0.16

102

288

Enterocolitis due to Clostridium difficile

122

361

3.44

34.23

1.4

0.41

0.40

g/l

0.10

271

Allergic conjunctivitis

571

3162

1.75

34.18

1.6

1.3

0.35

0.41

g/l

2.91

450

2271

Herpesviral [herpes simplex] infections, including avohilmo

290

1334

2.20

34.11

1.4

0.46

0.40

g/l

0.54

218

946

Viral pneumonia (unknown virus, not influenza)

247

4.02

34.03

1.2

1.3

0.39

g/l

0.02

180

Polypectomy (DHB20)

252

4.00

33.96

2.0

1.3

0.35

0.40

g/l

0.90

179

Any mental disorder

969

3104

1.57

33.88

1.4

0.39

0.42

g/l

1.52

705

2219

Mucosal proctocolitis

167

599

2.84

33.74

1.4

1.3

0.44

0.39

g/l

0.82

110

439

Other and unspecified tonsillitis

327

1299

2.11

33.56

1.4

0.36

0.41

g/l

1.28

247

894

Seropositive rheumatoid arthritis, wide

263

1171

2.27

33.51

1.5

1.4

0.42

0.41

g/l

0.20

207

832

All-cause Heart Failure

473

1769

1.87

33.46

1.4

0.50

0.42

g/l

1.33

335

1268

Weight loss

131

412

3.24

33.39

1.4

0.42

0.40

g/l

0.17

307

All anxiety disorders

621

2830

1.71

33.38

1.4

0.38

0.40

g/l

1.00

483

2016

Cerebrovascular diseases (FINNGEN)

276

852

2.29

33.35

1.3

0.43

g/l

0.02

205

608

Venous thromboembolism

475

2515

1.83

33.25

1.5

1.4

0.39

0.42

g/l

0.76

342

1809

Suppurative and necrotic conditions of lower respiratory tract

192

4.45

33.12

1.4

1.2

0.38

0.42

g/l

0.46

137

Atrial fibrillation and flutter with reimbursement

225

563

2.54

33.09

1.4

0.42

0.44

g/l

0.11

158

407

Postviral fatigue syndrome

12.92

32.99

2.0

1.4

0.33

0.39

g/l

0.41

Rotator cuff syndrome

520

1991

1.81

32.97

1.4

0.47

0.41

g/l

0.71

395

1393

Other symptoms and signs involving the digestive system and abdomen

167

606

2.79

32.91

1.4

1.3

0.37

0.43

g/l

0.79

111

459

Drug-induced osteoporosis

9.58

32.88

2.3

1.4

0.34

0.37

g/l

0.16

Congenital malformations of the respiratory system, including avohilmo

6.79

32.80

1.5

1.4

0.40

0.38

g/l

0.08

Pain in thoracic spine

167

609

2.78

32.64

1.4

1.3

0.39

0.44

g/l

0.98

132

425

Thrombocytopenia, unspecified

100

269

3.81

32.49

1.7

1.3

0.46

0.41

g/l

0.41

192

Other disorders of urethra and urinary system

628

2581

1.70

32.36

1.4

0.38

0.42

g/l

1.32

451

1886

Conjunctivitis (acute, non atopic), including avohilmo

901

3492

1.56

32.34

1.5

1.4

0.38

0.42

g/l

0.91

678

2466

Bacterial intestinal infections, IBD co-morbidities

198

791

2.54

32.24

1.4

1.3

0.39

0.41

g/l

0.33

148

566

Disorders of skin appendages

499

2802

1.78

32.22

1.4

0.42

0.40

g/l

0.28

375

2024

Continuous positive airway pressure

171

518

2.78

32.16

1.4

1.3

0.33

0.43

g/l

1.98

153

386

Somatoform disorder

188

738

2.58

31.78

1.4

1.3

0.31

0.41

g/l

4.20

140

511

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

625

3421

1.67

31.70

1.4

0.40

0.39

g/l

0.10

447

2474

Sequelae with surgical and medical care as external cause

219

924

2.40

31.69

1.5

1.4

0.40

0.43

g/l

0.45

164

648

Systemic lupus erythematosus

113

5.59

31.66

1.5

1.3

0.52

0.35

g/l

1.14

Other/unspecified seropositive rheumatoid arthritis

256

1156

2.24

31.56

1.5

1.4

0.42

0.41

g/l

0.19

203

819

Migraine with aura and triptan purchases

197

794

2.52

31.52

1.4

0.34

0.38

g/l

1.07

154

575

Secondary hypertension

243

3.88

31.43

1.3

1.2

0.45

0.48

g/l

0.16

176

COPD, hospital admissions 1, only main diagnosis

288

1159

2.15

31.42

1.3

1.4

0.46

0.44

g/l

0.17

215

824

Adalimumab

143

491

2.97

31.40

1.3

1.4

0.42

0.38

g/l

0.48

102

351

Iridocyclitis

244

1085

2.28

31.25

1.5

1.4

0.37

0.41

g/l

1.11

179

776

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

253

1147

2.23

30.91

1.5

1.4

0.41

g/l

0.10

200

814

Polyneuropathies and other disorders of the peripheral nervous system

220

941

2.37

30.86

1.4

0.43

0.44

g/l

0.10

169

674

Hypo-osmolality and hyponatraemia

178

686

2.61

30.67

1.4

0.40

0.43

g/l

0.53

113

492

Paralytic ileus and intestinal obstruction

230

1005

2.31

30.57

1.4

0.41

0.44

g/l

0.63

158

710

Other bacterial intestinal infections, including avohilmo

237

1051

2.28

30.53

1.3

0.40

0.41

g/l

0.09

179

747

Other and unspecified polyneuropathies, also in other diseases

195

795

2.49

30.45

1.4

0.43

0.42

g/l

0.11

151

574

Congenital malformations, deformations and chromosomal abnormalities

569

3202

1.69

30.44

1.5

1.4

0.40

0.39

g/l

0.08

406

2322

Cervicobrachial syndrome

218

934

2.36

30.43

1.6

1.3

0.39

0.45

g/l

1.26

175

653

Alcohol-induced chronic pancreatitis

259

3.77

30.35

1.3

0.41

0.40

g/l

0.03

190

Symptoms and signs involving cognition, perception, emotional state and behaviour

866

3756

1.55

30.22

1.4

0.40

0.41

g/l

0.18

633

2721

Disorders of lens

575

2083

1.72

30.22

1.4

0.41

0.42

g/l

0.32

413

1541

Congenital malformations of the respiratory system

6.91

30.17

1.5

1.4

0.36

0.39

g/l

0.25

Temporal arteritis

6.08

30.10

1.2

1.5

0.32

0.42

g/l

1.01

Other Crohn's disease

103

298

3.54

30.08

1.3

0.41

0.38

g/l

0.17

213

Pericarditis

5.85

30.03

1.4

1.2

0.41

0.39

g/l

0.15

Deviated nasal septum

284

1362

2.10

29.91

1.3

1.4

0.40

0.43

g/l

0.73

199

917

Non-follicular lymphoma

112

343

3.33

29.87

1.5

1.4

0.32

0.41

g/l

2.09

250

Gout, FINNGEN

239

1068

2.24

29.68

1.4

0.42

0.45

g/l

0.45

165

760

Other specified/unspecified inflammatory spondylopathies

171

4.45

29.60

1.6

1.4

0.40

0.42

g/l

0.18

120

Factors influencing health status and contact with health services

218

437

2.52

29.57

1.3

1.4

0.39

0.43

g/l

0.57

159

291

Migraine without aura and triptan purchases

199

831

2.43

29.52

1.4

0.33

0.38

g/l

2.04

152

605

Nonorganic sleeping disorders, excluding more controls

217

943

2.33

29.35

1.4

0.35

0.42

g/l

1.77

155

670

Paroxysmal tachycardia

206

714

2.42

29.34

1.5

1.3

0.46

0.43

g/l

0.16

147

505

Disorders of oesophagus in diseases classified elsewhere

7.79

29.08

1.5

1.2

0.53

0.41

g/l

0.85

Use of hypnotics and sedatives

936

3541

1.52

28.99

1.4

0.37

0.41

g/l

2.73

680

2548

Non-Hodgkin lymphoma, all

111

5.36

28.99

1.4

0.28

0.40

g/l

1.69

Other arthrosis

432

1581

1.84

28.96

1.3

1.4

0.39

0.42

g/l

0.81

317

1122

Other diseases of lip and oral mucosa

408

2243

1.83

28.93

1.4

0.41

g/l

0.16

310

1610

Cervical disc disorders

310

1557

2.01

28.89

1.4

0.37

0.44

g/l

2.83

219

1098

Other (seronegative) rheumatoid arthritis, wide

191

791

2.45

28.85

1.5

1.4

0.38

0.41

g/l

0.65

147

559

Sequelae of external causes of morbidity and mortality

259

1221

2.14

28.72

1.5

1.4

0.40

0.42

g/l

0.54

191

864

COPD-related respiratory insufficiency

116

372

3.17

28.63

1.4

0.36

0.42

g/l

1.47

275

Other ulcerative colitis

233

3.83

28.53

1.4

1.3

0.38

g/l

0.05

163

Dentofacial anomalies [including malocclusion]

673

3295

1.61

28.40

1.4

0.37

0.40

g/l

1.45

481

2395

Glomerulonephritis

122

407

3.06

28.22

1.8

1.4

0.44

0.41

g/l

0.42

296

Other skin changes

202

867

2.36

28.17

1.7

1.3

0.37

0.43

g/l

1.11

151

606

Giant cell arteritis with polymyalgia rheumatica

5.70

28.17

1.2

1.5

0.32

0.44

g/l

1.23

Zoster [herpes zoster]

187

776

2.44

28.13

1.5

1.4

0.34

0.41

g/l

2.56

146

552

Other encephalitis

5.82

28.07

1.3

0.35

0.41

g/l

0.37

Vasculitis limited to skin, not elsewhere classified

6.24

27.85

1.5

1.2

0.34

0.45

g/l

0.83

Cirrhosis of liver, NAS

188

4.15

27.83

1.3

0.55

0.40

g/l

1.80

132

Other arrhythmias

555

2478

1.68

27.80

1.4

0.43

0.40

g/l

0.42

388

1799

Other anxiety disorders

456

2214

1.76

27.73

1.4

1.3

0.37

0.40

g/l

1.43

362

1569

Insulin, combination of fast acting with intermediate-acting or long-acting

536

2909

1.68

27.69

1.5

1.4

0.42

0.41

g/l

0.11

360

2103

Exposure to unspecified factor

911

4153

1.50

27.51

1.4

0.37

0.41

g/l

2.98

604

3057

Acute and subacute iridocyclitis

203

883

2.33

27.48

1.5

1.3

0.37

0.40

g/l

0.59

145

633

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

162

637

2.58

27.40

1.4

0.52

0.41

g/l

2.27

111

464

Disorders of the thyroid gland

815

3462

1.53

27.24

1.5

1.4

0.38

0.41

g/l

1.32

567

2546

Follow-up examination after treatment for conditions other than malignant neoplasms

329

1116

1.97

27.17

1.4

1.3

0.38

0.43

g/l

1.15

259

698

Pneumococcal septicemia

118

5.09

27.16

1.5

1.3

0.40

0.43

g/l

0.21

Non-rheumatic valve diseases

383

1474

1.87

27.13

1.5

1.4

0.42

0.41

g/l

0.21

265

1060

Valvular heart disease excluding rheumatic fever

386

1492

1.86

27.04

1.5

1.4

0.42

0.41

g/l

0.21

267

1075

Systemic sclerosis (FG)

6.93

26.95

1.3

0.47

0.34

g/l

1.32

Obesity and other hyperalimentation

596

3477

1.62

26.85

1.4

0.39

0.41

g/l

0.23

437

2538

Pain and other conditions associated with female genital organs and menstrual cycle

212

781

2.29

26.80

1.4

0.39

0.41

g/l

0.09

158

562

Insulin medication

536

2675

1.67

26.79

1.5

1.4

0.42

0.40

g/l

0.34

360

1941

GI-bleeding

272

1341

2.04

26.73

1.4

0.44

g/l

0.06

194

963

Papulosquamous disorders

371

2033

1.84

26.64

1.5

1.4

0.38

0.41

g/l

1.22

280

1447

Encephalitis

105

5.34

26.64

1.3

0.35

0.39

g/l

0.27

Obesity

592

3461

1.62

26.61

1.4

0.39

0.41

g/l

0.22

433

2529

Hypoparathyroidism

117

5.03

26.41

2.4

1.4

0.37

0.39

g/l

0.13

158

625

2.56

26.39

1.6

1.4

0.35

0.40

g/l

1.14

429

Presence of other functional implants

487

1946

1.72

26.29

1.4

0.40

0.43

g/l

1.05

290

1444

L04AC Interleukin inhibitors

295

3.37

26.27

1.4

1.3

0.43

0.36

g/l

0.57

205

Anterior Iridocyclitis

212

958

2.24

26.23

1.5

1.3

0.37

0.40

g/l

0.69

152

684

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

6.21

26.08

1.3

0.19

0.40

g/l

3.47

Multiple myeloma

6.21

26.08

1.3

0.19

0.40

g/l

3.47

Ulcerative colitis (strict definition, require KELA)

193

842

2.32

26.00

1.3

1.4

0.38

0.39

g/l

0.04

125

605

Adverse effects, not elsewhere classified

220

1014

2.20

25.93

1.6

1.3

0.31

0.39

g/l

5.48

167

736

Viral pneumonia (known virus, not influenza)

5.78

25.85

1.5

1.3

0.34

0.44

g/l

0.88

Convulsions, not elsewhere classified

203

894

2.26

25.79

1.4

1.3

0.39

0.41

g/l

0.42

145

632

Mixed connective tissue disease

8.14

25.74

1.7

1.3

0.33

0.36

g/l

0.15

Asthma mixed form (mode), excluding more controls

5.67

25.70

1.5

1.3

0.32

0.41

g/l

1.28

Other or unspecified ileus, impaction or obstruction

166

680

2.47

25.67

1.3

1.4

0.43

0.44

g/l

0.07

108

479

Other viral diseases, including avohilmo

386

2143

1.80

25.66

1.5

1.3

0.38

0.39

g/l

0.49

286

1551

Arthrosis

551

1811

1.67

25.64

1.3

1.4

0.41

g/l

0.06

405

1284

Otitis media, unspecified

136

463

2.75

25.57

1.4

1.3

0.36

0.38

g/l

0.41

351

Gastroduodenal ulcer

202

901

2.25

25.51

1.4

0.48

0.46

g/l

0.21

138

637

Hypogonadotropic hypogonadism

129

4.75

25.42

1.2

1.3

0.31

0.37

g/l

0.82

Hypokalaemia

132

487

2.75

25.38

1.6

1.3

0.44

0.41

g/l

0.26

348

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

187

814

2.33

25.34

1.3

1.4

0.39

0.38

g/l

0.04

122

588

Other enthesopathies

267

1334

2.02

25.33

1.7

1.4

0.42

0.41

g/l

0.07

206

946

Other and unspecified vasculitis limited to skin

6.19

25.32

1.4

1.2

0.32

0.47

g/l

1.09

Non-selective monoamine reuptake inhibitors

325

1662

1.89

25.31

1.5

1.4

0.36

0.44

g/l

3.65

229

1207

Other specified/unspecified soft tissue disorders

129

4.67

25.28

1.5

1.3

0.41

g/l

0.01

Unknown and unspecified causes of morbidity

220

3.70

25.21

1.3

0.36

0.41

g/l

0.81

169

Agranulocytosis

129

473

2.77

25.15

1.4

1.3

0.40

0.39

g/l

0.07

336

Seronegative rheumatoid arthritis

112

380

2.99

25.13

1.4

1.3

0.36

0.41

g/l

0.77

263

Lung cancer and mesothelioma

111

310

3.06

25.11

1.2

1.3

0.51

0.44

g/l

0.79

210

Other diseases of urinary system

837

3142

1.50

24.72

1.4

0.40

0.41

g/l

0.26

590

2307

Nonalcoholic fatty liver disease

135

512

2.69

24.69

1.3

1.4

0.40

0.38

g/l

0.24

363

Disorders of parathyroid gland

182

782

2.32

24.62

1.8

1.3

0.37

0.42

g/l

0.96

128

552

Atopic dermatitis

541

2654

1.63

24.51

1.4

0.37

0.40

g/l

1.33

419

1927

Thyroiditis, ILD-related definition

127

468

2.76

24.51

1.5

1.3

0.39

0.40

g/l

0.15

345

Heart failure and coronary heart disease

320

1179

1.91

24.43

1.3

1.4

0.51

0.45

g/l

0.54

236

809

Psoriatic and enteropathic arthropathies

123

447

2.79

24.36

1.3

0.43

0.40

g/l

0.39

317

Cervicalgia

190

846

2.27

24.36

1.7

1.4

0.38

0.46

g/l

1.63

145

594

Asthma mixed form (mode)

5.36

24.20

1.5

1.3

0.32

0.43

g/l

1.72

Other inflammation of eyelid

153

622

2.49

24.18

1.5

1.3

0.45

0.42

g/l

0.10

115

450

Hypothyroidism, other/unspecified

745

3234

1.52

24.13

1.4

0.40

0.42

g/l

0.73

517

2382

Other and unspecified effects of external causes

281

1457

1.95

24.04

1.5

1.3

0.33

0.39

g/l

2.97

212

1041

Cystitis

707

2736

1.54

24.03

1.4

0.39

0.42

g/l

1.08

520

2010

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

109

375

2.96

23.94

1.5

1.3

0.33

0.39

g/l

1.24

272

Dermatitis due to substances taken internally

187

3.88

23.87

1.5

0.39

0.40

g/l

0.07

139

Secondary right heart disease

112

4.85

23.71

1.3

0.44

0.45

g/l

0.05

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

197

902

2.21

23.67

1.3

1.4

0.38

0.39

g/l

0.12

128

649

Diseases of spleen

6.92

23.60

1.8

1.3

0.49

0.44

g/l

0.26

Other diseases of the digestive system

263

1341

1.98

23.59

1.4

0.44

g/l

0.00

191

966

Emphysema

184

3.87

23.54

1.2

1.3

0.46

0.44

g/l

0.17

135

Other and unspecified urticaria

211

995

2.15

23.52

1.5

1.3

0.35

0.40

g/l

1.50

159

709

Cutaneous abscess, furuncle and carbuncle

261

1330

1.98

23.51

1.3

0.41

g/l

0.05

198

953

Other pulmonary heart/vessel disease

133

4.47

23.48

1.4

1.2

0.43

0.47

g/l

0.24

Myocarditis

137

4.39

23.45

1.4

1.2

0.35

0.39

g/l

0.39

Acute tubulo-interstitial nephritis

524

2740

1.62

23.45

1.4

0.40

0.41

g/l

0.16

382

2002

Recurrent aphthous stomatitis , including avohilmo

161

680

2.40

23.42

1.4

0.37

0.40

g/l

0.71

132

488

Migraine, single triptan purchase ok & required. ICD-code if available is included

693

3078

1.53

23.37

1.4

0.40

g/l

0.04

500

2230

Triptan medication for migraine, single purchase ok

693

3078

1.53

23.37

1.4

0.40

g/l

0.04

500

2230

Stomatitis and related lesions

210

992

2.14

23.31

1.4

0.38

0.40

g/l

0.33

171

709

Triptan medication for migraine, min. 3 purchases

531

2459

1.62

23.30

1.4

0.36

0.40

g/l

0.61

400

1786

Acute laryngitis and tracheitis

128

479

2.66

23.15

1.3

0.38

0.37

g/l

0.07

331

Hernia

798

3585

1.48

23.14

1.4

0.41

g/l

0.07

583

2562

Psychiatric diseases

818

2754

1.49

23.06

1.3

1.4

0.38

0.42

g/l

2.41

583

1984

Chronic gastritis

210

995

2.13

23.06

1.3

1.4

0.44

g/l

0.04

173

708

Systemic sclerosis

5.90

23.06

1.3

0.47

0.36

g/l

1.09

Diseases of arteries, arterioles and capillaries

527

2403

1.62

22.72

1.4

0.47

0.41

g/l

1.80

385

1709

Persons with potential health hazards related to communicable diseases

375

2143

1.75

22.70

1.4

0.32

0.39

g/l

4.23

234

1584

Non-ischemic cardiomyopathy

253

1009

2.00

22.66

1.4

0.52

0.43

g/l

0.76

178

710

Dizziness and giddiness

641

3253

1.54

22.64

1.4

0.42

0.41

g/l

0.11

468

2364

Glomerular disorders in diseases classified elsewhere

122

460

2.69

22.56

1.5

1.4

0.45

0.40

g/l

0.40

335

Haemorrhoids and perianal venous thrombosis

277

1450

1.91

22.49

1.3

1.4

0.39

0.43

g/l

0.70

193

1030

Hypothyreosis and Thyroxine purchase for inclusion criteria

768

3394

1.49

22.45

1.5

1.4

0.39

0.41

g/l

0.75

532

2499

Symptoms and signs involving the urinary system

643

3170

1.54

22.43

1.5

1.4

0.42

0.41

g/l

0.15

468

2273

Pyothorax

138

4.31

22.42

1.4

1.3

0.35

0.43

g/l

0.71

Other inflammation of eyelid, including avohilmo

409

2430

1.69

22.23

1.4

0.38

0.40

g/l

0.25

304

1758

Diabetes mellitus

877

3506

1.45

21.97

1.4

0.41

0.40

g/l

0.31

607

2570

Other viral diseases, not elsewhere classified

202

960

2.12

21.91

1.4

0.37

0.39

g/l

0.38

154

704

Lymphoid leukaemia

185

3.76

21.87

1.5

1.2

0.34

0.42

g/l

0.90

136

Deforming dorsopathies

242

1232

1.98

21.84

1.5

1.4

0.45

0.44

g/l

0.02

185

869

Other abnormal immunological findings in serum

5.87

21.82

1.7

1.3

0.57

0.40

g/l

1.21

Subjective visual disturbances

241

1227

1.98

21.82

1.4

1.3

0.32

0.41

g/l

5.78

183

860

6-mercaptopurine

5.17

21.72

2.1

1.2

0.45

0.36

g/l

0.55

Care involving dialysis

315

3.04

21.69

1.4

0.50

0.41

g/l

0.76

231

Benign neoplasm: Transverse colon

115

430

2.72

21.65

1.6

1.4

0.37

0.42

g/l

0.89

310

Obesity due to excess calories

440

2686

1.65

21.58

1.3

1.4

0.41

g/l

0.05

319

1953

Other viral diseases

298

1626

1.84

21.58

1.5

1.3

0.38

0.39

g/l

0.21

222

1179

Other symptoms and signs involving the circulatory and respiratory systems

196

3.63

21.53

1.5

1.3

0.42

0.41

g/l

0.02

144

Other diseases of hard tissues of teeth

432

1315

1.71

21.52

1.4

1.3

0.41

0.43

g/l

0.30

300

927

Other medical care

408

2036

1.69

21.49

1.3

1.4

0.42

0.43

g/l

0.13

285

1468

Gonarthrosis [arthrosis of knee](FG)

530

1903

1.61

21.48

1.4

1.3

0.39

0.42

g/l

0.57

399

1344

Dermatographic urticaria

286

3.14

21.43

1.7

1.4

0.35

0.37

g/l

0.21

205

Other disorders of eye and adnexa

158

689

2.32

21.42

1.4

0.31

0.41

g/l

4.24

122

489

Diabetes, varying definitions

869

3501

1.44

21.38

1.4

0.41

0.40

g/l

0.35

599

2566

Other viral diseases, not elsewhere classified, including avohilmo

278

1486

1.88

21.31

1.4

0.37

0.40

g/l

0.62

213

1076

Insulin, fast-acting

320

1796

1.79

21.31

1.5

1.3

0.40

0.41

g/l

0.23

221

1299

Ovarian cyst

296

896

1.90

21.31

1.3

1.4

0.37

0.40

g/l

1.12

217

631

Bronchitis, not specified as acute or chronic

271

3.18

21.31

1.6

1.3

0.42

0.43

g/l

0.05

194

Total colectomy operation

148

4.09

21.30

1.6

1.3

0.40

0.39

g/l

0.06

107

Total colectomy

148

4.09

21.30

1.6

1.3

0.40

0.39

g/l

0.06

107

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

806

3508

1.46

21.15

1.4

0.39

0.41

g/l

0.64

564

2551

Soft tissue disorders related to use, overuse and pressure

232

1181

1.98

21.00

1.4

0.41

0.42

g/l

0.08

180

830

Chronic iridocyclitis

172

3.81

20.97

1.5

1.3

0.34

0.40

g/l

0.92

127

Idiopathic thrombocytopenic purpura

108

4.69

20.92

1.4

1.3

0.45

0.44

g/l

0.06

Other metabolic disorders

144

610

2.39

20.87

1.8

1.3

0.32

0.39

g/l

2.25

432

Lung diseases due to external agents

122

479

2.58

20.78

1.3

0.39

0.42

g/l

0.40

359

Volume depletion

318

2.96

20.67

1.3

0.34

0.41

g/l

1.17

219

Intestinal stricture

264

1415

1.88

20.49

1.4

0.41

0.44

g/l

0.43

185

1007

Crohn's disease of small intestine

294

3.05

20.45

1.3

0.37

g/l

0.00

212

Selective serotonin reuptake inhibitors

816

2927

1.45

20.41

1.4

0.37

0.42

g/l

3.14

583

2122

Heart failure and bmi 25plus

256

885

1.94

20.32

1.4

0.49

0.41

g/l

0.65

171

584

Extracorporeal dialysis

229

3.35

20.28

1.5

1.3

0.52

0.40

g/l

0.75

165

Type 2 diabetes

817

3287

1.44

20.12

1.5

1.4

0.41

0.40

g/l

0.26

571

2398

Enthesopathies of lower limb, excluding foot

203

1002

2.04

20.09

1.4

1.3

0.37

0.45

g/l

2.32

159

703

Viral infections of the central nervous system, including avohilmo

324

2.92

20.06

1.4

0.35

0.39

g/l

0.42

229

Internal derangement of knee

297

1644

1.80

20.05

1.5

1.4

0.36

0.41

g/l

2.19

212

1173

Conjunctivitis (acute, non atopic)

272

1477

1.85

20.00

1.4

1.3

0.41

0.40

g/l

0.07

207

1064

Secondary and unspecified malignant neoplasm of lymph nodes

303

2.99

19.99

1.4

0.39

0.38

g/l

0.08

223

Other diseases of stomach and duodenum

202

3.48

19.89

1.4

1.3

0.39

0.40

g/l

0.07

149

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

5.51

19.86

1.4

1.3

0.32

0.35

g/l

0.22

Type 2 diabetes, wide definition

586

2426

1.53

19.48

1.5

1.4

0.43

0.41

g/l

0.53

440

1822

Viral infections of the central nervous system

292

3.00

19.44

1.4

0.32

0.39

g/l

1.20

202

Diseases of tongue

191

3.51

19.36

1.6

1.3

0.41

0.44

g/l

0.32

137

Acute pharyngitis

145

631

2.30

19.26

1.3

1.4

0.34

0.42

g/l

1.36

102

443

Pruritus

116

462

2.54

19.25

1.6

1.4

0.41

0.43

g/l

0.10

335

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

784

3240

1.44

19.19

1.4

0.42

0.40

g/l

0.55

541

2371

Insulin, fast-acting or short human

321

1861

1.74

19.16

1.5

1.3

0.40

0.42

g/l

0.34

222

1338

Other diseases of intestine

139

603

2.33

19.09

1.4

0.51

0.43

g/l

0.26

422

Hyperkinetic disorders, excluding more controls

141

571

2.33

19.09

1.3

0.32

0.38

g/l

1.73

110

406

SLE, ICD10

134

4.08

19.00

1.6

1.4

0.42

0.35

g/l

0.63

104

SLE, strict definition

134

4.08

19.00

1.6

1.4

0.42

0.35

g/l

0.63

104

Behavioural syndromes associated with physiological disturbances and physical factors

806

3844

1.42

18.95

1.3

1.4

0.37

0.41

g/l

1.83

584

2786

Seropositive rheumatoid arthritis, strict definition

144

637

2.29

18.93

1.5

1.3

0.46

0.41

g/l

0.78

112

448

Coxibs

220

570

2.04

18.85

1.3

0.38

0.44

g/l

1.20

157

402

Other and unspecified types of non-Hodgkin lymphoma, hilmo

126

4.15

18.81

1.6

1.3

0.33

0.40

g/l

0.57

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

122

4.21

18.76

1.5

1.3

0.40

0.41

g/l

0.05

Ocular pain

102

387

2.68

18.75

1.5

0.31

0.41

g/l

2.78

277

Panniculitis, unspecified

16.06

18.74

1.4

0.33

0.34

g/l

0.08

Systemic sclerosis, icd10

4.84

18.61

1.3

0.47

0.37

g/l

0.95

Sleep disorders

775

3752

1.43

18.58

1.3

1.4

0.37

0.41

g/l

3.19

560

2709

Atopic dermatitis, strict definition

294

1642

1.76

18.51

1.4

0.36

0.38

g/l

0.63

227

1185

Other disorders of ear

764

3458

1.43

18.48

1.5

1.4

0.41

g/l

0.15

556

2515

Congenital malformations of the musculoskeletal system, not elsewhere classified

5.57

18.47

1.4

1.3

0.33

0.34

g/l

0.07

Ascites

222

3.25

18.45

1.3

1.2

0.61

0.42

g/l

2.05

167

Genitourinary diseases

473

1486

1.60

18.42

1.3

1.4

0.38

0.41

g/l

1.11

348

1059

Insulin, intermediate and long-acting

443

2715

1.58

18.39

1.4

0.41

g/l

0.18

303

1963

Excessive, frequent and irregular menstruation

313

940

1.79

18.39

1.4

0.38

0.40

g/l

0.68

221

668

Coronary atherosclerosis

478

1917

1.58

18.38

1.4

0.44

0.41

g/l

0.66

348

1366

Localized swelling, mass and lump of skin and subcutaneous tissue

279

1575

1.78

18.36

1.7

1.3

0.37

0.42

g/l

1.75

233

1120

Cluster headache, strict

120

4.18

18.29

1.2

1.3

0.30

0.40

g/l

1.08

Heartburn

104

403

2.61

18.27

1.4

1.3

0.32

0.41

g/l

2.62

294

Abnormal findings on diagnostic imaging of central nervous system

189

3.46

18.27

1.6

1.4

0.35

0.39

g/l

0.50

141

Gout, idiopatic and unspecified

199

1010

1.99

18.27

1.4

0.44

0.46

g/l

0.26

135

733

Radiculopathy

132

571

2.33

18.27

1.4

1.3

0.49

g/l

0.01

407

Meniscus derangement

403

1638

1.64

18.25

1.3

1.4

0.38

0.41

g/l

1.16

271

1159

Malignant neoplasm of pancreas, including Hilmo

276

2.98

18.18

1.6

1.4

0.43

0.40

g/l

0.24

204

Insomnia

762

3732

1.43

18.17

1.3

1.4

0.37

0.41

g/l

3.09

552

2696

Exposure to other specified factors

697

4171

1.44

18.13

1.5

1.4

0.40

g/l

0.07

522

3001

Rare circulating lymphoid malignancy, including Hilmo

4.70

18.07

1.9

1.2

0.39

0.38

g/l

0.06

Other CVD (FINNGEN)

261

2.80

18.03

1.4

1.3

0.33

0.48

g/l

1.32

179

Chronic apical periodontitis

927

3767

1.38

17.96

1.4

0.39

0.41

g/l

0.57

649

2735

Panhypopituitarism

5.83

17.89

1.9

1.3

0.36

0.41

g/l

0.17

Senile cataract

472

1830

1.58

17.82

1.4

0.41

0.42

g/l

0.06

337

1360

Gastric ulcer

135

596

2.28

17.81

1.4

0.49

0.44

g/l

0.53

424

Other and unspecified drugs and medicaments

352

2.71

17.75

1.4

0.34

0.40

g/l

1.04

255

Other infectious diseases, including avohilmo

341

2.74

17.70

1.4

1.3

0.43

g/l

0.02

246

Other cataract

345

1530

1.68

17.69

1.5

1.4

0.42

0.41

g/l

0.04

247

1132

Psoriasis

254

1412

1.81

17.64

1.3

1.4

0.41

g/l

0.04

187

1006

Cluster headache, wide

128

3.99

17.59

1.2

1.3

0.30

0.40

g/l

1.22

Gonarthrosis

452

1611

1.59

17.58

1.3

1.4

0.40

0.41

g/l

0.31

339

1147

Ehlers-Danlos syndrome, including avohilmo

6.31

17.51

1.4

1.3

0.26

0.33

g/l

0.85

Ulcerative enterocolitis

107

4.32

17.49

1.4

1.3

0.39

0.37

g/l

0.11

Viral and other specified intestinal infections, including avohilmo

261

1408

1.80

17.49

1.5

1.3

0.39

g/l

0.06

187

1014

Type 2 diabetes, definitions combined

763

3132

1.42

17.43

1.5

1.4

0.43

0.40

g/l

0.55

534

2291

Fissure and fistula of anal and rectal regions

199

1029

1.95

17.33

1.3

1.4

0.49

0.42

g/l

0.37

134

727

Other meningitis

5.98

17.25

1.6

1.3

0.34

0.42

g/l

0.49

Reactive arthropathies, FINNGEN

258

2.99

17.22

1.4

1.3

0.45

0.39

g/l

0.55

181

Misadventures to patients during surgical and medical care

135

606

2.25

17.18

1.5

1.3

0.40

0.41

g/l

0.26

436

Hepatic failure, not elsewhere classified

113

4.17

17.12

1.4

1.3

0.51

0.35

g/l

1.36

Disorders of ocular muscles, binocular movement, accommodation and refraction

430

2739

1.56

17.11

1.5

1.4

0.39

0.40

g/l

0.25

320

1987

Abscess of lung

5.88

16.96

1.3

1.4

0.43

0.44

g/l

0.02

Diffuse large B-cell lymphoma, including Hilmo

150

3.67

16.92

1.5

0.31

0.38

g/l

0.97

115

Diffuse large B-cell lymphoma

150

3.67

16.92

1.5

0.31

0.38

g/l

0.97

115

Diffuse large B-cell lymphoma, helper endpoint

150

3.67

16.92

1.5

0.31

0.38

g/l

0.97

115

Ulcerative ileocolitis

155

3.64

16.91

1.3

0.35

0.37

g/l

0.11

111

Inflammatory diseases of female pelvic organs

525

2388

1.51

16.86

1.4

0.40

0.39

g/l

0.17

390

1750

Ehlers-Danlos syndrome

6.82

16.86

1.4

1.2

0.27

0.33

g/l

0.68

Congenital malformations and deformations of the musculoskeletal system

110

454

2.45

16.81

1.6

1.4

0.36

0.38

g/l

0.27

349

Other abnormalities of plasma proteins

6.68

16.78

2.1

1.4

0.44

0.36

g/l

0.19

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

5.60

16.77

1.5

1.2

0.50

0.41

g/l

0.42

Type 2 diabetes, strict (exclude DM1)

766

3170

1.41

16.75

1.5

1.4

0.43

0.40

g/l

0.55

536

2309

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

130

578

2.27

16.72

1.5

1.4

0.35

0.39

g/l

0.64

438

Keratitis

311

1860

1.68

16.68

1.5

1.4

0.39

0.41

g/l

0.43

217

1327

Polyarthritis, unspecified

111

4.15

16.66

1.8

1.4

0.41

g/l

0.01

Nonorganic sleeping disorders

217

1172

1.87

16.61

1.4

0.35

0.39

g/l

1.07

155

835

Chronic nephritic syndrome

134

3.82

16.54

2.0

1.3

0.49

0.39

g/l

1.03

Other infectious diseases

270

2.90

16.48

1.5

1.3

0.44

0.42

g/l

0.14

199

Diabetes medication

858

3644

1.38

16.48

1.4

0.41

0.40

g/l

0.35

598

2669

Missing teeth due to accident, extraction or parodontitis

494

2941

1.51

16.35

1.5

1.4

0.39

0.41

g/l

0.99

357

2116

Crohn's disease NAS

266

2.91

16.35

1.2

1.3

0.40

0.38

g/l

0.15

191

Crohn's disease of large intestine

203

3.22

16.34

1.3

0.35

0.39

g/l

0.29

146

Substance abuse, excluding more controls

440

2389

1.55

16.25

1.3

1.4

0.40

0.42

g/l

0.51

304

1693

Brachial plexus disorders

104

428

2.47

16.21

1.5

1.4

0.35

0.38

g/l

0.49

302

Other diseases of oesophagus

306

2.75

16.15

1.2

1.3

0.35

0.41

g/l

0.63

222

Exclusions for E4_PCOS_CONSORTIUM

619

2670

1.45

16.11

1.5

1.4

0.37

0.40

g/l

0.62

397

1985

Dental operations

434

1419

1.58

16.07

1.4

0.40

0.43

g/l

0.55

306

1032

Cardiomyopathy

137

636

2.17

16.03

1.3

0.45

0.44

g/l

0.15

101

464

Obesity, other/unspecified

305

1837

1.67

15.96

1.5

1.4

0.42

0.41

g/l

0.13

244

1325

Ischaemic heart disease, wide definition

588

2480

1.46

15.95

1.5

1.4

0.43

0.41

g/l

0.29

421

1782

Acute generalized exanthematous pustulosis

171

3.41

15.94

1.5

1.3

0.39

0.40

g/l

0.05

125

Oxicams

176

489

2.06

15.90

1.3

0.44

0.45

g/l

0.12

135

346

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

396

2.51

15.89

1.4

0.44

0.40

g/l

0.31

295

Other/unspecified rheumatoid arthritis

106

445

2.41

15.80

1.6

1.4

0.41

0.42

g/l

0.08

310

Complications of internal orthopaedic prosthetic devices, implants and grafts

173

882

1.98

15.76

1.4

0.38

0.43

g/l

0.98

123

626

Gout, unspecified

161

801

2.03

15.73

1.4

0.43

0.46

g/l

0.41

110

589

Pneumothorax

208

3.12

15.66

1.3

0.39

0.41

g/l

0.14

156

Trochanteric bursitis

125

566

2.23

15.61

1.6

1.4

0.42

0.41

g/l

0.10

399

Chronic ulcer of skin, not elsewhere classified

214

3.08

15.56

1.9

1.4

0.48

0.43

g/l

0.36

158

Postprocedural disorders of nervous system

307

2.71

15.55

1.5

1.4

0.35

0.38

g/l

0.42

226

Haemolytic anaemias

117

3.94

15.55

1.6

1.3

0.41

g/l

0.01

Postprocedural endocrine and metabolic disorders, not elsewhere classified

122

549

2.25

15.50

1.8

1.3

0.32

0.39

g/l

1.96

392

Injuries to the knee and lower leg

976

3947

1.34

15.43

1.5

1.4

0.40

0.41

g/l

0.26

723

2838

Disease of hard tissues of teeth, NOS

394

1296

1.60

15.41

1.4

1.3

0.45

0.43

g/l

0.11

266

912

Exophthalmic conditions

7.33

15.41

1.7

1.3

0.28

0.31

g/l

0.29

Diseases of oral cavity, salivary glands and jaws

404

1315

1.59

15.39

1.4

1.3

0.40

0.43

g/l

0.63

293

927

Personality disorders, excluding more controls

215

1183

1.83

15.38

1.3

1.4

0.37

0.41

g/l

0.88

153

840

Endocarditis

109

4.03

15.37

1.3

1.2

0.38

0.39

g/l

0.08

Disorders of mineral metabolism

332

2.63

15.34

1.3

0.48

0.41

g/l

0.29

239

Acetic acid derivatives and related substances

205

551

1.93

15.30

1.5

1.3

0.36

0.44

g/l

2.15

145

387

Algoneurodystrophy

123

3.84

15.30

1.6

1.4

0.31

0.34

g/l

0.41

Other neurological diseases

556

2973

1.46

15.22

1.4

0.38

0.41

g/l

1.12

399

2136

Ulcerative colitis (strict definition, all Crohn cases excluded)

145

704

2.08

15.20

1.2

1.4

0.42

0.38

g/l

0.54

515

Pleural plaque

249

2.88

15.19

1.3

0.50

0.46

g/l

0.35

185

Covid-19 suspected case

203

1106

1.85

15.16

1.3

0.46

0.39

g/l

0.87

179

774

Marginal zone B-cell lymphoma, including Hilmo

5.59

15.09

1.6

1.2

0.30

0.36

g/l

0.31

Type 2 diabetes, definitions combined, including avohilmo

757

3165

1.39

15.07

1.4

0.41

0.40

g/l

0.31

526

2306

Reactive arthropathies

335

2.60

15.06

1.4

0.46

0.43

g/l

0.29

233

Small fibre neuropathy

111

3.98

15.04

1.7

1.3

0.40

0.43

g/l

0.14

Benign neoplasm: Colon, unspecified

198

1073

1.86

15.03

1.5

1.4

0.46

0.45

g/l

0.06

146

764

Autonomic disorders

4.67

15.03

1.4

1.3

0.26

0.37

g/l

1.51

Invasive ventilation

273

2.79

15.02

1.3

0.33

0.40

g/l

1.00

205

Carrier of infectious disease

4.21

15.02

1.6

1.3

0.31

0.36

g/l

0.49

Chorioretinal inflammation

4.19

14.99

1.5

1.3

0.38

0.34

g/l

0.41

Substance use, excluding alcohol

190

1018

1.88

14.97

1.3

1.4

0.38

0.40

g/l

0.43

139

730

Retention of urine

255

1193

1.74

14.96

1.5

1.4

0.42

0.45

g/l

0.33

179

847

Ankylosing spondylitis

342

2.58

14.96

1.3

0.39

0.42

g/l

0.35

242

STROKE

418

1828

1.55

14.95

1.3

1.4

0.42

0.40

g/l

0.26

312

1311

Nephrotic syndrome

116

3.90

14.94

1.9

1.3

0.39

0.36

g/l

0.19

Diabetes, insulin treatment (Kela reimbursement)

811

3538

1.37

14.93

1.4

0.42

0.40

g/l

0.68

564

2580

Carpal tunnel syndrome

484

2836

1.48

14.92

1.5

1.4

0.40

0.42

g/l

0.44

362

2048

Disorders of muscles

396

2.45

14.90

1.4

1.3

0.41

g/l

0.00

276

Other disorders of skin and subcutaneous tissue, not elsewhere classified

127

592

2.17

14.80

1.7

1.4

0.39

0.40

g/l

0.22

425

Injuries to the abdomen, lower back, lumbar spine and pelvis

329

2028

1.61

14.79

1.3

1.4

0.43

0.42

g/l

0.21

242

1449

Generalized skin eruption due to drugs and medicaments

150

3.48

14.74

1.5

1.3

0.42

0.39

g/l

0.17

109

Etanercept

293

2.71

14.74

1.5

1.3

0.45

0.37

g/l

1.09

214

Faecal incontinence

270

2.77

14.73

1.4

1.3

0.28

0.43

g/l

5.12

190

Other disorders of bone

178

940

1.91

14.67

1.5

1.3

0.32

0.42

g/l

3.88

136

683

Viral and other specified intestinal infections

191

1006

1.87

14.63

1.6

1.3

0.39

g/l

0.01

132

727

Psoriatic arthropathies

406

2.42

14.60

1.3

1.4

0.42

0.43

g/l

0.12

287

Spondylolisthesis/Spondylolysis

146

721

2.04

14.60

1.7

1.3

0.48

0.47

g/l

0.01

110

513

Acquired haemolytic anaemia

4.56

14.58

1.6

1.4

0.39

0.42

g/l

0.13

Disorders of optic nerve and visual pathways

413

2.41

14.55

1.6

1.4

0.36

0.40

g/l

0.56

301

Crohn disease (strict definition, require KELA, min 2 HDR)

278

2.74

14.55

1.2

1.4

0.45

0.38

g/l

0.63

197

Cerebral cysts

218

2.99

14.50

1.8

1.3

0.39

g/l

0.01

161

Coeliac disease

116

527

2.23

14.44

1.7

1.4

0.44

0.40

g/l

0.42

380

Other and unspecified visual disturbances

106

464

2.31

14.43

1.6

1.3

0.32

0.41

g/l

2.48

326

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

4.39

14.36

1.2

1.4

0.29

0.40

g/l

1.04

Chronic lymphocytic leukaemia, helper endpoint

4.39

14.36

1.2

1.4

0.29

0.40

g/l

1.04

Chronic lymphocytic leukaemia

4.39

14.36

1.2

1.4

0.29

0.40

g/l

1.04

Viral warts

105

459

2.32

14.35

1.4

0.36

0.39

g/l

0.45

326

Secondary uncertain malignant neoplasm

113

510

2.24

14.28

1.4

0.45

0.41

g/l

0.47

375

Sacroiliitis, not elsewhere classified

163

3.31

14.25

1.3

1.4

0.41

g/l

0.03

113

Crohn disease (strict definition, require KELA)

281

2.71

14.25

1.2

1.3

0.45

0.38

g/l

0.57

199

Coxarthrosis [arthrosis of hip](FG)

353

1537

1.59

14.23

1.3

0.45

0.43

g/l

0.36

281

1082

Alcohol use disorder, Swedish definition

435

2647

1.50

14.22

1.3

1.4

0.42

0.41

g/l

0.34

274

1903

462

2795

1.48

14.21

1.3

1.4

0.43

0.41

g/l

0.43

291

2013

Persons encountering health services for specific procedures, not carried out

375

2.46

14.20

1.4

0.41

0.38

g/l

0.42

269

Postmenopausal osteoporosis with pathological fracture

179

3.17

14.13

1.3

1.4

0.29

0.41

g/l

1.89

133

Cardiac murmurs and other cardiac sounds

324

2.56

14.10

1.3

0.36

0.40

g/l

0.52

238

Tonsillectomy and adenotomy

501

2387

1.47

14.06

1.4

1.3

0.37

0.39

g/l

0.41

390

1699

Diplopia

122

573

2.15

13.99

1.8

1.3

0.39

0.41

g/l

0.31

415

Other diseases of anus and rectum

222

1268

1.75

13.97

1.2

1.4

0.44

0.42

g/l

0.09

167

898

Unspecified kidney failure

324

2.56

13.96

1.3

0.48

0.43

g/l

0.43

237

485

2895

1.46

13.92

1.3

1.4

0.42

0.41

g/l

0.42

309

2076

Other bursopathies

110

497

2.23

13.88

1.5

1.3

0.38

0.43

g/l

0.73

344

Extreme obesity with alveolar hypoventilation

142

3.45

13.76

1.4

1.3

0.30

0.38

g/l

0.96

Otalgia

381

2.42

13.73

1.8

1.3

0.36

0.39

g/l

0.43

279

Neuralgia and neuritis, unspecified

172

3.19

13.73

1.4

1.3

0.35

0.40

g/l

0.58

122

Vascular disorders of the intestines

182

3.11

13.73

1.2

1.3

0.46

g/l

0.06

129

Cluster headache, strict, including avohilmo

209

2.97

13.71

1.3

0.32

0.38

g/l

0.81

146

Oesophagitis

157

3.30

13.70

1.4

1.2

0.37

0.38

g/l

0.03

111

Other peripheral vascular diseases

317

2.56

13.58

1.3

1.4

0.43

0.39

g/l

0.47

234

Gout, strict definition

140

700

2.02

13.57

1.4

0.44

0.47

g/l

0.27

510

Disorders of calcium metabolism

232

2.84

13.55

1.3

1.4

0.50

0.41

g/l

0.30

169

Unspecified/other endometriosis

387

2.38

13.52

1.5

1.4

0.31

0.41

g/l

3.11

275

Other external causes of accidental injury

654

2346

1.40

13.50

1.4

1.3

0.37

0.42

g/l

2.40

470

1709

Coxarthrosis

334

1360

1.59

13.50

1.3

1.5

0.46

0.43

g/l

0.60

267

977

Erythema nodosum

4.01

13.50

1.7

1.4

0.36

g/l

0.03

Meningitis

195

3.03

13.48

1.5

1.3

0.32

0.39

g/l

0.97

143

Hyperlipidaemia, other/unspecified

282

1558

1.63

13.47

1.5

1.4

0.41

0.45

g/l

0.56

208

1123

Pyogenic arthritis

211

2.93

13.45

1.3

1.4

0.41

0.43

g/l

0.20

151

Other autoimmune haemolytic anaemias

6.55

13.40

1.8

1.3

0.39

0.51

g/l

0.40

Other noninfective disorders of lymphatic vessels and lymph nodes

116

3.70

13.35

1.5

1.3

0.70

0.36

g/l

0.56

Other enthesopathy of foot (+metatarsalgia)

392

2.37

13.34

1.6

1.3

0.50

0.42

g/l

0.16

275

Panic disorder

142

719

1.99

13.31

1.3

0.38

0.39

g/l

0.18

110

502

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

191

3.02

13.29

1.5

1.4

0.49

0.41

g/l

0.60

144

Falls/tendency to fall

877

3307

1.33

13.21

1.3

1.4

0.38

0.41

g/l

1.05

629

2383

Acute lymphadenitis

247

2.76

13.17

1.9

1.3

0.39

0.36

g/l

0.34

183

Hypersensitivity pneumonitis due to organic dust

5.63

13.16

1.3

1.5

0.50

0.40

g/l

0.37

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

276

1053

1.66

13.14

1.3

1.4

0.37

0.36

g/l

0.23

204

786

Cluster headache, wide,, including avohilmo

221

2.86

12.99

1.3

0.31

0.39

g/l

1.04

155

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

307

2.55

12.95

1.2

1.4

0.44

0.38

g/l

0.56

218

Other and unspecified nerve root and plexus disorders, also in other diseases

179

987

1.83

12.94

1.5

1.3

0.36

0.43

g/l

1.63

109

697

Childhood allergy (age < 16)

141

586

2.00

12.93

1.4

0.37

g/l

0.00

108

426

Hypothyroidism, strict autoimmune, 3 medication purchases required

644

3143

1.38

12.93

1.3

1.4

0.40

0.41

g/l

0.23

464

2317

Phlebitis and thrombophlebitis (not including DVT)

183

1019

1.81

12.81

1.4

0.35

0.43

g/l

2.01

133

746

Open wound of lower leg

137

696

1.99

12.74

1.4

1.3

0.35

0.41

g/l

1.13

499

Menorrhagia

257

853

1.69

12.74

1.4

0.36

0.41

g/l

1.47

182

602

Lichen simplex chronicus and prurigo

224

2.81

12.66

1.2

1.4

0.46

0.40

g/l

0.52

166

Benign neoplasm: Small intestine

135

3.40

12.65

1.2

1.4

0.42

g/l

0.01

Irregular menses

404

2041

1.49

12.63

1.5

1.4

0.34

0.41

g/l

3.21

301

1517

Rosacea

125

617

2.05

12.62

1.4

0.52

0.40

g/l

0.41

436

Fall on same level

933

3810

1.31

12.60

1.3

1.4

0.39

0.40

g/l

0.51

680

2751

Diseases of the myoneural junction and muscle

105

487

2.18

12.48

1.5

1.4

0.30

0.41

g/l

3.14

352

Cytomegalovirus infection, IBD co-morbidity

4.12

12.47

1.4

1.3

0.46

0.35

g/l

0.72

Other and unspecified rosacea

411

2.29

12.46

1.4

0.55

0.41

g/l

0.38

295

Psoriasis vulgaris

161

870

1.87

12.45

1.3

0.41

g/l

0.02

119

623

Other obstetric conditions, not elsewhere classified

280

1090

1.63

12.44

1.3

1.4

0.37

0.36

g/l

0.23

208

813

Cardiomyopathy, other and unspecified

260

2.65

12.44

1.3

0.46

0.38

g/l

1.05

193

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

218

1270

1.70

12.43

1.2

1.3

0.33

0.41

g/l

2.61

154

910

Viral warts, including avohilmo

198

1139

1.75

12.43

1.5

1.4

0.38

0.40

g/l

0.41

150

812

Raynaud syndrome

399

2.31

12.42

1.4

0.39

g/l

0.01

292

Benign neoplasm: Stomach

374

2.36

12.42

1.8

1.4

0.36

0.41

g/l

0.83

270

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

210

1065

1.73

12.38

1.3

0.35

0.38

g/l

0.77

162

768

Other coagulation defects

309

2.49

12.28

1.5

1.4

0.31

0.39

g/l

1.86

223

Benign neoplasm: Duodenum

4.06

12.27

1.2

1.3

0.45

0.48

g/l

0.17

Adenocarcinoma and ductal carcinoma of pancreas

104

3.72

12.25

1.2

1.4

0.50

0.39

g/l

0.64

Diseases of pulp and periapical tissues, including avohilmo

819

3197

1.33

12.24

1.4

0.40

0.41

g/l

0.50

580

2313

External causes of morbidity and mortality

513

1796

1.44

12.23

1.4

1.3

0.38

0.42

g/l

1.70

373

1309

Disturbance of activity and attention

140

709

1.95

12.22

1.3

1.4

0.32

0.38

g/l

2.10

109

511

Fentanyl

285

2.54

12.20

1.7

1.2

0.41

0.46

g/l

0.43

210

Systemic lupus erythematosus, unspecified

114

3.60

12.19

1.4

0.47

0.34

g/l

1.03

Disorders of vestibular function (Vertigo)

358

2325

1.51

12.16

1.3

1.4

0.39

0.41

g/l

0.49

251

1684

Oter anti-inflammatory and antirheumatic agents, non-steroids

156

444

1.94

12.09

1.4

1.3

0.37

0.45

g/l

2.01

118

314

Cervicocranial syndrome

391

2.30

12.07

1.6

1.2

0.29

0.46

g/l

8.04

281

Rash and other nonspecific skin eruption

404

2.28

12.07

1.4

0.38

0.40

g/l

0.34

303

Erythema multiforme

4.30

12.06

1.2

1.3

0.36

0.40

g/l

0.13

Supplementary factors related to causes of morbidity and mortality classified elsewhere

261

1628

1.61

12.03

1.8

1.3

0.37

0.42

g/l

1.36

194

1153

Myelodysplastic syndrome, including Hilmo

4.27

12.03

1.3

1.4

0.59

0.41

g/l

1.15

Chronic tubulo-interstitial nephritis

110

3.61

12.03

1.3

1.4

0.43

0.38

g/l

0.32

Lesion of ulnar nerve

127

642

2.00

12.02

1.5

1.3

0.38

0.45

g/l

0.98

459

Dermatophytosis

122

608

2.03

12.02

1.4

0.49

0.40

g/l

1.41

444

Injuries to the ankle and foot

605

3787

1.37

11.97

1.4

0.40

g/l

0.04

464

2714

Scleritis and episcleritis

266

2.60

11.93

1.6

1.5

0.35

0.39

g/l

0.47

202

Post-traumatic stress disorder

362

2.35

11.93

1.3

0.32

0.40

g/l

1.97

251

Other disorders of conjunctiva

117

576

2.05

11.92

1.5

1.3

0.41

g/l

0.04

412

Chronic suppurative otitis media, including avohilmo

326

2.42

11.88

1.8

1.4

0.32

0.40

g/l

2.13

240

Metatarsalgia

363

2.34

11.85

1.6

1.3

0.51

0.43

g/l

0.18

251

Hernia of abdominal wall

350

2340

1.50

11.82

1.5

1.4

0.46

0.41

g/l

0.50

260

1678

Accidents

641

2346

1.37

11.82

1.4

1.3

0.38

0.42

g/l

1.84

465

1709

Synovial cyst of popliteal space [Baker]

227

2.72

11.79

1.3

0.32

0.42

g/l

1.71

159

Dental caries, including avohilmo

537

1952

1.41

11.77

1.4

0.39

0.42

g/l

0.89

363

1415

Ulcerative rectosigmoiditis

352

2.36

11.77

1.3

0.33

0.39

g/l

0.77

249

Demyelinating diseases of the central nervous system

396

2.28

11.76

1.4

0.31

0.39

g/l

2.01

286

Superficial injury of lower leg

222

1338

1.67

11.76

1.3

1.4

0.41

g/l

0.00

176

952

Abnormal involuntary movements

119

593

2.03

11.74

1.4

1.3

0.35

0.41

g/l

1.43

428

Cerebral palsy and other paralytic syndromes

104

493

2.13

11.73

1.5

1.4

0.31

0.40

g/l

3.02

360

Vitamin deficiency

173

3.00

11.71

1.5

1.3

0.36

0.40

g/l

0.45

126

Vitamin deficiency, wide

173

3.00

11.71

1.5

1.3

0.36

0.40

g/l

0.45

126

Benign neoplasm: Pancreas

3.78

11.47

1.4

1.3

0.32

0.44

g/l

1.18

Dystonia

220

2.73

11.40

1.5

1.4

0.37

0.38

g/l

0.08

159

Fibroblastic disorders

159

880

1.82

11.40

1.4

1.3

0.53

0.44

g/l

0.39

114

624

Cytomegaloviral disease

3.84

11.38

1.4

1.3

0.46

0.36

g/l

0.59

Hyperparathyroidism

129

661

1.94

11.35

1.5

1.3

0.35

0.41

g/l

1.21

469

Injury, poisoning and certain other consequences of external causes

418

1429

1.47

11.34

1.5

1.3

0.39

0.43

g/l

1.05

305

1011

Disorders of vitreous body

376

2444

1.47

11.31

1.4

0.38

0.43

g/l

1.46

291

1758

Other CVD

142

761

1.88

11.29

1.4

1.3

0.43

0.44

g/l

0.07

557

Hyperkinetic disorders

145

763

1.87

11.27

1.3

1.4

0.32

0.38

g/l

2.18

114

559

Other follicular disorders

341

2.35

11.23

1.4

0.39

0.40

g/l

0.06

239

Caries of dentine, including avohilmo

582

2160

1.38

11.22

1.4

0.39

0.42

g/l

0.91

400

1580

Disorders of vitreous body and globe

385

2503

1.46

11.22

1.4

0.38

0.43

g/l

1.71

300

1802

Tongue abnormality

222

2.70

11.20

1.6

1.5

0.39

0.40

g/l

0.13

166

Cytomegaloviral disease, including avohilmo

3.80

11.20

1.4

1.3

0.46

0.36

g/l

0.62

Allergic urticaria

354

2.32

11.18

1.3

1.4

0.34

0.39

g/l

0.87

255

Cramp and spasm

189

2.85

11.16

1.4

1.3

0.38

0.40

g/l

0.17

137

Hyperkalaemia

178

2.90

11.13

1.6

1.4

0.43

0.44

g/l

0.11

134

Cellulitis

186

1086

1.72

11.13

1.4

1.3

0.38

0.42

g/l

0.62

146

779

Special screening examination for infectious and parasitic diseases

171

699

1.79

11.12

1.5

1.3

0.35

0.39

g/l

1.31

136

431

Disorders of lipoprotein metabolism and other lipidaemias

601

2686

1.36

11.10

1.5

1.4

0.40

0.42

g/l

0.69

451

1934

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

5.91

11.09

1.3

0.36

0.39

g/l

0.12

Injuries to the thorax

348

2355

1.48

11.06

1.5

1.4

0.42

0.43

g/l

0.12

269

1669

Bullous disorders

191

2.82

10.93

1.4

0.52

0.41

g/l

0.93

141

Other retinal disorders

463

2499

1.41

10.92

1.4

0.40

0.42

g/l

0.52

326

1806

Postprocedural disorders of digestive system, not elsewhere classified

108

3.49

10.88

1.9

1.3

0.31

0.39

g/l

0.91

Disorders of continuity of bone

462

2.12

10.85

1.4

1.3

0.38

0.39

g/l

0.10

328

Umbilical hernia

212

1291

1.65

10.83

1.6

1.4

0.52

0.41

g/l

0.74

155

929

Injuries to the wrist and hand

812

4157

1.30

10.83

1.4

0.37

0.41

g/l

2.01

602

2995

CR(E)ST syndrome

4.86

10.80

1.3

1.4

0.37

0.38

g/l

0.00

Malignant neoplasm of pancreas

209

2.71

10.79

1.2

1.5

0.42

0.39

g/l

0.21

154

Paracetamol or NSAID medication

120

295

2.06

10.79

1.4

1.3

0.38

0.43

g/l

0.51

222

Hepatomegaly and splenomegaly, not elsewhere classified

8.37

10.76

1.3

0.43

0.32

g/l

0.87

Colectomy operation

128

675

1.91

10.75

1.4

1.3

0.46

0.40

g/l

0.76

487

Combined immunodeficiencies

8.34

10.74

1.4

1.2

0.33

0.34

g/l

0.08

Conductive and sensorineural hearing loss

583

2855

1.36

10.72

1.5

1.4

0.42

g/l

0.02

408

2079

Sensorineural hearing loss

546

2659

1.37

10.69

1.5

1.4

0.41

0.42

g/l

0.09

378

1934

Mouth breathing

317

2122

1.50

10.64

1.4

0.42

0.41

g/l

0.06

224

1534

Other/unspecified reactive arthropathies

282

2.45

10.60

1.4

0.46

0.37

g/l

0.91

201

Vasomotor rhinitis (mode)

270

2.48

10.58

1.9

1.4

0.32

0.38

g/l

0.81

195

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

4.08

10.56

1.4

0.39

g/l

0.00

Endometriosis

245

884

1.62

10.54

1.3

1.4

0.38

0.40

g/l

0.21

184

623

Other congenital malformations

415

2.17

10.52

1.3

1.4

0.40

0.37

g/l

0.45

310

Other diseases of arteries and capillaries

332

2.31

10.52

1.7

1.4

0.41

0.40

g/l

0.13

245

Benign neoplasm of major salivary glands

370

2.24

10.52

1.7

1.4

0.35

0.40

g/l

0.77

275

Paralytic ileus

3.60

10.50

1.3

1.2

0.42

0.50

g/l

0.43

Abnormal findings on examination of urine, without diagnosis

157

2.98

10.50

1.4

1.3

0.37

0.41

g/l

0.31

113

Fracture of rib(s), sternum and thoracic spine

229

1433

1.61

10.49

1.5

1.4

0.44

g/l

0.07

179

1009

Endometriosis of pelvic peritoneum

134

655

1.87

10.44

1.4

0.44

0.41

g/l

0.16

465

Neuromuscular dysfunction of bladder

346

2.28

10.42

1.3

0.38

0.41

g/l

0.21

256

Benign neoplasm: Caecum

430

2.14

10.41

1.6

1.4

0.35

0.41

g/l

1.02

310

Polyuria

171

995

1.73

10.39

1.4

0.39

0.42

g/l

0.62

130

709

Other/unspecified synovitis and tenosynovitis

437

2.12

10.37

1.5

1.3

0.34

0.42

g/l

1.66

307

Ulcer of lower limb, not elsewhere classified

110

558

1.99

10.36

1.2

1.4

0.39

0.42

g/l

0.35

406

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

142

3.07

10.36

1.5

1.3

0.51

0.43

g/l

0.57

110

conjunctival haemorrhage

273

2.45

10.34

1.6

1.3

0.38

0.42

g/l

0.41

203

Benign neoplasm: salivary glands, exclude unknown (D119)

335

2.30

10.32

1.7

1.4

0.35

0.40

g/l

0.73

246

Hypotension

117

607

1.94

10.31

1.3

0.41

0.45

g/l

0.31

442

Artrosis, including avohilmo

623

2546

1.34

10.27

1.4

0.40

0.41

g/l

0.21

465

1794

Diseases of external ear

280

1844

1.53

10.26

1.4

0.36

0.42

g/l

2.10

206

1325

Other demyelinating diseases of the central nervous system

165

2.91

10.23

1.5

1.4

0.30

0.38

g/l

1.33

114

Other disorders starting during childhood or adolecense, excluding more controls

199

2.67

10.21

1.4

1.3

0.34

0.35

g/l

0.09

150

Chronic suppurative otitis media

233

2.56

10.19

1.8

1.3

0.33

0.40

g/l

1.23

169

Subacute thyroiditis

118

3.28

10.17

1.5

0.28

0.39

g/l

1.66

Nummular dermatitis

306

2.35

10.15

1.5

1.4

0.35

0.42

g/l

1.04

228

Calcific aortic valvular stenosis, diagnosis (helper)

181

1034

1.69

10.15

1.5

1.4

0.46

0.44

g/l

0.19

134

741

Operations 2 for CAVS

181

1034

1.69

10.15

1.5

1.4

0.46

0.44

g/l

0.19

134

741

Other (not insulin) diabetes medications

740

3335

1.31

10.13

1.4

0.41

g/l

0.08

516

2428

Failure and rejection of transplanted organs and tissues

4.61

10.12

1.4

0.39

0.37

g/l

0.10

Procreative management

295

1613

1.51

10.11

1.5

1.4

0.36

0.38

g/l

0.55

198

1152

Other disorders of kidney and ureter

107

543

1.99

10.10

1.4

0.42

0.41

g/l

0.06

397

Viral meningitis

134

3.12

10.10

1.4

1.3

0.28

0.38

g/l

1.81

100

Diseases of inner ear

402

2721

1.42

10.10

1.3

1.4

0.40

0.42

g/l

0.56

280

1966

Episcleritis

217

2.62

10.08

1.6

1.4

0.35

0.38

g/l

0.29

165

Type of accident

238

1520

1.57

10.03

1.8

1.3

0.38

0.42

g/l

0.88

176

1075

Calcific aortic valvular stenosis

181

1039

1.68

9.98

1.5

1.4

0.46

0.44

g/l

0.17

134

746

Calcific aortic valvular stenosis, operated

181

1039

1.68

9.98

1.5

1.4

0.46

0.44

g/l

0.17

134

746

Calcific aortic valvular stenosis, including rheumatic fever

181

1038

1.68

9.97

1.5

1.4

0.46

0.44

g/l

0.18

134

744

Speech and linguistic disorders, excluding more controls

318

2.26

9.91

1.2

1.3

0.37

g/l

0.04

230

Fenamates

107

362

2.02

9.91

1.5

1.3

0.34

0.45

g/l

2.68

262

Dipeptidyl peptidase 4 (DPP-4) inhibitors

387

2129

1.43

9.91

1.4

0.47

0.42

g/l

1.01

282

1543

Cutaneous lupus erythematosus

3.98

9.91

1.2

1.3

0.50

0.36

g/l

0.68

Hordeolum and other deep inflammation of eyelid

243

2.50

9.86

1.6

1.4

0.32

0.40

g/l

1.44

178

Peritonsillar abscess

144

811

1.79

9.82

1.3

1.4

0.40

0.41

g/l

0.07

107

546

Viral meningitis, including avohilmo

147

2.98

9.81

1.4

1.3

0.30

0.38

g/l

1.01

109

Restless leg syndrome

122

654

1.88

9.80

1.7

1.3

0.36

0.40

g/l

1.05

469

Allergic purpura

3.50

9.79

1.3

0.36

0.37

g/l

0.04

Adhesive capsulitis of shoulder

123

661

1.87

9.79

1.4

1.3

0.43

0.42

g/l

0.02

470

Disorders of choroid and retina

594

3127

1.33

9.75

1.5

1.4

0.40

0.42

g/l

0.63

422

2262

Vitamin D deficiency

3.94

9.75

1.3

0.33

0.36

g/l

0.20

Viral encephalitis, not elsewhere classified/unspecified

3.94

9.75

1.4

0.39

g/l

0.01

Iron deficiency anaemia secondary to blood loss (chronic)

116

613

1.91

9.72

1.4

1.3

0.40

0.42

g/l

0.35

431

Ankylosing spondylitis, ICD10

396

2.15

9.71

1.3

0.39

g/l

0.05

280

Injuries to the head

879

4118

1.27

9.70

1.5

1.4

0.37

0.41

g/l

3.03

639

2977

Elevated blood glucose level

319

2.28

9.68

2.0

1.3

0.40

g/l

0.00

225

Unspecified haematuria

294

1603

1.50

9.66

1.6

1.4

0.40

0.43

g/l

0.89

226

1136

Anaemia in chronic diseases classified elsewhere

4.00

9.64

1.5

1.3

0.39

0.43

g/l

0.24

Achalasia of cardia

4.89

9.59

1.3

1.4

0.33

0.34

g/l

0.05

Other/unspecified cytomegaloviral diseases

3.89

9.57

1.4

1.3

0.47

0.33

g/l

0.86

Oesophageal varices

128

3.10

9.54

1.7

1.3

0.61

0.38

g/l

1.64

Isolated proteinuria

113

3.26

9.51

1.4

1.3

0.40

0.39

g/l

0.05

Other specified and unspecified retinal disorders

113

3.24

9.49

1.5

1.2

0.35

0.41

g/l

0.55

Spontaneous rupture of synovium and tendon

278

2.36

9.48

1.7

1.3

0.37

0.42

g/l

0.50

198

Adenocarcinoma of pancreas

3.74

9.47

1.2

1.3

0.52

0.38

g/l

0.71

Other diseases of gallbladder

108

3.28

9.46

1.3

0.30

0.41

g/l

1.48

Other disorders of eyelid

299

1913

1.48

9.44

1.5

1.4

0.37

0.42

g/l

2.01

222

1380

Other noninflammatory disorders of vulva and perineum

407

2.11

9.43

1.4

0.37

0.40

g/l

0.37

287

Adult respiratory distress syndrome

7.14

9.42

1.0

1.3

0.23

0.33

g/l

0.99

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

368

2.16

9.41

1.3

1.4

0.35

0.38

g/l

0.27

275

Chronic hepatitis NAS

4.83

9.38

1.2

0.53

0.37

g/l

0.59

Other and unspecified iridocyclitis

173

2.76

9.38

1.8

1.3

0.34

0.39

g/l

0.50

128

Hodgkin lymphoma, hilmo

3.47

9.37

1.6

1.3

0.41

0.36

g/l

0.31

Gingivitis and periodontal diseases

755

3026

1.29

9.37

1.4

0.40

0.42

g/l

0.41

561

2157

Prurigo nodularis

4.02

9.36

1.1

1.4

0.48

0.44

g/l

0.17

Aortic aneurysm

151

857

1.74

9.36

1.5

1.4

0.44

0.46

g/l

0.15

100

620

Malignant neoplasm of other and unspecified parts of biliary tract

4.80

9.36

1.3

0.49

0.38

g/l

0.48

Polycystic ovarian syndrome, consortium definition

548

2340

1.35

9.35

1.4

0.34

0.40

g/l

4.05

404

1721

Haemorrhage, not elsewhere classified

3.38

9.33

1.4

1.2

0.40

0.46

g/l

0.46

Viral hepatitis, IBD co-morbidity

109

3.24

9.30

1.1

1.3

0.46

0.44

g/l

0.11

Other or ill-defined heart diseases

185

2.68

9.29

1.5

1.2

0.41

0.36

g/l

0.38

130

Disorders of refraction and accommodation

244

1590

1.54

9.27

1.4

1.3

0.39

g/l

0.08

186

1147

Other localized connective tissue disorders

4.24

9.23

1.6

1.3

0.31

0.34

g/l

0.34

Other specified/unspecified bacterial intestinal infections

245

2.44

9.22

1.2

1.4

0.32

0.38

g/l

0.78

179

Any death

452

2303

1.38

9.18

1.2

1.5

0.46

0.41

g/l

1.28

320

1635

Optic neuritis

181

2.70

9.17

1.5

1.4

0.34

0.39

g/l

0.74

131

Problems related to lifestyle

452

2.03

9.17

1.3

0.37

0.41

g/l

0.46

306

Primary adrenocortical insufficiency

4.75

9.16

2.0

1.3

0.39

0.37

g/l

0.12

Immunodeficiency associated with other major defects

27.05

9.15

1.4

1.2

0.33

0.58

g/l

—

Dental pulpitis, including avohilmo

736

3676

1.29

9.15

1.4

0.38

0.41

g/l

1.38

514

2665

Kidney transplant status

222

2.52

9.15

1.7

1.3

0.45

0.40

g/l

0.48

159

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

240

1551

1.54

9.14

1.5

1.4

0.38

g/l

0.01

189

1128

Special screening examination for other diseases and disorders

405

2.09

9.12

1.2

1.3

0.36

0.42

g/l

0.81

249

Atherosclerosis, excluding cerebral and coronary sclerosis

247

1267

1.54

9.11

1.6

1.4

0.49

0.45

g/l

0.64

189

902

Conduction disorders

194

961

1.62

9.08

1.4

1.3

0.44

0.42

g/l

0.22

131

695

Dialysis

154

2.84

9.05

1.3

0.48

0.41

g/l

0.24

109

Other and unspecified disorders of vitreous body

310

2092

1.46

9.03

1.4

0.38

0.42

g/l

1.06

244

1507

Colonic or urogenital fistula

208

1322

1.58

9.02

1.3

1.4

0.48

0.42

g/l

0.34

143

944

Tuberculosis, IBD comorbidity

188

2.63

9.01

2.2

1.3

0.51

0.42

g/l

0.75

139

Substance abuse

440

2995

1.37

8.99

1.3

1.4

0.40

0.41

g/l

0.13

304

2140

Osteonecrosis

236

2.45

8.97

1.4

1.3

0.41

0.40

g/l

0.07

170

Smoking dependency

389

2.11

8.96

1.3

1.4

0.39

g/l

0.06

279

Benign neoplasm: Descending colon

255

2.38

8.92

1.4

0.40

0.41

g/l

0.10

185

Benign neoplasm: Ascending colon

108

575

1.89

8.91

1.5

1.3

0.45

0.41

g/l

0.15

412

Superficial injury of abdomen, lower back and pelvis

132

748

1.78

8.89

1.2

1.3

0.43

0.40

g/l

0.36

546

Tuberculosis, wide, including avohilmo

207

2.54

8.88

2.2

1.3

0.51

0.44

g/l

0.59

155

Malignant neoplasm, including Hilmo

668

3003

1.30

8.87

1.3

1.4

0.41

0.40

g/l

0.22

461

2204

Malignant neoplasm, wide definition

669

3007

1.30

8.86

1.3

1.4

0.41

0.40

g/l

0.23

461

2206

Mental and behavioural disorders due to tobacco

391

2.09

8.85

1.3

1.4

0.39

g/l

0.01

281

Idiopathic gout

332

2.19

8.83

1.3

0.47

0.43

g/l

0.31

241

Perforation of tympanic membrane

378

2.11

8.82

1.3

1.4

0.36

0.40

g/l

0.58

277

Hypertensive heart and/or renal disease

168

734

1.68

8.81

1.4

0.55

0.46

g/l

0.46

124

506

Ganglion

153

907

1.70

8.77

1.5

1.4

0.38

0.41

g/l

0.48

119

645

Other keratitis

101

529

1.93

8.77

1.6

1.4

0.35

0.40

g/l

1.20

385

Nonspecific lymphadenitis

251

2.38

8.77

1.4

1.3

0.47

0.36

g/l

0.65

189

Other sleep disorders

453

2.00

8.75

1.4

0.40

0.42

g/l

0.14

327

Infective dermatitis

481

1.97

8.73

1.4

1.3

0.49

0.42

g/l

0.82

353

Ulcer of oesophagus

197

2.57

8.73

1.3

1.2

0.49

0.43

g/l

0.39

143

Myeloid leukaemia

3.61

8.72

1.4

1.3

0.38

0.46

g/l

0.60

Appendectomy

502

3592

1.33

8.70

1.3

1.4

0.44

0.40

g/l

0.44

353

2600

Mental and behavioural disorders due to psychoactive substance use

452

3063

1.36

8.68

1.3

1.4

0.40

0.41

g/l

0.09

308

2192

Pemphigoid

3.78

8.65

1.5

1.3

0.54

0.48

g/l

0.24

Other endocrine disorders

242

2.37

8.58

1.3

0.36

0.38

g/l

0.20

191

Lichen planus

100

526

1.92

8.57

1.8

1.3

0.33

0.40

g/l

1.77

378

Acute bronchiolitis

255

2.29

8.57

1.4

1.3

0.38

0.36

g/l

0.13

203

Pleural plaque with presence of asbestos

211

2.49

8.55

1.3

1.2

0.56

0.47

g/l

0.58

156

Ulcerative proctitis

254

2.35

8.54

1.4

1.3

0.31

0.38

g/l

1.45

186

Hyperhidrosis

3.46

8.52

1.4

1.3

0.48

0.41

g/l

0.38

Atypical facial pain

188

2.59

8.51

1.6

1.4

0.38

0.40

g/l

0.10

141

Female infertility, cervical, vaginal, other or unspecified origin

193

769

1.61

8.46

1.4

0.37

0.40

g/l

0.43

148

550

Portal vein thrombosis

4.40

8.46

2.1

1.2

0.47

0.42

g/l

0.26

Hallux valgus (acquired)

216

993

1.56

8.46

1.5

0.40

0.44

g/l

0.76

165

719

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

160

2.73

8.45

1.3

1.4

0.34

0.38

g/l

0.40

120

Cardiodefibrillation

226

1481

1.53

8.45

1.3

1.4

0.45

g/l

0.05

135

1071

Other disorders of central nervous system

4.78

8.42

1.4

0.26

0.42

g/l

0.96

Thyroiditis

313

2.20

8.41

1.5

0.30

0.42

g/l

3.07

230

Nonischemic cardiomyopathy

345

2.13

8.41

1.2

1.4

0.47

0.39

g/l

1.01

252

Arthropathic psoriasis

524

1.91

8.35

1.3

1.4

0.44

0.40

g/l

0.53

378

Nail disorders

380

2.07

8.34

1.2

1.4

0.39

g/l

0.06

270

Infliximab

3.41

8.26

1.3

0.29

0.37

g/l

0.92

Other and unspecified coagulation defects

215

2.45

8.25

1.5

1.4

0.31

0.39

g/l

1.33

151

Olecranon bursitis

215

2.45

8.24

1.4

1.2

0.40

0.43

g/l

0.23

151

Squamous cell neoplasms and carcinomas of the skin

277

2.25

8.20

1.1

1.5

0.47

0.44

g/l

0.13

203

Other abnormal findings of blood chemistry

174

2.62

8.20

1.6

1.4

0.31

0.39

g/l

1.00

127

Non-allergic asthma

329

2.15

8.20

1.9

1.5

0.47

0.41

g/l

0.65

233

Other congenital malformations, including avohilmo

116

649

1.80

8.20

1.3

1.4

0.39

g/l

0.04

476

Abnormal blood-pressure reading, without diagnosis

140

2.82

8.18

1.7

1.4

0.31

0.40

g/l

1.77

104

Autoimmune hyperthyroidism

216

2.43

8.16

1.4

0.31

0.41

g/l

2.09

157

Seborrhoeic keratosis

180

1134

1.60

8.15

1.5

1.4

0.43

0.42

g/l

0.09

145

814

Other and unspecified haemorrhagic conditions

4.11

8.13

1.8

1.3

0.50

0.43

g/l

0.21

Psoriatic arthropathies, ICD10

501

1.92

8.12

1.3

1.4

0.42

0.39

g/l

0.53

359

Other bullous disorders

3.29

8.12

1.3

0.50

0.42

g/l

0.37

Inflammation of lacrimal passages (acute and unspecified)

4.21

8.04

1.7

1.2

0.33

0.35

g/l

0.18

Juvenile arthritis (FINNGEN)

182

2.56

8.01

1.3

1.4

0.40

0.36

g/l

0.30

133

Juvenile rheumatoid arthirtis

3.49

7.99

1.3

1.4

0.37

0.36

g/l

0.05

Stenosis and insufficiency of lacrimal passages

340

2.11

7.95

1.3

0.38

0.43

g/l

0.46

244

Excessive attrition of teeth

483

3628

1.32

7.94

1.5

1.4

0.38

0.41

g/l

1.10

358

2638

Other symptoms and signs involving cognitive functions and awareness

326

2059

1.41

7.92

1.5

1.4

0.37

0.43

g/l

1.42

235

1471

Cardiomyopathies, Primary/intrinsic

443

1.96

7.88

1.3

1.4

0.46

0.44

g/l

0.11

325

Female infertility

205

789

1.56

7.85

1.4

0.39

0.41

g/l

0.12

154

563

Peripheral artery disease

261

1408

1.47

7.84

1.5

1.4

0.50

0.44

g/l

1.10

203

999

Other extrapyramidal and movement disorders in other diseases

183

1169

1.57

7.84

1.5

1.4

0.37

0.41

g/l

1.23

144

833

Generalized anxiety disorder

136

806

1.70

7.82

1.3

0.36

0.40

g/l

0.73

105

565

Tuberculosis, wide

202

2.45

7.82

2.2

1.3

0.51

0.44

g/l

0.51

150

Pure hypercholesterolaemia

517

2498

1.32

7.81

1.4

0.41

0.43

g/l

0.50

392

1797

Other aneurysm

167

2.60

7.78

1.6

1.2

0.56

0.42

g/l

1.19

122

Phobic anxiety disorders

114

644

1.78

7.76

1.5

1.3

0.39

g/l

0.01

448

Barrett oesophagus

150

2.70

7.75

1.5

1.3

0.50

0.39

g/l

0.36

104

Allergic contact dermatitis

105

582

1.82

7.69

1.4

1.3

0.35

0.41

g/l

1.29

415

Angina pectoris

354

1693

1.39

7.69

1.5

1.4

0.44

0.41

g/l

0.60

244

1203

Other nonthrombocytopenic purpura

6.96

7.69

1.7

1.3

0.47

0.45

g/l

0.06

Other diseases of blood and blood-forming organs

241

2.31

7.68

1.3

0.32

0.39

g/l

1.02

173

Diseases of peritoneum

406

1.99

7.67

1.5

1.4

0.63

0.41

g/l

0.66

296

Desensitization to allergens

267

2.24

7.66

1.4

0.35

0.37

g/l

0.33

190

Vulvovaginal ulceration/inflammation in other diseases

319

2.12

7.65

1.5

1.4

0.40

g/l

0.03

234

Iron deficiency

140

2.76

7.64

1.3

0.40

0.37

g/l

0.31

105

Fracture of lumbar spine and pelvis

152

932

1.64

7.64

1.3

1.4

0.45

0.42

g/l

0.43

108

663

Diseases of pulp and periapical tissues and dental caries

456

1745

1.34

7.61

1.4

1.3

0.39

0.42

g/l

0.97

309

1264

Dislocation, sprain and strain of joints and ligaments of knee

476

3275

1.32

7.60

1.4

0.36

0.41

g/l

2.58

345

2356

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

356

2.04

7.55

1.1

1.4

0.45

0.44

g/l

0.11

262

Other psoriatic arthropathies

486

1.89

7.52

1.3

1.4

0.42

0.39

g/l

0.57

351

Other obstructive and reflux uropathy

141

2.73

7.52

1.2

1.3

0.54

0.40

g/l

0.49

105

Later onset COPD

154

759

1.64

7.52

1.2

1.4

0.54

0.44

g/l

1.74

114

542

Acne

519

1.85

7.49

1.3

0.41

0.39

g/l

0.26

372

Other specified and unspecified disorders of eyelid

4.50

7.48

2.0

1.3

0.21

0.45

g/l

2.27

Hypertensive Heart Disease

148

682

1.65

7.45

1.4

0.55

0.46

g/l

0.39

107

468

Glaucoma

376

2352

1.36

7.45

1.4

0.40

0.43

g/l

0.31

255

1710

Other/unspecified enthesopathies, not elsewhere classified

296

2.15

7.43

1.9

1.3

0.36

0.42

g/l

0.65

213

Pacemaker

218

1357

1.50

7.43

1.3

1.4

0.44

g/l

0.03

141

973

Trigeminal neuralgia

226

2.33

7.42

1.8

1.4

0.34

0.39

g/l

0.42

167

Symptoms and signs involving emotional state

120

2.88

7.41

1.2

1.3

0.30

0.36

g/l

0.79

Acute myeloid leukaemia and myelodysplastic syndromes

3.79

7.38

1.5

1.2

0.49

0.38

g/l

0.72

Unspecified misadventure during surgical and medical care

208

2.38

7.37

1.5

1.3

0.43

0.39

g/l

0.30

151

Benign paroxysmal vertigo

209

1394

1.51

7.37

1.3

1.4

0.38

0.40

g/l

0.38

144

1001

Testicular dysfunction

172

2.54

7.36

1.3

1.2

0.33

0.39

g/l

0.37

117

Vascular diseases of the intestine

104

3.02

7.36

1.1

1.2

0.46

0.44

g/l

0.09

Atrophic disorders of skin

121

709

1.72

7.34

1.5

1.4

0.35

0.40

g/l

1.30

506

Disorders resulting from impaired renal tubular function

132

2.77

7.32

1.3

0.55

0.43

g/l

0.36

Disorders of plasma-protein metabolism, not elsewhere classified

7.66

7.30

1.5

1.3

0.33

0.32

g/l

—

Lateral epicondylitis

541

1.82

7.29

1.5

1.3

0.38

0.42

g/l

0.46

376

Other and unspecified follicular disorders

161

2.58

7.29

1.7

1.3

0.38

0.40

g/l

0.20

114

Acute peritonitis

228

2.31

7.27

1.5

1.3

0.44

0.42

g/l

0.13

167

Complications following infusion, transfusion and therapeutic injection

4.39

7.26

1.7

1.2

0.34

0.44

g/l

0.54

Diabetes insipidus

4.65

7.26

2.1

1.3

0.27

0.33

g/l

—

Follicular lymphoma, hilmo

144

2.68

7.25

1.6

1.4

0.27

0.40

g/l

1.69

106

256

1599

1.44

7.24

1.5

1.4

0.43

g/l

0.01

193

1141

Anogenital herpesviral [herpes simplex] infection, including avohilmo

550

1.81

7.23

1.4

1.5

0.40

0.39

g/l

0.12

394

Cardiomyopathy (excluding other)

464

1.89

7.22

1.4

1.3

0.46

0.45

g/l

0.08

340

Otitis externa

182

1185

1.54

7.21

1.4

1.3

0.35

0.40

g/l

1.27

142

850

Other epidermal thickening

156

2.60

7.21

1.4

0.36

0.42

g/l

0.56

119

Oral lichen planus

3.17

7.17

2.0

1.3

0.30

0.35

g/l

0.54

Gluteal tendinitis

145

2.65

7.15

1.3

1.4

0.32

0.43

g/l

1.84

107

Testicular hypofunction

157

2.59

7.14

1.3

1.2

0.34

0.40

g/l

0.31

108

Eustachian salpingitis and obstruction

397

1.96

7.10

1.6

1.3

0.33

0.40

g/l

1.24

282

Myocardial infarction

294

1459

1.41

7.07

1.4

0.45

0.42

g/l

0.40

216

1025

Amyloidosis

3.67

7.06

1.5

1.3

0.25

0.45

g/l

1.88

Acute epiglottitis

4.28

7.05

1.7

1.3

0.40

0.43

g/l

—

Scar conditions and fibrosis of skin

158

2.57

7.04

1.2

1.4

0.30

0.39

g/l

1.79

116

Nonpyogenic thrombosis of intracranial venous system

4.52

7.03

1.3

0.27

0.36

g/l

1.09

Morphin

3.91

7.00

1.6

1.2

0.75

0.61

g/l

0.36

Impingement syndrome of shoulder

154

973

1.59

6.97

1.4

0.36

0.43

g/l

2.45

124

694

Other disorders of optic [2nd] nerve and visual pathways

252

2.21

6.95

1.7

1.3

0.37

0.39

g/l

0.18

186

Paralytic strabismus

252

2.20

6.95

1.6

1.4

0.36

0.41

g/l

0.52

183

Intracranial injury

435

3090

1.31

6.94

1.5

1.4

0.37

0.42

g/l

1.97

318

2224

Unspecified fall

377

2767

1.34

6.94

1.5

1.4

0.39

0.41

g/l

0.55

262

2012

Unspecific neurodegenerative disorder

105

1226

0.58

6.93

1.2

1.4

0.39

0.45

g/l

1.08

871

Decubitus ulcer and pressure area

171

2.48

6.92

1.6

1.2

0.45

0.47

g/l

0.09

127

Noninflammatory disorders of female genital tract

271

945

1.44

6.92

1.5

1.3

0.38

0.40

g/l

0.44

195

671

Acute nasopharyngitis (common cold)

474

1.85

6.92

1.3

1.4

0.41

0.44

g/l

0.20

317

Other contact dermatitis

305

2.08

6.91

1.6

1.4

0.31

0.41

g/l

1.89

227

Other shoulder lesions

366

1.98

6.91

1.3

0.60

0.42

g/l

0.32

257

Appendicitis, broad definition

553

3903

1.27

6.89

1.4

0.40

0.41

g/l

0.05

381

2831

Intestinal adhesions without obstruction

279

2.13

6.88

1.7

1.4

0.39

0.43

g/l

0.36

202

Contact with and exposure to communicable diseases

253

1771

1.43

6.82

1.4

0.32

0.39

g/l

2.22

135

1305

Other embolism and thrombosis

524

1.81

6.81

1.7

1.3

0.43

0.40

g/l

0.27

385

Golimumab

161

2.53

6.79

1.2

1.3

0.40

0.36

g/l

0.31

121

Diseases of appendix

556

3921

1.27

6.78

1.4

0.40

0.41

g/l

0.07

384

2845

Disorders of adult personality and behaviour

229

1584

1.45

6.77

1.3

1.4

0.36

0.39

g/l

0.91

165

1133

Skin changes due to chronic exposure to nonionizing radiation

237

1489

1.45

6.77

1.5

1.4

0.43

0.44

g/l

0.10

176

1054

Abnormal findings in nipple discharge synovial fluid wound secretions

3.98

6.76

1.5

1.3

0.34

0.37

g/l

0.14

Other specified and unspecified disorders of eye and adnexa

138

2.65

6.74

1.2

1.4

0.31

0.36

g/l

0.40

105

Acute appendicitis, no complications

423

3213

1.31

6.71

1.4

0.38

0.41

g/l

0.80

290

2330

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

302

2.07

6.71

1.6

1.4

0.40

g/l

0.02

220

Duodenal ulcer

322

2.03

6.70

1.2

1.3

0.53

0.44

g/l

0.66

236

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

109

638

1.72

6.68

1.4

0.39

0.41

g/l

0.24

466

Fracture of foot, except ankle

195

1311

1.49

6.68

1.4

1.3

0.38

0.41

g/l

0.54

151

930

Benign neoplasm: Parotid gland

296

2.08

6.67

1.5

1.4

0.34

0.40

g/l

0.79

218

Other disorders of patella

122

736

1.67

6.67

1.2

1.4

0.37

0.40

g/l

0.67

517

Personality disorders

215

1475

1.46

6.65

1.3

1.4

0.37

0.40

g/l

0.46

153

1052

Other/unspecified enthesopathies of lower limb, excluding foot

270

2.13

6.64

1.2

1.3

0.44

0.45

g/l

0.14

197

Malignant neoplasm

632

2951

1.26

6.63

1.3

1.4

0.40

g/l

0.06

429

2170

Hidradenitis suppurativa

169

2.46

6.63

1.3

1.4

0.40

0.36

g/l

0.45

120

Benign neoplasm of mouth and pharynx

464

1.85

6.61

1.4

1.3

0.34

0.40

g/l

1.07

333

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

7.13

6.61

1.3

1.2

0.43

0.32

g/l

—

Localized scleroderma [morphea]

4.24

6.59

1.4

1.3

0.31

0.33

g/l

0.18

Malignant neoplasm

630

2943

1.26

6.59

1.3

1.4

0.40

g/l

0.02

428

2164

Other juvenile arthritis

176

2.42

6.55

1.3

1.4

0.40

0.39

g/l

0.12

125

Other and unspecified acquired haemolytic anaemias

6.39

6.54

1.9

1.3

0.36

0.31

g/l

—

Acne vulgaris

387

1.92

6.53

1.2

1.3

0.41

0.38

g/l

0.24

272

Thoracic aortic aneurysm

102

591

1.74

6.50

1.6

1.4

0.42

g/l

0.03

430

MS-disease / Multiple Sclerosis

327

2.01

6.47

1.4

0.29

0.38

g/l

1.91

240

Injuries to the shoulder and upper arm

637

3953

1.25

6.45

1.4

0.40

0.41

g/l

0.11

465

2838

Fracture at wrist and hand level

268

1918

1.40

6.45

1.3

1.4

0.37

0.41

g/l

1.20

182

1364

Corneal ulcer

142

898

1.59

6.45

1.6

1.3

0.39

0.40

g/l

0.11

643

DVT of lower extremities

127

782

1.63

6.43

1.4

1.3

0.41

g/l

0.05

567

Major coronary heart disease event excluding revascularizations

367

1810

1.34

6.43

1.3

1.4

0.44

0.42

g/l

0.44

269

1272

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

281

2.08

6.43

1.4

1.3

0.34

0.36

g/l

0.21

218

Plantar fascial fibromatosis

369

1.94

6.42

1.4

1.3

0.57

0.42

g/l

0.31

257

Occupational exposure to risk-factors

119

2.73

6.37

1.7

1.2

0.52

0.43

g/l

0.49

Haemorrhage in early pregnancy

212

1421

1.46

6.35

1.2

1.5

0.34

0.38

g/l

2.05

162

1057

Disorders of lacrimal system and orbit in diseases classified elsewhere

3.14

6.35

1.3

0.44

0.32

g/l

0.84

Pneumonitis due to solids and liquids

255

2.13

6.35

1.3

1.2

0.35

0.42

g/l

0.62

190

Superficial injury of wrist and hand

171

1132

1.52

6.34

1.4

0.34

0.41

g/l

1.62

133

815

Benign neoplasm: Rectum

125

770

1.63

6.33

1.5

1.4

0.37

0.42

g/l

1.27

103

553

Unspecified nephritic syndrome

3.22

6.33

1.6

1.3

0.58

0.41

g/l

0.81

Hypertrophic disorders of skin

236

2.18

6.33

1.3

1.4

0.35

0.38

g/l

0.28

170

Endocrine disorders, other/unspecified

3.40

6.32

1.2

1.3

0.17

0.35

g/l

—

Alzheimer disease, including avohilmo

1006

0.56

6.30

1.4

0.41

0.45

g/l

0.48

709

Recurrent dislocation of patella

198

2.30

6.29

1.1

1.4

0.33

0.39

g/l

0.88

140

Hypercalcemia

149

2.52

6.29

1.2

1.4

0.65

0.41

g/l

0.46

108

Actinic keratosis

227

1443

1.44

6.29

1.5

1.4

0.40

0.44

g/l

0.90

168

1022

Other hearing loss

174

1120

1.51

6.28

1.5

1.4

0.38

0.44

g/l

1.63

115

798

Myocardial infarction, strict

268

1357

1.40

6.26

1.4

0.45

0.43

g/l

0.22

200

949

Other abnormal uterine and vaginal bleeding

155

715

1.56

6.26

1.3

1.4

0.36

0.40

g/l

0.85

109

501

Impetigo

205

2.27

6.26

1.4

1.3

0.53

0.38

g/l

0.51

159

Other and unspecified diseases of blood and blood-forming organs

3.10

6.22

1.4

1.3

0.32

0.41

g/l

0.68

Extrapyramidal and movement disorders

261

1878

1.39

6.22

1.6

1.4

0.37

0.43

g/l

2.07

193

1351

Radial styloid tenosynovitis [de Quervain]

199

2.28

6.22

1.7

1.4

0.49

0.38

g/l

0.99

145

Ingrowing nail

225

2.20

6.21

1.2

1.3

0.44

0.39

g/l

0.39

163

Alopecia areata

104

2.84

6.19

1.4

0.46

0.36

g/l

0.60

Thyrotoxicosis, other and/or unspecified

146

939

1.56

6.18

1.3

1.4

0.34

0.39

g/l

1.67

107

669

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

233

1648

1.42

6.15

1.2

1.4

0.38

0.41

g/l

0.77

168

1194

Glucagon-like peptide-1 (GLP-1) analogues

233

1648

1.42

6.15

1.2

1.4

0.38

0.41

g/l

0.77

168

1194

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

229

1616

1.42

6.12

1.2

1.4

0.37

0.41

g/l

1.09

174

1161

Use of pramipexole

150

973

1.55

6.12

1.4

0.35

0.41

g/l

1.63

108

695

Allergic colitis

116

2.72

6.11

1.4

0.33

0.39

g/l

0.54

Alcoholic liver disease

390

1.89

6.11

1.2

1.4

0.45

0.37

g/l

1.11

289

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

222

1560

1.43

6.08

1.3

1.4

0.40

0.41

g/l

0.16

162

1106

Lichen simplex chronicus

105

2.80

6.07

1.3

0.44

0.41

g/l

0.21

Abscess of anal and rectal regions

349

1.94

6.05

1.3

0.37

0.40

g/l

0.40

246

Epilepsy

204

1408

1.45

6.04

1.3

1.4

0.39

0.43

g/l

0.75

155

1034

Other dialysis

117

2.69

6.02

1.2

1.3

0.40

0.42

g/l

0.13

Hypersplenism

8.54

5.95

1.3

0.59

0.36

g/l

—

Arthropathies in other diseases classified elsewhere

112

2.71

5.94

1.3

1.4

0.38

0.42

g/l

0.29

Disorders of psychological development

102

562

1.69

5.90

1.3

1.4

0.35

0.38

g/l

0.51

406

Autoimmune thyroiditis

3.35

5.89

1.2

1.3

0.31

0.40

g/l

0.65

Benign neoplasm: Rectum, anus and anal canal

135

863

1.57

5.89

1.4

0.37

0.42

g/l

0.97

108

620

Other disorders of bladder

460

1.79

5.88

1.3

0.44

0.43

g/l

0.03

335

Degenerative diseases of the nervous system

1050

0.58

5.87

1.2

1.4

0.40

0.44

g/l

0.64

745

Superficial injury of hip and thigh

101

602

1.69

5.84

1.4

1.3

0.40

g/l

0.07

426

Artificial opening status

186

2.28

5.82

1.5

0.33

0.44

g/l

1.39

142

Type 1 diabetes

184

1259

1.47

5.79

1.4

1.3

0.42

0.40

g/l

0.14

131

910

Diabetic maculopathy, excluding more controls

426

1.82

5.79

1.4

0.42

0.39

g/l

0.30

305

Benign neoplasm: Sigmoid colon

128

812

1.58

5.79

1.6

1.4

0.37

0.42

g/l

1.10

587

Mature T/NK-cell lymphomas, hilmo

4.00

5.75

1.3

0.26

0.36

g/l

—

Adjustment and management of implanted device

108

658

1.65

5.75

1.1

1.4

0.42

0.45

g/l

0.22

479

Acute posthaemorrhagic anaemia

2.94

5.74

1.3

0.38

0.44

g/l

0.31

Bell's palsy

508

1.74

5.74

1.4

1.3

0.34

0.42

g/l

2.00

361

Convalescence

200

2.22

5.74

1.5

0.36

0.38

g/l

0.13

142

Trigger finger

583

1.69

5.72

1.4

1.3

0.38

0.42

g/l

0.66

413

Acute appendicitis

512

3798

1.25

5.69

1.4

0.41

g/l

0.01

356

2752

Abnormalities of gait and mobility

458

1.78

5.67

1.4

1.3

0.40

0.43

g/l

0.25

337

Statin medication

511

2281

1.26

5.67

1.4

0.38

0.40

g/l

0.55

368

1603

Endometriosis of rectovaginal septum and vagina

288

2.00

5.65

1.6

1.4

0.36

0.42

g/l

0.71

201

Urethritis and urethral syndrome

3.23

5.62

1.4

0.33

0.37

g/l

0.30

Thyrotoxicosis

182

1255

1.46

5.57

1.5

1.4

0.34

0.39

g/l

1.88

133

895

Other and unspecified aplastic anaemias

4.74

5.54

1.5

1.3

0.51

0.36

g/l

—

Other and unspecified psoriasis

263

2.03

5.53

1.2

1.4

0.46

0.41

g/l

0.40

196

Excessive vomiting in pregnancy

382

1.85

5.53

1.4

1.5

0.37

0.38

g/l

0.10

281

Heterophoria

375

1.86

5.52

1.6

1.4

0.37

g/l

0.02

264

Bruxism

2.95

5.50

1.4

0.36

g/l

0.00

Endometriosis ASRM stages 1,2

137

894

1.54

5.50

1.4

0.44

0.37

g/l

0.53

645

Spasmodic torticollis

123

2.56

5.48

1.7

1.4

0.41

0.36

g/l

0.22

Glaucoma suspect

238

1725

1.38

5.48

1.4

0.43

g/l

0.01

159

1247

Strabismus

200

1404

1.43

5.48

1.7

1.4

0.39

g/l

0.02

140

1012

Lichen ruber planus, wide definition including periferal and oral lichen planus

161

1088

1.49

5.47

1.7

1.4

0.37

0.41

g/l

1.11

124

783

AV-block

501

1.68

5.47

1.3

1.4

0.50

0.42

g/l

1.00

366

Otitis externa, unspecified

554

1.69

5.44

1.4

0.36

0.40

g/l

0.54

408

Crohn disease (strict definition, all UC cases excluded)

218

2.13

5.43

1.1

1.3

0.37

0.36

g/l

0.06

154

Infections with a predominantly sexual mode of transmission, including avohilmo

306

2109

1.33

5.43

1.3

1.4

0.38

0.39

g/l

0.19

229

1510

Female genital prolapse

185

702

1.47

5.42

1.8

1.3

0.38

0.40

g/l

0.35

130

498

Ventral hernia

157

1058

1.49

5.41

1.4

0.50

0.42

g/l

0.36

120

760

Speech and linguistic disorders

446

1.75

5.37

1.4

1.3

0.35

0.37

g/l

0.14

333

Drug-induced neutropenia

287

1.97

5.36

1.5

1.4

0.40

0.38

g/l

0.12

210

Amyloidosis, other/unspecified

3.60

5.35

1.4

1.3

0.22

0.42

g/l

1.70

Alcohol abuse, main dg, excluding more controls

106

656

1.62

5.35

1.3

1.4

0.40

0.43

g/l

0.38

460

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

143

948

1.52

5.34

1.4

0.49

0.39

g/l

0.47

100

679

Other disorders starting during childhood or adolescence

278

1.98

5.31

1.4

0.34

0.36

g/l

0.21

216

Other erythematous conditions

125

2.51

5.31

1.3

1.4

0.37

0.38

g/l

0.08

Benign neoplasm of other and unspecified endocrine glands

100

612

1.64

5.29

1.4

1.3

0.34

0.40

g/l

1.13

446

Other and unspecified glaucoma

207

2.14

5.29

1.5

1.3

0.30

0.47

g/l

3.38

150

Tubulo-interstitial nephritis, not specified as acute or chronic

214

2.12

5.26

1.3

1.4

0.45

0.41

g/l

0.29

159

Injuries to the neck

175

1212

1.45

5.26

1.4

0.36

0.41

g/l

1.35

136

860

Striking against or struck by other objects

257

1898

1.36

5.25

1.4

0.34

0.41

g/l

3.00

174

1357

Dermatophytosis, including avohilmo

469

3678

1.25

5.24

1.4

0.39

0.40

g/l

0.37

339

2630

Valvular operations

492

1.72

5.23

1.5

1.4

0.47

0.44

g/l

0.19

365

Pure hyperglyceridaemia

2.92

5.22

1.4

0.38

0.41

g/l

0.12

Papilloedema, unspecified

2.92

5.22

1.4

1.3

0.30

0.40

g/l

1.12

Erosion of teeth , including avohilmo

209

1497

1.40

5.21

1.3

1.4

0.37

0.38

g/l

0.18

149

1074

Presence of cardiac and vascular implants and grafts

251

1352

1.37

5.21

1.5

1.4

0.44

0.45

g/l

0.12

190

991

Familial hypercholesterolemia

561

1.67

5.20

1.6

1.4

0.41

0.44

g/l

0.31

401

Congenital malformations of the urinary system

256

2.01

5.19

1.2

1.3

0.43

0.38

g/l

0.48

188

Other hammer toe(s) (acquired)

100

557

1.64

5.18

1.6

1.5

0.37

0.41

g/l

0.65

402

Persistent mood disorders

135

891

1.52

5.17

1.3

1.4

0.34

0.41

g/l

2.45

105

619

Artificial joint operation, meniscal resection

627

3295

1.22

5.16

1.4

0.40

0.42

g/l

0.52

448

2366

Other condition

111

702

1.59

5.14

1.8

1.3

0.37

0.40

g/l

0.62

504

Tuberculosis

164

2.27

5.14

2.2

1.3

0.50

0.43

g/l

0.47

122

Disorders of tooth development and eruption

109

554

1.61

5.14

1.4

1.3

0.32

0.41

g/l

2.46

396

Calculus of kidney and ureter

195

1386

1.41

5.09

1.4

0.41

0.44

g/l

0.51

139

995

Malignant neoplasm of eye, brain and central nervous system

146

2.35

5.09

1.4

0.34

0.35

g/l

0.07

111

Mantle cell lymphoma, including Hilmo

4.55

5.09

1.8

1.3

0.27

0.30

g/l

—

Biguanides

677

3387

1.21

5.07

1.4

0.41

g/l

0.18

481

2454

Propionic acid derivatives

182

629

1.46

5.07

1.4

1.3

0.34

0.43

g/l

3.37

135

451

Anti-inflammatory and antirheumatic products, non-steroids

182

629

1.46

5.07

1.3

0.37

0.43

g/l

1.30

133

451

Flat foot [pes planus] (acquired)

364

1.83

5.06

1.3

1.6

0.64

0.42

g/l

0.34

265

Alzheimer disease

849

0.57

5.06

1.2

1.4

0.40

0.46

g/l

0.71

605

Right bundle-branch block

116

2.53

5.05

1.1

1.2

0.43

0.39

g/l

0.22

Oral lichen planus, including avohilmo , including avohilmo

294

1.92

5.02

1.5

0.35

0.39

g/l

0.62

209

Amenorrhoea

294

1.92

5.01

1.8

1.5

0.33

0.39

g/l

1.08

213

Other and unspecified epidermal thickening

2.67

5.01

1.3

0.39

0.41

g/l

0.08

Specific development disorders of scholastic skills

234

2.03

5.00

1.4

1.3

0.29

0.37

g/l

1.51

174

Sleep disorders, other/unspecified

160

2.28

5.00

1.2

1.4

0.33

0.38

g/l

0.67

113

Lesion of lateral popliteal nerve

180

2.19

4.95

1.5

1.3

0.40

0.42

g/l

0.19

125

Poisoning by drugs, medicaments and biological substances

180

1269

1.42

4.94

1.3

1.4

0.36

0.40

g/l

0.68

129

911

Perioral dermatitis

2.70

4.94

1.5

1.3

0.47

0.37

g/l

0.55

Maternal care for other conditions predominantly related to pregnancy

162

1092

1.45

4.92

1.2

1.4

0.37

g/l

0.03

117

818

Spondylopathies in diseases classified elsewhere

4.66

4.90

1.2

1.3

0.44

0.58

g/l

—

Neovascular glaucoma

124

2.44

4.89

1.5

1.3

0.39

0.41

g/l

0.11

Abrasion of teeth

266

2002

1.33

4.88

1.3

1.4

0.35

0.41

g/l

1.96

195

1443

Vitamin B12 deficiency anaemia

318

1.87

4.88

1.3

1.4

0.43

g/l

0.03

232

Other female pelvic inflammatory diseases

112

720

1.56

4.86

1.3

1.4

0.40

g/l

0.01

513

Other problems related to primary support group, including family circumstances

586

1.62

4.85

1.4

0.36

0.38

g/l

0.25

431

Diseases of male genital organs

347

1345

1.30

4.85

1.4

0.38

0.43

g/l

1.57

254

942

Other maternal disorders predominantly related to pregnancy

409

2022

1.27

4.84

1.3

1.4

0.36

0.40

g/l

1.42

299

1502

Hypocalcemia

2.87

4.84

1.4

1.3

0.41

0.42

g/l

0.06

Ptosis of eyelid

414

1.75

4.83

1.8

1.3

0.29

0.42

g/l

3.91

300

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

327

1.85

4.81

1.3

0.36

g/l

0.05

226

Malignant neoplasm of digestive organs, including Hilmo

272

1504

1.33

4.79

1.4

1.5

0.44

0.43

g/l

0.17

183

1109

Congenital malformations of the urinary system, including avohilmo

271

1.94

4.78

1.2

1.3

0.44

0.38

g/l

0.49

200

Suppurative otitis media, unspecified

2.91

4.77

1.7

1.4

0.42

0.39

g/l

0.09

Tobacco use

223

2.04

4.77

1.3

0.39

g/l

0.00

158

Dermatitis due to ingested food

162

2.21

4.77

1.2

1.4

0.29

0.38

g/l

1.74

134

Specific personality disorders

180

1279

1.41

4.75

1.3

1.4

0.38

0.39

g/l

0.19

134

914

Other and unspecified nail disorders

2.83

4.74

1.3

0.34

0.40

g/l

0.39

Tinnitus

160

1114

1.44

4.73

1.4

0.39

0.42

g/l

0.39

120

800

Osteomyelitis

224

2.03

4.71

1.5

1.2

0.38

0.41

g/l

0.25

165

Chronic Coagulation defects

2.68

4.68

1.8

1.3

0.31

0.38

g/l

0.52

Any dementia

106

1128

0.65

4.68

1.2

1.4

0.42

0.45

g/l

0.36

798

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

374

1.78

4.67

1.3

1.4

0.49

0.40

g/l

1.05

270

Other nonscarring hair loss

4.40

4.67

1.1

1.4

0.40

0.33

g/l

—

Oesophageal obstruction

2.66

4.66

1.3

1.2

0.66

0.43

g/l

0.43

Achilles tendinitis

411

1.74

4.66

1.7

1.3

0.37

0.44

g/l

1.85

299

Other and unspecified myopathies

309

1.86

4.65

1.4

1.3

0.34

0.42

g/l

1.11

228

Other disorders of the musculoskeletal system and connective tissue

104

665

1.57

4.64

1.5

1.4

0.35

0.40

g/l

0.75

482

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

218

1607

1.36

4.62

1.2

1.4

0.33

0.39

g/l

2.08

154

1158

Any event in cancer register

668

3259

1.20

4.62

1.3

1.4

0.41

0.40

g/l

0.10

463

2398

Artificial joint re-operation

226

2.01

4.60

1.3

1.5

0.41

0.43

g/l

0.21

169

Benign neoplasm: Pituitary gland, craniopharyngeal duct

206

2.06

4.59

1.4

1.3

0.38

0.39

g/l

0.02

152

Glaucoma secondary to other eye disorders

128

2.37

4.59

1.5

1.3

0.39

0.45

g/l

0.31

Carcinoma in situ of skin of other and unspecified parts of face

240

1.97

4.58

1.3

0.52

0.43

g/l

0.47

186

Gonarthrosis,primary

592

2953

1.21

4.57

1.4

0.40

0.42

g/l

0.76

445

2120

Schizophrenia

798

0.51

4.57

1.1

1.4

0.40

0.39

g/l

0.03

562

Graves ophthalmopathy, strict

2.76

4.54

1.3

1.4

0.41

0.36

g/l

0.38

Mixed conductive and sensorineural hearing loss

452

1.69

4.54

1.4

1.3

0.42

0.39

g/l

0.24

324

Acne, including avohilmo

170

971

1.42

4.53

1.4

1.3

0.41

0.38

g/l

0.53

133

704

Infections with a predominantly sexual mode of transmission

228

1694

1.35

4.52

1.4

0.38

g/l

0.09

175

1197

Other and unspecified injuries of lower leg

356

1.78

4.52

1.4

1.3

0.40

0.38

g/l

0.13

249

Hyperaldosteronism

2.68

4.51

1.6

1.2

0.46

0.44

g/l

0.06

Excessive earwax

439

3217

1.24

4.50

1.5

1.4

0.43

0.41

g/l

0.21

301

2336

Convergence insufficiency and excess

3.48

4.49

1.2

1.3

0.38

0.36

g/l

—

Arterial embolism and thrombosis

161

2.19

4.49

1.3

1.2

0.35

0.45

g/l

1.28

122

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

129

845

1.49

4.46

1.2

1.4

0.39

g/l

0.00

100

631

Poisoning by medicine

162

1144

1.42

4.46

1.3

1.4

0.36

0.39

g/l

0.44

112

815

Injuries to the hip and thigh

314

2192

1.29

4.45

1.4

0.41

0.43

g/l

0.31

246

1560

Medial epicondylitis

130

2.33

4.44

1.4

0.45

0.36

g/l

0.62

Other chondrocalcinosis

4.15

4.44

1.6

1.4

0.41

0.50

g/l

0.33

Sudden idiopathic hearing loss

395

1.73

4.44

1.9

1.3

0.39

g/l

0.04

290

Visual impairment including blindness (binocular or monocular)

223

1.99

4.40

1.3

0.38

0.42

g/l

0.39

160

Type 1 diabetes, wide definition, subgroup 1

140

965

1.46

4.37

1.4

1.3

0.37

0.40

g/l

0.41

106

728

Cauda equina syndrome

3.27

4.37

1.2

1.4

0.35

0.34

g/l

—

Bacterial, viral and other infectious agents, including avohilmo

412

1.71

4.37

1.4

0.35

0.38

g/l

0.27

286

Dementia, including avohilmo

148

1436

0.70

4.37

1.2

1.4

0.40

0.44

g/l

0.49

103

1014

Thyrotropin deficiency

3.42

4.36

1.5

1.3

0.38

0.33

g/l

—

Superficial injury of ankle and foot

636

1.57

4.36

1.5

1.3

0.36

0.38

g/l

0.23

457

Discitis, unspecified

3.25

4.36

1.4

1.2

0.58

0.61

g/l

—

Degeneration of macula and posterior pole

278

1646

1.31

4.33

1.4

0.39

0.43

g/l

0.94

204

1196

Contusion of toe(s) without damage to nail

101

2.51

4.31

1.4

1.2

0.40

0.37

g/l

0.20

Obsessive-compulsive disorder

274

1.87

4.30

1.5

1.3

0.32

0.40

g/l

1.81

187

Deficiency of other B group vitamins

2.99

4.30

1.8

1.2

0.45

0.39

g/l

0.30

Myopia

103

670

1.55

4.30

1.3

1.4

0.36

0.38

g/l

0.24

470

Tuberculosis of other organs, strict, including avohilmo

2.99

4.30

1.9

1.3

0.53

0.46

g/l

0.19

Lichen planus, including avohilmo

131

896

1.47

4.29

1.8

1.4

0.36

0.41

g/l

0.99

102

635

Use of anticholinesterases

1044

0.63

4.29

1.3

1.4

0.41

0.45

g/l

0.41

743

N06DA Anticholinesterases

1044

0.63

4.29

1.3

1.4

0.41

0.45

g/l

0.41

743

Thyrotoxicosis with diffuse goitre

639

1.56

4.28

1.5

1.3

0.32

0.39

g/l

1.71

456

Anogenital herpesviral [herpes simplex] infection

297

1.83

4.25

1.5

1.4

0.37

0.38

g/l

0.02

215

D07AA Corticosteroids, weak (group I)

118

791

1.50

4.25

1.5

1.4

0.36

0.39

g/l

0.76

587

Urolithiasis

204

1511

1.35

4.23

1.4

0.41

0.44

g/l

0.56

142

1082

Other specified/unspecified dorsopathies

2.58

4.23

1.6

1.4

0.35

0.41

g/l

0.53

Transport accidents

333

2187

1.27

4.22

1.5

1.3

0.38

0.42

g/l

1.49

246

1593

Panniculitis affecting regions of neck and back

102

2.47

4.22

1.7

1.4

0.36

0.47

g/l

0.93

Mantle cell lymphoma

4.93

4.22

1.8

1.2

0.30

0.33

g/l

—

KRA_PSY_EATING, excluding more controls

317

1.79

4.18

1.3

0.30

0.39

g/l

1.80

224

Scoliosis

313

1.80

4.18

1.3

0.37

0.44

g/l

0.92

228

Other specified and unspecified personality disorders

410

1.69

4.18

1.3

1.4

0.34

0.38

g/l

0.71

291

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

133

891

1.46

4.17

1.2

1.4

0.39

g/l

0.02

102

662

Event of undetermined intent

292

1.83

4.16

1.2

1.3

0.41

0.39

g/l

0.10

209

Other disorders of nervous system

249

1.90

4.16

1.3

1.5

0.42

0.38

g/l

0.30

186

Leisure time condition

130

894

1.46

4.16

1.8

1.3

0.39

0.41

g/l

0.30

636

Speech therapy

170

1227

1.39

4.15

1.6

1.4

0.41

g/l

0.06

158

869

Acute gastritis

235

1.93

4.15

1.5

1.3

0.37

0.40

g/l

0.28

172

Unspecified privation

464

1.65

4.15

1.6

1.4

0.32

0.39

g/l

1.54

336

Necrosis of pulp, including avohilmo

429

3460

1.23

4.12

1.4

0.40

0.41

g/l

0.07

297

2513

Other and unspecified disorders of skin and subcutaneous tissue

222

1.95

4.11

1.6

1.4

0.30

0.41

g/l

2.75

163

Ankylosing spondylitis, strict definition

188

2.04

4.10

1.2

1.3

0.43

0.34

g/l

0.80

135

Respiratory tuberculosis

148

2.18

4.09

2.3

1.3

0.50

0.43

g/l

0.46

109

Respiratory tuberculosis, confirmed and not-confirmed

148

2.18

4.09

2.3

1.3

0.50

0.43

g/l

0.46

109

Other disorders of bone density and structure

2.66

4.08

1.3

0.37

0.34

g/l

0.12

Viral conjunctivitis, including avohilmo

155

2.15

4.07

1.5

1.3

0.31

0.39

g/l

1.00

118

Cerebrovascular diseases

476

2714

1.22

4.06

1.3

1.4

0.44

0.41

g/l

0.48

358

1927

Deep endometriosis

406

1.69

4.05

1.5

1.4

0.36

0.39

g/l

0.23

295

Dislocation, sprain and strain of joint and ligaments of hip

123

2.30

4.05

1.3

0.39

g/l

0.01

Dementia

136

1322

0.70

4.03

1.2

1.4

0.38

0.44

g/l

1.18

936

Open wound of ankle and foot

491

1.62

4.03

1.3

0.39

g/l

0.04

346

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

169

2.09

4.02

1.3

1.4

0.37

g/l

0.01

117

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

105

2.41

4.00

1.3

1.5

0.48

0.37

g/l

0.22

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

317

2175

1.27

3.99

1.5

1.4

0.42

0.38

g/l

0.35

242

1605

Injury of muscle and tendon at forearm level

2.86

3.98

1.3

0.52

0.38

g/l

0.29

Tooth eruption problems

115

752

1.48

3.98

1.4

0.36

0.38

g/l

0.38

558

Molar incisor enamel hypoplasia

215

1.93

3.95

1.4

0.38

0.36

g/l

0.15

175

Follicular cysts of skin and subcutaneous tissue

127

879

1.45

3.95

1.4

1.3

0.34

0.40

g/l

1.44

624

Cyst of kidney

254

1.86

3.94

1.5

1.3

0.36

0.41

g/l

0.62

184

Exposure to other and unspecified inanimate mechanical forces

357

1.72

3.93

1.4

1.3

0.38

0.39

g/l

0.11

256

Status epilepticus

106

2.38

3.91

1.4

1.3

0.34

0.43

g/l

0.74

Spirochaetal infections, other/unspecified

380

1.70

3.91

1.3

1.4

0.37

0.41

g/l

0.42

271

Use of other anti-dementia drugs

756

0.58

3.90

1.4

0.36

0.47

g/l

1.61

550

Use of memantine

756

0.58

3.90

1.4

0.36

0.47

g/l

1.61

550

Inflammatory disease of uterus

102

678

1.51

3.89

1.4

0.34

0.38

g/l

0.68

484

Early lumbar disc prolapse, operated

426

1.65

3.89

1.2

1.3

0.36

0.42

g/l

0.52

287

Visual field defects

307

1.77

3.85

1.5

1.3

0.40

0.41

g/l

0.11

222

Injury of nerves at forearm level

3.12

3.83

1.3

1.4

0.38

0.35

g/l

—

Hypertrophic scar

214

1.93

3.82

1.4

0.33

0.38

g/l

0.49

155

Other superficial mycoses

2.63

3.82

1.6

1.3

0.45

0.40

g/l

0.22

Chronic mastoiditis

2.63

3.82

2.3

1.2

0.46

0.44

g/l

0.06

Other facial nerve disorders

2.45

3.82

1.6

1.3

0.48

0.38

g/l

0.40

Other disorders of binocular movement

2.57

3.82

1.4

1.3

0.37

0.36

g/l

0.02

Other misadventures during surgical and medical care

2.57

3.82

1.4

1.3

0.34

0.40

g/l

0.42

Dissection of aorta

2.45

3.81

1.8

1.3

0.43

0.42

g/l

0.05

Pain associated with micturition

523

1.58

3.78

1.4

0.51

0.40

g/l

0.29

378

Hyperfunction of pituitary gland

201

1.96

3.78

1.4

1.3

0.38

0.42

g/l

0.31

143

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

287

2237

1.27

3.76

1.4

0.41

0.39

g/l

0.18

228

1597

Respiratory conditions due to other external agents

2.95

3.75

1.6

1.3

0.42

0.38

g/l

0.30

Tuberculosis of other organs

2.95

3.75

2.1

1.3

0.56

0.45

g/l

0.31

Other peripheral vertigo

362

1.70

3.75

1.5

1.4

0.36

0.40

g/l

0.53

267

Osteitis due to dental implant

4.27

3.75

1.5

1.3

0.42

0.38

g/l

—

Graves ophthalmopathy

2.43

3.75

1.3

1.4

0.40

0.35

g/l

0.40

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

134

2.19

3.74

2.1

1.3

0.36

0.39

g/l

0.27

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

112

766

1.47

3.73

1.3

1.4

0.45

0.41

g/l

0.40

567

Other specified disorders of muscle

2.59

3.73

1.5

1.2

0.36

0.39

g/l

0.09

Presbycusis

388

1.66

3.71

1.6

1.2

0.32

0.48

g/l

3.54

281

Mental and behavioural disorders due to sedatives or hypnotics

296

1.77

3.71

1.3

1.4

0.35

0.38

g/l

0.22

213

Dilated cardiomyopathy

463

1.61

3.71

1.4

1.3

0.48

0.41

g/l

0.77

335

Other disorders of veins

272

2104

1.28

3.71

1.3

1.4

0.36

0.42

g/l

2.43

190

1537

Tuberculosis of other organs, strict

2.82

3.70

2.0

1.3

0.56

0.46

g/l

0.27

Herpesviral keratitis and keratoconjunctivitis

148

2.11

3.69

1.6

1.3

0.41

0.39

g/l

0.11

110

Diabetic retinopathy, excluding more controls

175

715

1.37

3.69

1.4

1.5

0.45

0.41

g/l

0.43

110

487

Chromosomal abnormalities, not elsewhere classified

122

2.25

3.68

1.4

1.3

0.48

0.34

g/l

0.85

Benign neoplasm of eye and adnexa

433

1.63

3.68

1.7

1.4

0.36

0.41

g/l

0.53

320

Left hemicolectomy

2.72

3.67

1.4

1.2

0.40

0.42

g/l

0.06

Caries of enamel

708

3980

1.16

3.67

1.4

0.39

0.40

g/l

0.27

561

2824

Benign lipomatous neoplasm of other sites/unspecified

297

1.76

3.66

1.2

1.4

0.38

0.40

g/l

0.13

219

Other symptoms and signs involving the urinary system

418

1.64

3.66

1.5

1.3

0.35

0.42

g/l

1.00

302

Sequelae of injuries, of poisoning and of other consequences of external causes

164

1205

1.37

3.65

1.4

1.3

0.36

0.42

g/l

1.39

116

860

Dislocation, sprain and strain of joints and ligaments of head

176

2.01

3.65

1.5

1.3

0.39

0.40

g/l

0.08

127

Dislocation, sprain and strain of joints and ligaments at neck level

116

803

1.45

3.64

1.5

1.4

0.36

0.39

g/l

0.43

563

Hypertrophy of breast in women and men

141

1011

1.40

3.64

1.4

1.3

0.33

0.38

g/l

1.64

726

Myocardial infarction, without ST-elevation

218

1504

1.31

3.64

1.4

0.45

0.44

g/l

0.06

172

1066

Dissociative [conversion] disorders

149

2.10

3.64

1.2

1.3

0.27

0.39

g/l

2.09

101

Benign neoplasm of middle ear and respiratory system

283

1.78

3.64

1.8

1.3

0.39

0.40

g/l

0.02

202

Left ventricular outflow tract obstruction (LVOTO), broad definition

497

1.58

3.63

1.6

1.3

0.36

0.40

g/l

0.66

365

Other and unspecified nonscarring hair loss

4.11

3.63

1.1

1.4

0.43

0.32

g/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

143

2.12

3.60

1.6

1.3

0.36

g/l

0.01

107

Hemiplegia

163

2.04

3.60

1.3

0.32

0.41

g/l

1.09

118

Other acquired deformities of musculoskeletal system and connective tissue

177

2.00

3.59

1.9

1.3

0.44

0.38

g/l

0.31

122

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

143

2.11

3.59

1.6

1.2

0.46

0.43

g/l

0.13

108

Any dementia, excluding more controls

999

0.68

3.58

1.2

1.4

0.42

0.45

g/l

0.38

703

Delirium, not induced by alcohol and other psychoactive substances

412

1.63

3.57

1.4

1.3

0.45

0.44

g/l

0.04

297

Examination and encounter for administrative purposes

270

1.79

3.56

1.2

0.50

0.47

g/l

0.13

160

Mental and behavioural disorders due to alcohol

340

2624

1.24

3.55

1.3

1.4

0.42

0.41

g/l

0.19

222

1866

Alzheimer’s disease, strict definition

707

0.59

3.54

1.1

1.4

0.44

0.46

g/l

0.18

512

Disorder of lipoprotein metabolism, unspecified

493

1.57

3.52

1.3

1.4

0.44

0.43

g/l

0.01

350

Medicines for HER+ breast cancer

137

1757

0.72

3.51

1.2

1.4

0.41

0.39

g/l

0.22

1293

Primary open-angle glaucoma

173

1240

1.35

3.50

1.3

1.4

0.34

0.44

g/l

4.81

113

886

Disorder of the sleep-wake schedule

2.65

3.49

1.5

1.3

0.36

0.35

g/l

0.04

Chalazion

510

1.56

3.49

1.7

1.3

0.55

0.40

g/l

0.32

366

Female infertility, associated with anovulation

332

1.70

3.48

1.5

1.4

0.34

0.40

g/l

1.11

239

Palmar fascial fibromatosis [Dupuytren]

503

1.56

3.46

1.4

1.3

0.51

0.46

g/l

0.17

354

Unstable angina pectoris

189

1119

1.33

3.45

1.4

0.43

0.44

g/l

0.14

147

772

Chondrocostal junction syndrome [Tietze]

139

2.11

3.44

1.5

1.3

0.35

0.38

g/l

0.24

101

Bacterial, viral and other infectious agents

387

1.64

3.43

1.4

1.3

0.36

0.38

g/l

0.24

267

Malignant neoplasm of thyroid gland, including Hilmo

311

1.72

3.43

1.7

1.4

0.34

0.37

g/l

0.33

225

Kyphosis

3.58

3.42

1.2

1.3

0.36

0.56

g/l

—

Persons encountering health services in circumstances related to reproduction

426

2367

1.21

3.42

1.3

1.4

0.36

0.40

g/l

1.63

308

1713

Embedded teeth, including avohilmo

427

1.60

3.39

1.4

0.41

0.38

g/l

0.32

308

Use of donepezil

629

0.54

3.39

1.2

1.4

0.42

0.47

g/l

0.30

462

Injury of unspecified body region

298

1.72

3.35

1.5

1.3

0.33

0.40

g/l

0.91

221

Campylobacter enteritis

2.34

3.35

1.3

0.39

0.35

g/l

0.26

Sixth [abducent] nerve palsy

121

2.17

3.33

1.6

1.3

0.29

0.42

g/l

1.73

Malignant neoplasm of endocrine gland, including Hilmo

352

1.66

3.32

1.6

1.4

0.34

0.37

g/l

0.30

249

Endometriosis of ovary

105

684

1.45

3.31

1.3

0.39

0.41

g/l

0.20

481

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

407

2623

1.21

3.31

1.4

0.37

0.41

g/l

1.24

284

1950

Injuries to unspecified part of trunk, limb or body region

438

1.58

3.30

1.6

1.3

0.35

0.41

g/l

1.04

322

Cholesteatoma of middle ear

162

1.99

3.30

2.2

1.3

0.34

0.43

g/l

1.08

118

Malignant neoplasm of breast, ER-positive, including Hilmo

118

1227

0.71

3.29

1.2

1.4

0.42

0.39

g/l

0.37

912

Hypertrophy of tongue papillae

2.83

3.28

1.6

1.3

0.47

0.39

g/l

—

Cardiac arrest

148

1.96

3.28

1.1

1.3

0.37

0.42

g/l

0.53

104

Other disorders of glucose regulation and pancreatic internal secretion

338

1.67

3.28

1.8

1.3

0.38

0.40

g/l

0.15

240

Complications of other internal prosthetic devices, implants and grafts

122

2.15

3.26

1.2

1.3

0.39

0.42

g/l

0.15

Malignant neoplasm of breast, HER-positive

118

1226

0.71

3.25

1.2

1.4

0.42

0.39

g/l

0.36

911

Other noninflammatory disorders of vagina

316

1.69

3.25

1.3

0.35

0.41

g/l

0.56

224

Acute myeloid leukaemia

3.39

3.24

1.5

1.2

0.40

g/l

—

Acute myeloid leukaemia, including Hilmo

3.39

3.24

1.5

1.2

0.40

g/l

—

Acute myeloid leukaemia, helper endpoint

3.39

3.24

1.5

1.2

0.40

g/l

—

Primary open-angle glaucoma, strict

142

1039

1.37

3.23

1.4

0.33

0.44

g/l

5.23

737

Carcinoma in situ of skin of upper limb, including shoulder

2.53

3.22

1.4

1.3

0.56

0.43

g/l

0.38

Postmenopausal bleeding

152

581

1.37

3.21

1.3

0.37

0.40

g/l

0.64

107

409

Other secondary gonarthrosis

199

1.87

3.21

1.3

1.4

0.29

0.38

g/l

1.28

146

Benign neoplasm: Rectosigmoid junction

130

2.10

3.19

1.1

1.3

0.42

g/l

0.04

Malignant neoplasm of breast

167

1423

0.75

3.17

1.2

1.4

0.42

0.38

g/l

0.46

112

1061

Mixed and other personality disorders

380

1.62

3.17

1.5

1.4

0.28

0.37

g/l

2.50

275

Prolonged pregnancy

734

0.61

3.17

1.2

1.4

0.37

0.35

g/l

0.12

546

Congenital malformations of ovaries, fallopian tubes and broad ligaments

251

1.77

3.17

1.3

1.4

0.39

g/l

0.01

186

Chondropathies

107

752

1.43

3.16

1.6

1.4

0.33

0.39

g/l

1.91

533

Atopic conjunctivitis

179

1.92

3.15

1.5

1.3

0.39

g/l

0.00

138

Other strabismus

155

1154

1.34

3.15

1.6

1.4

0.41

0.38

g/l

0.33

108

828

Malignant neoplasm of breast, HER2-negative

167

1421

0.76

3.14

1.2

1.4

0.42

0.38

g/l

0.46

112

1059

Wet age-related macular degeneration

519

1.51

3.14

1.4

0.44

0.48

g/l

0.26

391

Normotensive glaucoma

282

1.71

3.12

1.5

1.3

0.38

0.44

g/l

0.55

210

Abdominal aortic aneurysm (AAA)

272

1.72

3.11

1.5

1.2

0.44

0.48

g/l

0.42

206

Sequelae of injuries of neck and trunk

105

2.21

3.10

1.6

1.3

0.28

0.40

g/l

1.20

Effects of foreign body entering through natural orifice

167

1265

1.32

3.10

1.3

1.4

0.41

0.42

g/l

0.11

113

903

Myelodysplastic syndrome

3.72

3.10

1.4

1.3

0.58

0.29

g/l

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

238

1.78

3.10

2.2

1.5

0.36

0.39

g/l

0.28

174

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

253

1.75

3.08

1.4

0.34

0.38

g/l

0.42

190

Amiodarone users

360

1.62

3.07

1.2

1.4

0.41

g/l

0.00

262

Suicide or other Intentional self-harm

169

1285

1.32

3.06

1.3

1.4

0.34

0.39

g/l

1.44

120

919

Residual foreign body in soft tissue

188

1.87

3.06

1.4

1.3

0.38

0.40

g/l

0.06

129

Melanocytic naevi

216

1697

1.28

3.05

1.4

0.40

0.41

g/l

0.04

170

1222

Pilonidal cyst

400

1.58

3.04

1.4

1.3

0.44

0.38

g/l

0.75

283

Gonarthrosis, primary, with knee surgery

349

2242

1.21

3.04

1.4

0.41

0.43

g/l

0.41

257

1618

Benign neoplasm of meninges

408

1.58

3.03

1.7

1.4

0.35

0.40

g/l

0.84

289

Benign neoplasm: Cerebral meninges

369

1.61

3.03

1.7

1.4

0.35

0.41

g/l

0.89

264

Injuries to the elbow and forearm

507

3712

1.17

3.03

1.4

0.40

0.41

g/l

0.06

371

2694

Salpingitis and oophoritis

117

843

1.39

3.01

1.4

0.31

0.39

g/l

2.67

606

Glaucoma-related operations

175

1.90

3.00

1.4

1.3

0.33

0.43

g/l

1.31

129

Psoriasis (vulgaris), strict definition

120

2.10

2.99

1.1

1.3

0.43

0.37

g/l

0.48

Amputation

316

1.65

2.99

1.4

1.2

0.54

0.42

g/l

1.07

230

Other benign neoplasms of connective and other soft tissue

410

1.57

2.98

1.5

1.4

0.33

0.39

g/l

0.78

294

Meralgia paraesthetica

127

2.07

2.98

1.5

1.4

0.31

0.39

g/l

0.53

Unspecified event, undetermined intent

2.26

2.98

1.4

1.3

0.40

0.37

g/l

0.14

Disorders of breast

333

2418

1.21

2.97

1.5

1.4

0.37

0.39

g/l

0.55

251

1768

Congenital malformations of genital organs

487

1.52

2.97

1.2

1.4

0.37

0.38

g/l

0.15

368

Melanoma in situ

148

1.98

2.95

1.4

0.40

0.42

g/l

0.09

108

Other disorders of pigmentation

162

1.93

2.95

1.4

0.42

0.40

g/l

0.09

118

Primary gonarthrosis, bilateral

311

2134

1.22

2.95

1.3

1.4

0.40

0.43

g/l

0.67

244

1543

Sequelae of other external causes

220

1.78

2.93

1.7

1.3

0.40

0.39

g/l

0.08

158

Seborrhoeic dermatitis

412

1.56

2.92

1.3

0.43

0.41

g/l

0.13

311

Solid cancers, including Hilmo

587

2953

1.16

2.91

1.3

1.4

0.42

0.40

g/l

0.50

403

2168

Other diseases of spinal cord

2.23

2.91

1.3

0.29

0.38

g/l

0.76

Malignant neoplasm of breast, including Hilmo

174

1445

0.77

2.91

1.2

1.4

0.42

0.38

g/l

0.47

119

1075

Malignant neoplasm of breast, HER2-negative, including Hilmo

174

1445

0.77

2.90

1.2

1.4

0.42

0.38

g/l

0.47

119

1075

Malignant neoplasm of digestive organs

228

1382

1.26

2.90

1.4

0.43

g/l

0.01

150

1017

Gestational [pregnancy-induced] hypertension

174

1337

1.30

2.90

1.6

1.4

0.44

0.38

g/l

0.38

132

978

Monoamine oxidase A inhibitors

477

1.52

2.89

1.2

1.3

0.43

0.42

g/l

0.06

337

Scabies

214

1.79

2.88

1.7

1.3

0.45

0.39

g/l

0.48

154

L01XX Other antineoplastic agents

185

1.85

2.87

1.2

1.4

0.39

0.42

g/l

0.11

136

150

971

1.33

2.86

1.3

1.4

0.41

0.45

g/l

0.66

103

695

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

157

1.93

2.84

1.4

0.41

0.35

g/l

0.69

120

Cystic kidney disease

116

2.09

2.84

1.3

0.49

0.41

g/l

0.43

Fall on same level involving ice and snow

398

3358

1.19

2.83

1.6

1.4

0.39

0.42

g/l

0.81

286

2441

Malignant neoplasm of thyroid gland

283

1.67

2.83

1.7

1.4

0.35

0.37

g/l

0.25

206

Other puerperal infections

392

1.57

2.82

1.4

0.30

0.38

g/l

2.18

287

Astigmatism

298

1.65

2.82

1.3

1.4

0.40

0.37

g/l

0.23

216

Arthropod-borne viral fevers and viral haemorrhagic fevers

400

1.56

2.82

1.3

0.37

0.40

g/l

0.38

293

Other and unspecified local infections of skin and subcutaneous tissue

424

1.54

2.82

1.5

1.3

0.43

0.38

g/l

0.27

317

Hydronephrosis

432

1.53

2.81

1.4

1.3

0.44

0.41

g/l

0.18

320

Other and unspecified primary disorders of muscles

3.67

2.81

2.1

1.3

0.22

0.39

g/l

—

Other and unspecified trigeminal disorders

2.68

2.81

1.1

1.5

0.28

0.36

g/l

—

Acute nephritic syndrome

2.49

2.80

1.6

1.3

0.29

0.44

g/l

—

Superficial injury of head

154

1171

1.32

2.80

1.6

1.3

0.35

0.42

g/l

2.05

127

834

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

119

872

1.37

2.80

1.3

1.4

0.32

0.39

g/l

1.46

615

Benign neoplasm of ovary

103

737

1.40

2.79

1.2

1.5

0.35

0.40

g/l

1.04

529

Speech disturbances, not elsewhere classified

307

1.64

2.79

1.3

0.35

0.41

g/l

0.47

224

Viral haemorrhagic fevers, not elsewhere classified/unspecified

315

1.63

2.78

1.4

1.3

0.35

0.40

g/l

0.51

224

Emotional disorders starting during childhood or adolecense, excluding more controls

174

1.85

2.78

1.4

1.3

0.27

0.36

g/l

2.16

128

Carbimazole or st.post thyroidectomy, condition for graves disease

139

1045

1.33

2.77

1.7

1.4

0.34

0.39

g/l

1.61

739

Malignant neoplasm, without specification of site, including Hilmo

117

2.06

2.76

1.7

1.4

0.47

0.40

g/l

0.28

Contact with other hot fluids

131

2.00

2.76

1.3

0.40

0.38

g/l

0.10

Certain conditions originating in the perinatal period

391

1.53

2.76

1.3

0.38

0.37

g/l

0.06

303

Sub-endpoint used in defining T1D endpoints

185

1423

1.28

2.75

1.4

1.3

0.40

0.41

g/l

0.07

134

1026

Dysplasia of cervi uteri

141

742

1.34

2.75

1.4

0.37

0.40

g/l

0.59

103

529

Respiratory tuberculosis, not confirmed, including avohilmo

104

2.13

2.75

2.8

1.3

0.51

0.44

g/l

0.34

Uterine polyps

165

735

1.31

2.75

1.3

0.34

0.41

g/l

1.46

122

518

Other congenital malformations of skin

167

1.87

2.72

1.3

0.43

0.39

g/l

0.32

128

Adenomyosis (Endometriosis of uterus)

540

1.47

2.72

1.2

1.4

0.38

0.40

g/l

0.19

384

Peripheral arterial reconstruction

582

1.45

2.72

1.4

0.49

0.47

g/l

0.20

422

Acidosis

2.45

2.72

1.1

1.2

0.30

0.45

g/l

1.08

Varicose veins

368

2333

1.19

2.71

1.5

1.4

0.38

0.42

g/l

1.16

256

1705

Muscle strain

2.16

2.71

1.2

1.4

0.30

0.39

g/l

0.96

Congenital malformations of the circulatory system

106

744

1.39

2.71

1.6

1.4

0.39

g/l

0.11

555

Social phobias

388

1.55

2.71

1.5

1.3

0.32

0.40

g/l

1.99

267

Corns and callosities

249

1.70

2.69

1.2

1.4

0.51

0.42

g/l

0.88

182

L02BG Aromatase inhibitors

110

1474

0.73

2.68

1.2

1.4

0.41

0.39

g/l

0.22

1071

Embedded and impacted teeth

196

1254

1.27

2.67

1.4

0.41

0.37

g/l

1.26

156

896

Mental and behavioural disorders due to opioids

161

1.88

2.67

1.5

1.3

0.41

0.33

g/l

0.53

111

Malignant neoplasm of endocrine gland

311

1.62

2.67

1.7

1.4

0.35

0.37

g/l

0.28

225

Specific development disorders of speech and language

277

1.65

2.67

1.4

1.3

0.41

0.38

g/l

0.34

210

Other benign neoplasms of skin

233

1881

1.24

2.66

1.6

1.4

0.39

0.42

g/l

0.73

176

1339

Entropion and trichiasis of eyelid

227

1.73

2.66

1.5

1.3

0.40

0.45

g/l

0.42

166

Alzheimer’s disease (Late onset)

637

0.63

2.66

1.1

1.4

0.44

0.47

g/l

0.26

461

Hypoplasia of dental enamel , including avohilmo

204

1.76

2.66

1.4

0.39

0.35

g/l

0.30

170

Behavioural disorders, excluding more controls

2.35

2.64

1.3

0.33

0.35

g/l

—

Infective bursitis

2.23

2.64

1.2

1.3

0.30

0.41

g/l

1.17

Personal history of other diseases and conditions

575

1.44

2.64

1.5

1.4

0.32

0.40

g/l

1.63

438

Alcohol abuse, main dg

106

771

1.38

2.63

1.3

1.4

0.40

0.42

g/l

0.18

546

Other local infections of skin and subcutaneous tissue

456

1.50

2.62

1.5

1.3

0.42

0.39

g/l

0.19

339

Other menopausal disorders

162

692

1.31

2.60

1.8

1.3

0.39

0.40

g/l

0.13

117

488

100

2.12

2.60

2.1

1.3

0.44

0.34

g/l

1.11

Allergic contact dermatitis due to drugs in contact with skin

2.32

2.59

1.3

0.38

0.37

g/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

285

1582

1.22

2.58

1.7

1.4

0.40

0.42

g/l

0.48

210

1172

Isolated proteinuria with specified morphological lesion

3.11

2.58

3.1

1.4

0.39

0.37

g/l

—

Pustular psoriasis

185

1.80

2.57

1.2

1.5

0.42

0.35

g/l

0.54

134

Other specified disorders of kidney and ureter

114

2.04

2.57

1.5

1.3

0.34

0.44

g/l

0.64

Hypertrophic cardiomyopathy

149

1.89

2.57

1.4

1.3

0.37

0.41

g/l

0.32

107

Disturbances of smell and taste

149

1.89

2.56

1.3

1.5

0.36

0.35

g/l

0.06

104

Familial hypercholesterolemia, with ischemic heart disease

268

1.65

2.56

1.4

1.3

0.38

0.46

g/l

1.01

200

Malignant neoplasm of small intestine, including Hilmo

2.15

2.55

1.1

1.5

0.44

0.36

g/l

0.31

Crossbite

362

1.53

2.55

1.3

1.4

0.44

0.36

g/l

1.07

287

Papillary adenocarcinoma of thyroid gland

208

1.74

2.54

1.9

1.4

0.35

0.37

g/l

0.15

152

All dysplastic lesions of the vagina

101

2.10

2.54

1.5

1.4

0.42

0.34

g/l

0.30

Congenital malformations of eye, ear, face and neck

300

1.61

2.53

1.3

0.43

0.39

g/l

0.28

219

Pregnancy hypertension

275

2028

1.21

2.53

1.5

1.4

0.42

0.39

g/l

0.34

209

1492

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

147

1131

1.30

2.52

1.2

1.4

0.35

0.38

g/l

0.84

106

807

Superficial injury of forearm

501

1.46

2.52

1.5

1.4

0.35

0.38

g/l

0.47

364

Vertical strabismus

129

1.96

2.51

1.3

0.49

0.40

g/l

0.47

100

Oligomenorrhoea

136

1.93

2.51

1.8

1.4

0.27

0.40

g/l

2.62

101

Female infertility, tubal origin

209

1.73

2.50

1.2

1.4

0.35

0.38

g/l

0.17

154

2.13

2.50

1.3

0.26

0.37

g/l

1.83

Peripheral artery operations in Hilmo

420

1.50

2.50

1.5

1.3

0.53

0.43

g/l

1.03

308

Other noninflammatory disorders of uterus, except cervix

120

594

1.35

2.49

1.5

1.3

0.43

0.40

g/l

0.27

420

Contraceptive management

294

1704

1.21

2.49

1.4

0.36

0.40

g/l

0.99

216

1239

Congenital ovarian cysts

202

1.75

2.49

1.2

1.4

0.38

g/l

0.04

150

Open wound of wrist and hand

308

2488

1.20

2.49

1.3

1.4

0.40

0.41

g/l

0.25

232

1765

Other degenerative diseases of the nervous system

147

821

1.31

2.49

1.4

0.34

0.46

g/l

3.08

106

579

Benign neoplasm of bone and articular cartilage

397

1.52

2.48

2.0

1.4

0.29

0.38

g/l

2.16

283

Other malignant neoplasms of skin (=non-melanoma skin cancer)

271

1513

1.22

2.48

1.6

1.4

0.40

0.42

g/l

0.43

201

1115

Respiratory tuberculosis, not confirmed

102

2.07

2.47

2.9

1.3

0.50

0.45

g/l

0.22

Stroke, excluding SAH

350

2131

1.19

2.46

1.2

1.4

0.47

0.42

g/l

0.54

262

1507

Cystic kidney disease, including avohilmo

123

1.97

2.46

1.3

0.49

0.40

g/l

0.48

Other symptoms and signs involving general sensations and perceptions

137

1.91

2.46

1.2

1.3

0.40

0.43

g/l

0.11

Essential (haemorrhagic) thrombocythaemia

123

1.97

2.46

1.2

1.4

0.38

0.35

g/l

0.12

Impacted teeth

145

957

1.30

2.45

1.3

0.42

0.38

g/l

0.75

119

682

Impotence

218

1.71

2.45

1.4

1.3

0.35

0.42

g/l

1.05

148

Secondary polycythaemia

2.26

2.45

1.4

1.3

0.35

0.37

g/l

—

Transient ischemic attack

300

1992

1.20

2.45

1.4

0.40

0.43

g/l

0.73

218

1419

Other arterial embolism and thrombosis

2.26

2.45

1.4

1.3

0.34

0.46

g/l

0.80

Benign neoplasm of other and unspecified intrathoracic organs

2.95

2.43

1.9

1.4

0.49

0.32

g/l

—

Aortic valve malfunction, age under 60 years

448

1.48

2.42

1.6

1.3

0.38

0.39

g/l

0.09

327

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

124

768

1.33

2.42

1.2

1.4

0.48

0.42

g/l

0.68

555

Benign neoplasm: Long bones of lower limb

131

1.93

2.41

1.8

1.4

0.26

0.31

g/l

0.63

Dementia in Alzheimer disease

477

0.59

2.41

1.1

1.3

0.42

0.48

g/l

0.46

346

Other and unspecified mood [affective] disorders

312

1.58

2.41

1.2

1.4

0.30

0.38

g/l

1.39

220

Pustulosis palmaris et plantaris

160

1.83

2.40

1.1

1.5

0.40

0.37

g/l

0.22

120

Use of antiglaucoma preparations and miotics

227

1.68

2.39

1.3

0.35

0.45

g/l

1.10

170

104

715

1.36

2.39

1.3

1.4

0.41

0.47

g/l

0.72

514

Benign neoplasm: Pelvic bones, sacrum and coccyx

4.25

2.38

1.4

1.2

0.32

0.39

g/l

—

Other renal tubulo-interstitial diseases

2.23

2.38

1.1

1.3

0.36

0.34

g/l

—

Medical abortion

418

1937

1.17

2.38

1.3

1.4

0.41

0.38

g/l

0.77

308

1422

Hallux rigidus

524

1.44

2.37

1.4

1.6

0.40

0.42

g/l

0.20

381

Postprocedural musculoskeletal disorders, not elsewhere classified

274

1.62

2.37

1.4

1.5

0.30

0.41

g/l

2.03

201

Open wound of forearm

426

1.49

2.36

1.3

0.53

0.39

g/l

1.27

307

Type 1 diabetes, wide definition

143

1106

1.30

2.36

1.4

0.37

0.40

g/l

0.29

108

807

Other disorders of breast

668

1.38

2.35

1.4

0.39

g/l

0.08

475

Inflammatory diseases of prostate (prostatitis)

509

1.44

2.34

1.2

1.4

0.35

0.49

g/l

1.93

356

Psychotic depression

221

1.68

2.34

1.2

1.5

0.41

0.43

g/l

0.13

153

Drug-induced systemic lupus erythematosus

3.30

2.33

1.4

0.75

0.44

g/l

—

Emotionally unstable personality disorder

627

1.39

2.33

1.4

0.37

g/l

0.00

447

Background retinopathy and retinal vascular changes

2.33

2.32

1.5

1.2

0.36

0.41

g/l

—

Benign neoplasm: Skin of eyelid, including canthus

661

1.38

2.32

1.7

1.4

0.38

0.40

g/l

0.23

476

Heart failure and hypertrophic cardiomyopathy

2.40

2.30

1.4

1.3

0.46

0.47

g/l

—

Melanocytic naevi, other sites/unspecified

372

1.51

2.30

1.6

1.4

0.32

0.38

g/l

0.90

263

Ménière disease

364

1.52

2.29

1.5

1.4

0.42

0.40

g/l

0.15

261

Alcohol use disorder, ICD-based

262

2180

1.20

2.28

1.2

1.4

0.42

g/l

0.01

169

1561

Disorders of speech understanding and production

196

1.71

2.28

1.5

1.3

0.40

0.38

g/l

0.07

157

Brain meningioma, including Hilmo

185

1.74

2.28

1.6

1.5

0.27

0.36

g/l

1.33

134

Hypoglycaemia, other or unspecified

254

1.62

2.27

2.0

1.3

0.32

0.39

g/l

1.07

180

Presence of other devices

129

975

1.30

2.27

1.3

1.4

0.39

0.44

g/l

1.00

106

728

Maltreatment syndromes

231

1.66

2.27

1.2

1.4

0.40

0.34

g/l

0.61

170

Benign thyroid growths and nodules

186

1388

1.25

2.27

1.8

1.4

0.38

0.40

g/l

0.24

138

1001

Major anomalies of jaw size

113

1.97

2.26

1.3

0.40

0.35

g/l

0.31

Myeloproliferative diseases

294

1.57

2.24

1.2

1.4

0.40

0.42

g/l

0.09

215

Emotional disorders and disorders of social functioning with onset specific to childhood

242

1.63

2.23

1.4

0.30

0.36

g/l

1.19

183

Impacted cerumen

448

1.46

2.23

1.4

1.3

0.38

0.43

g/l

0.67

329

Malignant neoplasm of liver and intrahepatic bile ducts

2.11

2.23

1.3

1.2

0.40

0.44

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers, including avohilmo

115

872

1.32

2.23

1.4

0.36

0.40

g/l

0.86

633

Urethral stricture

179

1.74

2.22

1.2

0.42

0.44

g/l

0.08

134

Oral leukoplakia, including avohilmo

2.06

2.22

1.3

0.50

0.40

g/l

0.35

Other diseases of peritoneum

157

1.80

2.22

1.4

0.94

0.38

g/l

0.62

120

Benign neoplasm: Adrenal gland

319

1.54

2.21

1.2

1.4

0.29

0.39

g/l

2.17

230

Polyp of the female genital tract

170

761

1.27

2.21

1.3

0.35

0.41

g/l

1.02

127

536

Benign neoplasm: Skin, unspecified

150

1.81

2.21

1.2

1.4

0.32

0.37

g/l

0.39

108

Degenerative macular diseases

400

1.48

2.20

1.5

1.3

0.38

0.45

g/l

0.84

294

Blepharochalasis

163

1296

1.26

2.20

1.5

1.3

0.40

0.42

g/l

0.29

118

929

Recurrent dislocation and subluxation of joint

288

1.57

2.19

1.2

1.4

0.35

0.38

g/l

0.22

195

Endometriosis diagnosis and infertility diagnosis occurring together

559

1.40

2.18

1.4

0.40

0.37

g/l

0.10

397

Other congenital malformations of circulatory system

2.04

2.17

2.8

1.3

0.49

0.34

g/l

0.87

Ischaemic Stroke, excluding all haemorrhages

320

1998

1.18

2.17

1.3

1.4

0.48

0.43

g/l

0.52

235

1423

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

151

1.80

2.17

1.4

1.3

0.33

0.39

g/l

0.79

113

Other predominantly sexually transmitted diseases, not elsewhere classified

121

929

1.31

2.16

1.2

1.4

0.34

0.38

g/l

0.66

659

Somnolence, stupor and coma

144

1.82

2.15

1.4

0.36

0.40

g/l

0.21

107

Additional codes for the location of defect, injury or illness

227

1.64

2.15

1.6

1.3

0.34

0.39

g/l

0.45

164

Endometriosis ASRM stages 3,4

142

1115

1.28

2.14

1.4

0.38

g/l

0.04

113

793

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

2.40

2.13

1.1

1.4

0.44

0.37

g/l

—

Varicella [chickenpox]

220

1.65

2.13

1.2

1.3

0.34

0.37

g/l

0.14

156

IgA nephropathy (IgA glomerulonephritis)

2.07

2.12

1.7

1.3

0.55

0.39

g/l

0.69

Nontoxic multinodular goitre

104

784

1.33

2.12

1.5

1.4

0.41

g/l

0.00

563

Malignant neoplasm of skin, including Hilmo

316

1796

1.18

2.11

1.6

1.4

0.44

0.42

g/l

0.16

231

1329

Hyperprolactinaemia

145

1.81

2.11

1.4

0.31

0.36

g/l

0.47

103

Lesion of femoral nerve

3.26

2.11

1.1

1.4

0.45

0.28

g/l

—

Hypertrophy of breast

117

898

1.31

2.11

1.5

1.4

0.33

0.38

g/l

1.12

647

Coxarthrosis, primary

349

2487

1.17

2.09

1.3

1.4

0.45

0.42

g/l

0.68

285

1774

Glucosamine medication

254

1694

1.20

2.09

1.3

1.4

0.42

g/l

0.01

181

1223

Superficial injury of thorax

692

1.35

2.08

1.6

1.3

0.42

0.41

g/l

0.08

502

Vitreous haemorrhage

398

1.46

2.06

1.5

1.4

0.36

0.40

g/l

0.71

293

Benign neoplasm: Skin of trunk

161

1.75

2.06

2.2

1.3

0.41

0.39

g/l

0.06

124

Hypertensive Renal Disease

1.99

2.05

1.7

1.3

0.43

0.42

g/l

0.06

Autism spe, excluding more controls

1.99

2.05

1.5

1.4

0.24

0.37

g/l

2.23

UC patients in KELA-register (code 208), prior to 1994

154

1.77

2.04

1.6

1.4

0.28

0.37

g/l

1.06

114

Vestibular neuronitis

358

1.49

2.04

1.3

1.4

0.45

0.40

g/l

0.28

265

Pediculosis, acariasis and other infestations

278

1.56

2.03

1.6

1.3

0.47

0.39

g/l

0.59

199

Other vitreous opacities

147

1.78

2.03

1.4

0.34

0.38

g/l

0.40

108

Diabetic nephropathy, excluding more controls

543

1.35

2.02

1.4

1.5

0.48

0.39

g/l

0.94

368

Other abnormal findings in urine

2.53

2.02

1.5

1.4

0.22

0.48

g/l

—

Unspecified urinary incontinence

327

1.50

2.00

1.4

0.35

0.42

g/l

0.70

231

Mental and behavioural disorders due to alcohol, excluding acute intoxication

277

2329

1.18

1.99

1.2

1.4

0.41

g/l

0.02

179

1676

Short stature starting before birth

2.68

1.98

1.4

1.2

0.46

0.42

g/l

—

Malignant neoplasm of brain

119

1.86

1.97

1.3

1.2

0.31

0.36

g/l

0.60

Bitten or struck by other mammals

570

1.37

1.97

1.4

0.41

0.38

g/l

0.28

405

Stroke, including SAH

371

2306

1.16

1.96

1.3

1.4

0.46

0.42

g/l

0.45

280

1632

Injury of muscle and tendon at shoulder and upper arm level

215

1787

1.21

1.95

1.4

0.42

0.43

g/l

0.16

153

1283

Primary hyperparathyroidism

437

1.42

1.94

1.7

1.4

0.36

0.41

g/l

0.49

306

Injury of muscle and tendon at hip and thigh level

496

1.40

1.93

1.3

1.4

0.38

g/l

0.00

359

Use of glatiramer acetate

2.14

1.93

1.3

1.4

0.36

0.33

g/l

—

Chronic periodontitis, including avohilmo

673

3861

1.11

1.93

1.4

0.41

g/l

0.15

508

2751

Amputation of toe

234

1.59

1.93

1.4

1.2

0.56

0.44

g/l

0.81

169

Status post-ami

118

694

1.29

1.92

1.3

1.4

0.43

0.47

g/l

0.39

104

488

Non-small cell lung cancer, adenocarcinoma

180

1.67

1.92

1.1

1.4

0.41

0.42

g/l

0.10

133

Calcific tendinitis of shoulder

211

1.62

1.91

1.2

1.4

0.37

0.38

g/l

0.03

144

Malignant neoplasm of bronchus and lung, including Hilmo

104

663

1.31

1.91

1.2

1.5

0.52

0.43

g/l

1.25

487

Arterial embolism and thrombosis of lower extremity artery

1.93

1.90

1.2

0.37

0.46

g/l

0.82

Other infective otitis externa

235

1.58

1.90

1.2

1.4

0.34

0.40

g/l

0.71

172

Pedestrian injured in transport accident

275

1.53

1.89

1.3

1.4

0.40

g/l

0.03

198

Malignant neoplasm of oral cavity, including Hilmo

143

1.76

1.89

1.2

1.3

0.45

0.37

g/l

0.59

105

Hydatidiform mole

0.00

1.89

0.0

1.5

—

0.35

—

False labour

205

1051

1.21

1.87

1.3

1.4

0.36

g/l

0.01

143

785

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

292

1.51

1.87

1.5

1.3

0.38

0.36

g/l

0.13

211

L02BA Anti-estrogens

756

0.70

1.86

1.1

1.5

0.39

g/l

0.01

540

Biomechanical lesions, not elsewhere classified

174

1.68

1.86

1.2

1.4

0.35

0.39

g/l

0.31

126

In situ neoplasms

236

1989

1.19

1.86

1.3

1.4

0.44

0.41

g/l

0.43

163

1438

Foreign body in respiratory tract

205

1.62

1.86

1.5

1.4

0.55

0.38

g/l

1.05

154

Foreign body on external eye

706

1.32

1.85

1.2

1.3

0.39

0.42

g/l

0.41

502

Brain meningioma

182

1.66

1.85

1.7

1.5

0.28

0.36

g/l

1.18

132

Atlantoaxial subluxation

3.59

1.85

1.2

1.5

0.31

0.37

g/l

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

100

767

1.31

1.85

1.4

0.36

0.40

g/l

0.85

563

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

167

1.69

1.84

1.5

1.3

0.33

0.34

g/l

0.02

128

Other and unspecified injuries of ankle and foot

167

1.69

1.84

2.0

1.3

0.39

0.38

g/l

0.06

117

Benign lipomatous neoplasm

174

1429

1.22

1.82

1.3

1.4

0.41

0.42

g/l

0.07

117

1031

Cysts of oral region, not elsewhere classified

238

1.56

1.81

1.7

1.4

0.33

0.40

g/l

0.91

173

Unspecified dementia

271

0.53

1.81

1.0

1.3

0.58

0.49

g/l

0.27

207

Insulin, fast-acting (human)

631

1.34

1.81

1.3

0.38

g/l

0.02

444

Postmenopausal atrophic vaginitis

140

606

1.26

1.81

1.6

1.3

0.45

0.40

g/l

0.49

111

427

!Aliquae complicationes praecoces traumatis

168

1.68

1.81

1.4

1.3

0.38

0.41

g/l

0.22

119

Early complications of trauma

168

1.68

1.81

1.4

1.3

0.38

0.41

g/l

0.22

119

Dronedarone medication

1.93

1.81

1.3

1.1

0.31

0.39

g/l

0.56

Primary coxarthrosis, bilateral

152

1232

1.24

1.80

1.4

0.42

g/l

0.01

124

868

Fracture of skull and facial bones

134

1071

1.25

1.80

1.5

1.3

0.38

0.42

g/l

0.71

755

Melanocytic naevi of lower limb, including hip

176

1.66

1.80

1.5

1.3

0.26

0.40

g/l

2.91

127

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

336

1.46

1.79

1.2

1.4

0.36

0.38

g/l

0.21

225

Myeloproliferative diseases (CML excluded)

263

1.53

1.78

1.2

1.4

0.41

0.42

g/l

0.04

192

Universal erythroderma, KELA reimbursement

2.37

1.78

1.1

1.4

0.34

0.37

g/l

—

Malignant neoplasm of small intestine

2.11

1.76

1.1

1.5

0.33

0.40

g/l

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

216

1.58

1.76

1.6

1.4

0.46

0.38

g/l

0.42

162

Injury of muscle and tendon at wrist and hand level

634

1.33

1.76

1.4

0.35

0.43

g/l

1.17

456

Other superficial mycoses, including avohilmo

514

1.37

1.75

1.2

1.4

0.33

0.38

g/l

0.91

372

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

330

1.46

1.74

1.4

0.41

0.38

g/l

0.20

238

Other/unspecified disorders of vestibular function

147

1.71

1.74

1.1

1.4

0.32

0.42

g/l

0.98

110

Perineal laceration during delivery

770

0.74

1.72

1.7

1.4

0.46

0.36

g/l

1.55

563

Preterm labour and delivery

161

1320

1.22

1.72

1.4

0.43

0.37

g/l

0.58

110

975

Other appendicitis

364

1.43

1.72

1.2

1.4

0.33

0.39

g/l

1.06

258

Periodontitis

670

3867

1.10

1.72

1.4

0.41

0.40

g/l

0.17

507

2755

Other otitis externa (chronic)

282

1.50

1.71

1.4

0.35

0.39

g/l

0.45

208

Open wound of abdomen, lower back and pelvis

118

1.79

1.70

1.2

0.40

0.37

g/l

0.18

Other specified/unspecified hearing loss

324

1.46

1.69

1.6

1.3

0.39

0.40

g/l

0.14

236

Contusion of ankle

172

1.64

1.67

1.6

1.3

0.42

0.38

g/l

0.13

124

Other acquired deformities of ankle and foot

3.20

1.67

1.2

1.6

0.34

0.41

g/l

—

Cerebral aneurysm, nonruptured

375

1.42

1.67

1.4

0.39

g/l

0.01

267

Haemangioma, any site

375

1.42

1.67

1.7

1.4

0.39

0.40

g/l

0.02

269

Malignant neoplasm of skin

291

1701

1.16

1.65

1.6

1.4

0.44

0.42

g/l

0.14

215

1259

Hepatocellular carcinoma, including Hilmo

1.94

1.65

1.4

1.2

0.46

0.44

g/l

—

Contact with heat and hot substances

237

1.53

1.62

1.3

0.43

0.39

g/l

0.36

173

Other eating disorders

229

1.53

1.62

1.3

1.4

0.33

0.37

g/l

0.36

160

Diffuse brain injury

1.85

1.62

1.1

1.3

0.37

0.44

g/l

0.39

Superficial injury of shoulder and upper arm

557

1.33

1.61

1.6

1.4

0.45

0.40

g/l

0.58

404

Graves disease, strict definition

480

1.36

1.60

1.4

0.34

0.39

g/l

0.75

347

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

1.96

1.60

1.5

1.4

0.37

0.39

g/l

—

Congenital malformations of the nervous system

106

1.81

1.59

1.2

1.3

0.44

0.34

g/l

0.73

Left bundle-branch block

238

1.52

1.59

1.3

0.47

0.38

g/l

0.51

172

Other disorders of Eustachian tube

106

1.80

1.59

1.3

0.27

0.39

g/l

1.94

Basal cell carcinoma, including Hilmo

263

1532

1.16

1.58

1.7

1.4

0.38

0.42

g/l

0.82

194

1132

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

396

1.39

1.58

1.2

1.5

0.35

0.38

g/l

0.21

289

Solid cancers

544

2871

1.11

1.58

1.3

1.4

0.42

0.40

g/l

0.48

372

2107

Peripheral retinal degeneration

1.83

1.57

1.4

1.3

0.35

0.37

g/l

—

Intentional self-harm by sharp object

114

1.77

1.57

1.3

0.30

0.36

g/l

0.34

Conduct disorder

1.86

1.56

1.3

0.33

0.34

g/l

—

Fitting and adjustment of other devices

195

1448

1.19

1.56

1.4

0.36

0.44

g/l

2.73

166

1035

Melanocytic naevi of trunk

595

1.32

1.56

1.2

1.4

0.33

0.39

g/l

1.19

436

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

199

1.56

1.55

1.5

1.4

0.50

0.42

g/l

0.39

149

L01XE Protein kinase inhibitors

176

1.60

1.55

1.4

1.3

0.43

0.39

g/l

0.19

128

Other conjunctival vascular disorders and cysts

1.94

1.55

1.7

1.3

0.38

0.40

g/l

—

Hydrocele

432

1.37

1.54

1.3

1.4

0.40

0.49

g/l

0.79

305

Other congenital malformations of skin, including avohilmo

373

1.40

1.54

1.3

0.39

0.40

g/l

0.09

270

Glaucoma, exfoliation

281

1.46

1.54

1.4

1.3

0.37

0.46

g/l

0.92

214

Retinal detachments and breaks

195

1650

1.18

1.53

1.6

1.4

0.35

0.44

g/l

3.31

143

1201

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

399

1.38

1.52

1.2

1.4

0.35

0.39

g/l

0.32

279

Carcinoma in situ of skin

282

1.46

1.52

1.4

0.51

0.43

g/l

0.44

206

Congenital lens malformations

2.92

1.52

1.2

1.5

0.32

0.31

g/l

—

L02BB Anti-androgens

296

0.57

1.51

2.8

1.2

0.45

0.48

g/l

—

217

Lichen sclerosus et atrophicus

485

1.34

1.51

1.6

1.4

0.37

0.41

g/l

0.50

339

Varicella [chickenpox], including avohilmo

266

1.47

1.51

1.2

1.4

0.36

0.37

g/l

0.07

197

Lesion of sciatic nerve

108

1.77

1.50

1.3

1.2

0.44

0.45

g/l

0.03

Acute alcohol intoxication, ICD10

125

1016

1.23

1.50

1.4

0.42

g/l

0.09

732

Varicose veins of other sites

250

1.49

1.50

1.2

1.3

0.52

0.37

g/l

1.00

178

Disorders of synovium and tendon in diseases classified elsewhere

2.08

1.49

1.4

1.3

0.34

0.38

g/l

—

Family history of other conditions

2.02

1.49

1.2

1.3

0.39

0.36

g/l

—

Contusion of other and unspecified parts of foot

234

1.50

1.49

1.2

1.3

0.33

0.37

g/l

0.48

161

Sequelae of infectious and parasitic diseases, including avohilmo

300

1.44

1.49

1.4

0.38

0.39

g/l

0.11

213

malignant neoplasm of male genital organs

730

0.79

1.46

1.3

1.5

0.45

0.47

g/l

0.16

536

Use of interferon beta-1a

102

1.78

1.45

1.3

1.4

0.33

g/l

0.04

Haemangioma and lymphangioma, any site

420

1.36

1.45

1.6

1.4

0.39

g/l

0.04

305

Other and unspecified disorders of adult personality and behaviour

2.77

1.44

1.2

1.5

0.27

0.35

g/l

—

Anomalies of dental arch relationship, including avohilmo

135

1004

1.22

1.44

1.4

0.38

g/l

0.01

102

725

Car occupant injured in other and unspecified transport accidents

118

959

1.23

1.43

1.6

1.4

0.36

0.40

g/l

0.78

684

Conductive hearing loss, unspecified

336

1.40

1.43

1.3

0.38

g/l

0.08

244

Benign neoplasm of urinary organs

164

1.59

1.43

1.2

1.3

0.36

0.38

g/l

0.16

119

Overexertion and strenuous or repetitive movements

456

1.34

1.42

1.2

1.4

0.32

0.38

g/l

0.79

327

Sequelae of infectious and parasitic diseases

295

1.43

1.41

1.4

0.37

0.39

g/l

0.11

211

Single spontaneous delivery

179

1118

0.84

1.41

1.4

0.36

0.38

g/l

0.50

112

859

Injury of eye and orbit

720

1.27

1.40

1.2

1.3

0.41

0.43

g/l

0.17

508

Other salmonella infections, including avohilmo

150

1.61

1.38

1.6

1.3

0.57

0.35

g/l

0.98

109

Exposure to other and unspecified forces of nature

2.65

1.37

1.8

1.2

0.19

0.39

g/l

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

239

1.47

1.37

1.5

1.4

0.37

0.38

g/l

0.03

171

Early lumbar disc prolapse operation

555

1.30

1.37

1.2

1.4

0.36

g/l

0.01

383

Fracture of lower leg, including ankle

348

3042

1.12

1.37

1.5

1.4

0.41

g/l

0.03

259

2182

Malignant neoplasm of respiratory system and intrathoracic organs

100

664

1.25

1.37

1.2

1.5

0.45

0.42

g/l

0.33

488

Hypermetropia

348

1.38

1.36

1.5

1.4

0.44

0.37

g/l

0.52

263

Other salmonella infections

112

1.71

1.35

1.4

1.3

0.68

0.34

g/l

1.20

Outcome of delivery

536

0.77

1.35

1.2

1.4

0.36

0.35

g/l

0.13

399

Foreign body in ear

1.88

1.35

1.4

1.3

0.45

0.36

g/l

—

Mental disorders, not otherwise specified

384

1.36

1.33

1.3

1.4

0.31

0.36

g/l

0.94

275

Alzheimer’s disease (Late onset), excluding more controls

327

0.69

1.33

1.1

1.6

0.45

0.44

g/l

0.02

221

Malignant neoplasm of prostate

688

0.80

1.32

1.3

1.5

0.46

0.47

g/l

0.07

509

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

168

1.56

1.31

1.3

1.4

0.40

0.37

g/l

0.13

126

Bicipital tendinitis

176

1.54

1.31

1.3

0.40

0.39

g/l

0.08

124

Complications predominantly related to the puerperium

165

1400

1.18

1.31

1.5

1.4

0.35

0.38

g/l

0.84

126

1026

Wide developmental disorders, excluding more controls

141

1.60

1.30

1.4

1.3

0.27

0.37

g/l

2.15

105

Enterobiasis

2.83

1.29

2.0

1.1

0.30

0.46

g/l

—

Basal cell carcinoma

246

1463

1.15

1.29

1.7

1.4

0.38

0.43

g/l

1.01

182

1074

Sequelae of injuries of upper limb

464

1.32

1.29

1.2

1.4

0.35

0.37

g/l

0.27

336

Malignant neoplasm of brain, including Hilmo

169

1.55

1.29

1.3

1.4

0.32

0.36

g/l

0.36

130

Acute alcohol intoxication

148

1247

1.19

1.28

1.4

0.42

0.43

g/l

0.03

899

Undefined dementia

248

0.59

1.28

1.0

1.3

0.58

0.50

g/l

0.25

188

Ovarian dysfunction

353

1.36

1.27

1.4

1.5

0.34

0.38

g/l

0.37

256

329

0.64

1.27

1.1

1.3

0.52

0.41

g/l

0.59

243

Alzheimer disease, excluding more controls

412

0.74

1.26

1.2

1.5

0.37

0.45

g/l

1.16

279

Diabetic retinopathy

207

1108

1.16

1.26

1.4

0.43

0.42

g/l

0.17

132

777

Parkinson's disease

552

0.72

1.25

1.7

1.3

0.33

0.45

g/l

1.71

402

Sequelae of other and unspecified infectious and parasitic diseases

236

1.45

1.25

1.5

1.4

0.37

0.38

g/l

0.08

169

Disorder of external ear, unspecified

123

1.64

1.24

1.6

1.4

0.47

0.39

g/l

—

Behavioural disorders

100

1.71

1.24

1.3

1.2

0.33

0.35

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

398

1.34

1.24

1.2

1.4

0.38

g/l

0.01

281

Diabetic nephropathy

724

1.24

1.4

1.5

0.48

0.44

g/l

0.34

495

Other congenital malformations of the digestive system, including avohilmo

260

1.42

1.23

1.6

1.3

0.47

0.38

g/l

0.80

202

Fracture of neck

204

1.48

1.22

1.0

1.3

0.32

0.45

g/l

1.58

148

Scabies, including avohilmo

807

1.23

1.21

1.6

1.4

0.41

0.38

g/l

0.31

579

Impacted maxillary molar

288

1.39

1.21

1.5

1.4

0.44

0.36

g/l

0.85

199

Benign neoplasm: Skin of other and unspecified parts of face

400

1.33

1.20

1.5

1.4

0.43

0.41

g/l

0.13

297

Retinal vascular occlusion

400

1.33

1.20

1.2

1.3

0.37

0.44

g/l

1.17

288

Bursitis of shoulder

1.84

1.19

1.5

1.4

0.44

0.36

g/l

—

Pediculosis, acariasis and other infestations, including avohilmo

116

963

1.21

1.19

1.5

1.4

0.41

0.39

g/l

0.19

694

Injury of muscle and tendon at lower leg level

728

1.24

1.19

1.8

1.3

0.39

0.44

g/l

0.59

522

Intermittent heterotropia

280

1.40

1.19

1.4

0.46

0.37

g/l

0.61

206

Congenital malformations of great arteries

138

1.58

1.19

1.7

1.4

0.31

0.36

g/l

0.39

114

Early syphilis

2.12

1.19

2.8

1.3

0.57

0.41

g/l

—

Malignant neoplasm of head and neck

289

1.39

1.19

1.2

1.4

0.42

0.39

g/l

0.16

211

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

332

1.36

1.18

1.2

1.4

0.33

0.37

g/l

0.45

235

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

358

1.34

1.18

1.1

1.4

0.37

0.40

g/l

0.32

265

Benign mammary dysplasia

604

1.26

1.18

1.5

0.44

0.41

g/l

0.22

424

Non-small cell lung cancer, adenocarcinoma, helper endpoint

206

1.46

1.17

1.1

1.4

0.41

g/l

0.04

156

Other congenital malformations of the digestive system

213

1.45

1.17

1.6

1.3

0.45

0.37

g/l

0.65

163

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

0.00

1.16

0.0

1.3

—

0.40

—

Infectious mononucleosis

411

1.32

1.16

2.1

1.4

0.38

g/l

0.04

291

Infectious mononucleosis, including avohilmo

411

1.32

1.16

2.1

1.4

0.38

g/l

0.04

291

Foreign body entering into or through eye or natural orifice

359

1.34

1.16

1.3

0.38

0.40

g/l

0.18

262

Nonalcoholic steatohepatitis

2.08

1.16

1.5

1.4

0.43

0.37

g/l

—

Organic, including symptomatic, mental disorders

216

1734

0.87

1.16

1.2

1.4

0.38

0.43

g/l

1.43

151

1231

Congenital malformations of heart and great arteries

648

1.25

1.15

1.3

1.4

0.36

0.38

g/l

0.25

482

Benign neoplasm of thyroid gland

118

1.62

1.15

2.4

1.3

0.52

0.35

g/l

0.78

Motorcycle rider injured in other and unspecified transport accidents

266

1.40

1.14

1.4

1.2

0.44

0.36

g/l

0.86

188

Focal brain injury

191

1.47

1.13

1.5

1.3

0.45

0.42

g/l

0.11

137

Malignant neoplasm of urinary organs, including Hilmo

413

1.31

1.13

1.1

1.4

0.37

0.41

g/l

0.43

310

Premature rupture of membranes

838

0.82

1.12

1.3

1.4

0.39

0.36

g/l

0.31

627

Unspecified maternal hypertension

1.98

1.12

1.1

1.4

0.31

0.38

g/l

—

Laparoscopic right hemicolectomy

192

1.46

1.11

1.3

0.50

0.44

g/l

0.21

142

LSIL lesion of the cervix uteri, vagina or vulva

735

1.23

1.11

1.4

0.38

0.37

g/l

0.17

522

Sequelae of injuries of head

217

1.43

1.11

1.5

1.3

0.38

g/l

0.02

152

Obstructed labour due to maternal pelvic abnormality

717

1.23

1.11

1.3

1.4

0.59

0.36

g/l

0.93

518

Orchitis and epididymitis

362

1.33

1.11

1.3

1.4

0.47

0.45

g/l

0.10

251

Pregnancy with abortive outcome

413

1953

1.10

1.11

1.4

0.41

0.38

g/l

0.81

296

1434

Malignant neoplasm of head and neck, including Hilmo

362

1.33

1.11

1.2

1.5

0.42

0.40

g/l

0.15

271

Parkinson's disease, strict definition

493

0.73

1.11

1.8

1.3

0.35

0.45

g/l

1.39

354

Amblyopia ex anopsia

176

1.48

1.10

1.2

1.3

0.48

0.36

g/l

0.88

134

Coxarthrosis, primary, with hip surgery

249

2048

1.13

1.10

1.3

1.4

0.46

0.42

g/l

0.72

200

1456

Retinal vascular disorders

406

1.31

1.10

1.2

1.3

0.37

0.45

g/l

1.34

294

Congenital cataract

2.42

1.10

1.0

1.5

0.31

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

337

1.34

1.10

1.2

1.4

0.33

0.37

g/l

0.43

248

Sexual dysfunction

1.83

1.09

1.7

1.4

0.44

0.40

g/l

0.19

Retinal haemorrhage

1.74

1.09

1.4

1.3

0.23

0.45

g/l

—

Diabetic maculopathy

551

1.25

1.09

1.5

0.42

g/l

0.00

385

Bipolar affective disorders

113

947

1.20

1.08

1.4

1.3

0.37

0.39

g/l

0.18

661

Benign neoplasm: Choroid

244

1.40

1.07

1.2

1.5

0.34

0.40

g/l

0.52

181

Parkinson's disease, including avohilmo

581

0.76

1.07

1.6

1.3

0.38

0.45

g/l

0.81

423

Macular pucker

622

1.24

1.06

1.7

1.4

0.43

0.44

g/l

0.09

443

Malignant melanoma of skin

489

0.73

1.06

1.4

0.75

0.39

g/l

0.42

360

Malignant neoplasm of prostate, including Hilmo

704

0.83

1.05

1.3

1.5

0.45

0.47

g/l

0.17

521

Other and unspecified mononeuropathies of lower limb

1.68

1.04

1.2

1.3

0.49

0.40

g/l

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.85

1.03

1.5

1.3

0.29

0.34

g/l

—

Other and unspecified mononeuropathies, also in other diseases

1.64

1.03

1.4

1.3

0.42

0.40

g/l

0.09

Eating disorders

525

1.26

1.03

1.3

1.4

0.44

0.40

g/l

0.16

381

Exposure to other and unspecified animate mechanical forces

138

1.53

1.03

1.4

1.3

0.36

g/l

0.00

106

Myocardial infarction, with ST-elevation

626

1.23

1.01

1.2

1.4

0.40

0.45

g/l

0.82

455

Fracture of forearm

354

2892

1.10

1.01

1.3

1.4

0.39

0.41

g/l

0.32

258

2088

Other and unspecified injuries of abdomen, lower back and pelvis

1.89

1.00

1.0

1.2

0.43

0.29

g/l

—

Pedal cyclist injured in noncollision transport accidents

597

0.77

1.00

1.4

0.40

0.39

g/l

0.11

429

Malignant neoplasm of other connective and soft tissue, including Hilmo

131

1.53

1.00

1.8

1.4

0.46

0.36

g/l

0.38

101

Other and unspecified injuries of shoulder and upper arm

123

1.55

1.00

1.2

1.3

0.35

0.37

g/l

0.12

Other lesions of median nerve

1.72

0.99

1.1

1.2

0.26

0.43

g/l

—

Non-small cell lung cancer, including Hilmo

513

1.25

0.98

1.1

1.5

0.52

0.42

g/l

1.22

381

Assault

683

1.22

0.98

1.2

1.4

0.45

0.36

g/l

1.77

474

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system, including Hilmo

0.00

0.98

0.0

1.3

—

0.34

—

Nontoxic goitre/thyroid nodule

158

1375

1.15

0.98

1.8

1.4

0.39

0.40

g/l

0.17

119

979

Abnormal findings in secretions and smears from cervix uteri vagina vulva

311

2071

1.11

0.97

1.4

0.37

0.39

g/l

0.72

229

1545

Malignant neoplasm of mesothelium and soft tissue

124

1.54

0.97

1.5

1.4

0.48

0.37

g/l

0.34

Benign neoplasm: Kidney

116

1.56

0.96

1.2

1.4

0.27

0.38

g/l

1.55

Erectile dysfunction

284

1.34

0.96

1.8

1.2

0.47

0.43

g/l

0.18

206

Anorexia (incl.atypical)

258

1.36

0.96

1.1

1.4

0.53

0.41

g/l

0.30

178

malignant neoplasm of male genital organs, including Hilmo

105

748

0.84

0.96

1.3

1.5

0.46

0.47

g/l

0.06

546

Focal epilepsy

120

1024

1.17

0.96

1.3

1.4

0.38

0.40

g/l

0.17

739

Malignant neoplasm of stomach, including Hilmo

157

1.47

0.96

1.4

1.3

0.43

0.41

g/l

0.10

117

Fracture of femur

122

939

1.17

0.95

1.4

0.47

0.45

g/l

0.29

667

Primary ovarian failure

1.70

0.95

1.3

0.49

0.37

g/l

—

Short Achilles tendon (acquired)

1.70

0.95

1.5

1.4

0.40

0.36

g/l

—

Primary angle-closure glaucoma

125

1.53

0.94

1.7

1.4

0.32

0.46

g/l

1.91

Meningococcal infection

2.25

0.94

1.2

1.1

0.55

0.28

g/l

—

Meningococcal infection, including avohilmo

2.25

0.94

1.2

1.1

0.55

0.28

g/l

—

Periodontal disease, other/unspecified

101

1.59

0.94

1.4

0.29

0.40

g/l

—

Separation of retinal layers (serosa)

158

1.46

0.93

2.4

1.3

0.43

0.38

g/l

0.29

117

Other ill-defined and unspecified causes of mortality

277

1.34

0.93

1.2

0.53

0.45

g/l

0.52

205

Delivery, wide proxy

146

892

0.87

0.92

1.4

0.37

g/l

0.01

101

671

Delivery

188

1121

0.88

0.91

1.5

1.4

0.38

g/l

0.12

122

861

Long labour

114

1128

0.85

0.91

1.3

1.4

0.39

0.35

g/l

0.80

839

Eating disorder

454

1.26

0.91

1.3

1.4

0.30

0.39

g/l

2.06

334

Pedestrian injured in collision with pedal cycle

102

1.58

0.90

1.4

1.3

0.32

0.37

g/l

0.46

Schizophrenia or delusion

148

1692

0.87

0.90

1.1

1.4

0.39

0.40

g/l

0.17

1193

Crushed, pushed or stepped on by crowd or human stampede

376

1.28

0.89

1.2

1.3

0.39

g/l

0.00

268

Sequelae of cerebrovascular disease

177

1335

1.13

0.89

1.3

1.4

0.43

g/l

0.01

134

936

Malignant neoplasm of stomach

135

1.49

0.89

1.4

0.39

0.41

g/l

0.12

103

Schizophrenia, schizotypal and delusional disorders

149

1700

0.88

1.1

1.4

0.39

0.40

g/l

0.21

1198

Diabetic neuropathy

508

1.24

0.88

1.5

1.4

0.50

0.44

g/l

0.55

347

Carcinoma in situ of breast, intraductal

358

0.72

0.87

1.3

1.4

0.46

0.37

g/l

0.29

255

Malignant neoplasm of bronchus and lung

571

1.20

0.87

1.2

1.5

0.50

0.43

g/l

0.78

426

Focal epilepsy, strict definition

109

933

1.17

0.86

1.3

0.39

0.40

g/l

0.07

675

Non-small cell lung cancer

347

1.28

0.86

1.2

1.4

0.44

0.43

g/l

0.05

258

Inguinal hernia

338

2055

1.09

0.86

1.3

1.4

0.46

0.40

g/l

1.33

241

1437

Open bite

299

1.31

0.86

1.3

1.4

0.37

g/l

0.05

225

Toxic effects of substances chiefly nonmedicinal as to source

549

1.22

0.86

1.3

0.35

0.37

g/l

0.27

395

Contact with machinery

477

1.24

0.85

1.2

1.3

0.44

0.39

g/l

0.39

339

Retinoschisis and retinal cysts

1.68

0.85

2.7

1.3

0.42

g/l

—

Open wound of head

333

2868

1.09

0.85

1.5

1.4

0.38

0.42

g/l

0.88

226

2037

Use of disulfiram, acamprosate or naltrexone

415

1.26

0.84

1.4

1.3

0.31

0.38

g/l

1.67

290

Hyperplasia of prostate

181

902

1.13

0.84

1.5

1.4

0.42

0.46

g/l

0.47

136

642

Emotional disorders starting during childhood or adolescence

245

1.34

0.84

1.4

0.27

0.38

g/l

2.99

190

Thiazolidinediones

433

1.25

0.84

1.3

1.4

0.43

0.41

g/l

0.15

313

Scissor bite

164

0.60

0.83

1.5

0.31

0.37

g/l

—

132

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

1.71

0.83

1.5

1.3

0.29

0.34

g/l

—

Early syphilis, including avohilmo

1.75

0.83

2.8

1.3

0.57

0.40

g/l

—

Redundant prepuce, phimosis and paraphimosis

117

996

1.16

0.82

1.2

1.4

0.36

0.43

g/l

1.84

693

Hereditary corneal dystrophies

113

1.51

0.82

1.2

1.5

0.20

0.42

g/l

4.53

Sequelae of injuries of lower limb

435

1.24

0.82

1.5

1.4

0.38

g/l

0.00

317

Aneurysms, operations, SAH

699

1.19

0.81

1.4

0.42

0.40

g/l

0.20

493

Spontaneous abortion

282

1720

1.10

0.81

1.3

1.4

0.37

0.38

g/l

0.15

212

1274

Malignant neoplasm of bladder, including Hilmo

359

1.27

0.81

1.5

1.4

0.43

0.45

g/l

0.15

275

Vascular syndromes of brain in cerebrovascular disorders

130

1.47

0.81

1.3

1.2

0.65

0.45

g/l

0.61

Fall on and from stairs and steps

149

1314

1.14

0.81

1.5

1.3

0.40

0.41

g/l

0.19

104

942

Other fall from one level to another

135

1182

1.14

0.80

1.3

1.4

0.36

0.42

g/l

1.46

107

857

Male infertility

198

1.37

0.80

1.3

0.39

0.37

g/l

0.14

131

All dysplastic lesions of the cervix uteri, vagina or vulva

178

1549

1.12

0.80

1.4

0.38

g/l

0.02

135

1135

Intentional self-harm by hanging, strangulation and suffocation

0.00

0.79

0.0

1.3

—

0.36

—

Foreign body or object entering through skin

268

1.31

0.79

1.4

1.3

0.39

0.37

g/l

0.09

192

Other specified/unspecified nutritional deficiencies

0.00

0.79

0.0

1.5

—

0.31

—

Epidural haemorrhage

0.00

0.78

0.0

1.3

—

0.55

—

Exposure to other and unspecified man-made environmental factors

1.63

0.78

1.1

1.3

0.37

0.34

g/l

0.15

Nontoxic single thyroid nodule

286

1.30

0.78

2.0

1.4

0.29

0.41

g/l

2.30

206

Granulomatous disorders of skin and subcutaneous tissue

1.56

0.78

1.7

1.2

0.36

0.43

g/l

—

Diabetic retinopathy, strict definition

722

1.17

0.77

1.4

1.5

0.45

0.41

g/l

0.36

497

Fracture of shoulder and upper arm

206

1856

1.11

0.77

1.5

1.4

0.39

0.42

g/l

0.63

153

1327

Polycystic ovarian syndrome, broad definition

548

1.21

0.76

1.4

0.33

0.38

g/l

1.02

407

Juvenile osteochondrosis

132

1.45

0.76

1.7

1.4

0.31

0.35

g/l

0.25

Autism

132

1.45

0.76

1.5

1.4

0.24

0.35

g/l

2.00

Other spirochaetal diseases, including avohilmo

204

1842

1.11

0.75

1.4

0.36

0.41

g/l

1.98

168

1321

Other spirochaetal diseases

202

1823

1.11

0.75

1.4

0.35

0.41

g/l

2.05

167

1306

Other disorders of cornea

404

1.24

0.75

1.2

1.4

0.35

0.39

g/l

0.42

294

Typhoid and paratyphoid fevers, including avohilmo

2.11

0.75

1.4

1.3

0.56

0.32

g/l

—

Pedal cyclist injured in collision with pedestrian or animal

2.10

0.75

1.4

1.3

0.40

0.37

g/l

—

Traumatic subdural haemorrhage

420

1.23

0.74

1.5

1.4

0.50

0.51

g/l

0.02

297

Autism spe

133

1.44

0.74

1.5

1.4

0.24

0.34

g/l

1.86

102

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

1.85

0.73

1.0

1.3

0.45

0.39

g/l

—

Other congenital malformations of heart

1.81

0.73

1.6

1.2

0.31

0.39

g/l

—

Unspecified parasitic disease

2.02

0.73

1.0

1.2

0.59

0.40

g/l

—

Colitis due to radiation

2.01

0.73

1.4

1.3

0.18

0.45

g/l

—

Medical treatment for female infertility

130

1136

1.14

0.72

1.4

0.32

0.37

g/l

2.03

104

825

HSIL lesion of the vulva

1.68

0.72

1.1

1.3

0.31

0.35

g/l

—

Aggressive periodontitis

1.59

0.72

1.2

1.3

0.55

0.36

g/l

—

Migraine with aura, drug-induced

1.76

0.71

2.7

1.4

0.27

0.30

g/l

—

Unspecified parasitic disease, including avohilmo

1.94

0.71

1.0

1.2

0.59

0.40

g/l

—

Pregnancy, childbirth and the puerperium

125

742

0.88

0.71

1.3

1.5

0.40

0.38

g/l

0.22

555

Thyrotoxicosis with toxic single thyroid nodule

1.94

0.71

1.8

1.5

0.44

0.30

g/l

—

Puerperal sepsis

581

1.19

0.71

1.7

1.4

0.39

g/l

0.03

416

Other disorders of the genitourinary system

517

1.20

0.70

1.5

1.4

0.43

0.41

g/l

0.10

366

Focal epilepsy, mode (most common among epilepsy diagnosis)

102

887

1.15

0.70

1.3

1.4

0.39

0.40

g/l

0.08

640

Viral agents as the cause of diseases classified to other chapters, including avohilmo

101

1.49

0.70

1.3

0.37

0.40

g/l

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

381

1.24

0.70

1.3

1.4

0.32

0.36

g/l

0.46

273

Helminthiases

1.56

0.70

1.6

1.3

0.33

0.35

g/l

—

Lesion of plantar nerve

230

1.31

0.69

1.9

1.4

0.42

0.40

g/l

0.09

167

Mandibular retrognathia

318

1.26

0.69

1.5

1.4

0.37

0.38

g/l

0.11

233

Prepatellar bursitis

152

1.39

0.69

1.1

1.3

0.52

0.41

g/l

0.82

108

Polycystic ovarian syndrome

248

1.29

0.68

1.3

1.4

0.32

0.40

g/l

1.22

174

Abscess of Bartholin gland

110

1.46

0.68

1.1

1.3

0.39

0.36

g/l

0.13

Femoral hernia

127

1.42

0.68

1.3

0.38

0.40

g/l

—

Generalized epilepsy, mode (most common among epilepsy diagnosis)

128

1.41

0.66

1.4

1.3

0.34

0.36

g/l

0.15

Assault by bodily force

394

1.22

0.65

1.3

0.47

0.34

g/l

2.32

275

Ill-defined and unknown causes of mortality

304

1.25

0.65

1.2

0.52

0.45

g/l

0.41

227

Maternal care for other known or suspected fetal problems

150

843

1.12

0.63

1.3

1.4

0.38

0.36

g/l

0.40

105

636

Foreign body in alimentary tract

207

1.31

0.63

1.4

1.3

0.41

0.42

g/l

0.04

151

Single delivery by forceps and vacuum extractor

528

0.86

0.63

1.3

1.5

0.36

0.34

g/l

0.24

416

Retinal breaks without detachment

737

1.16

0.63

1.7

1.4

0.34

0.41

g/l

1.40

538

Malignant melanoma of skin, including Hilmo

590

0.83

0.63

1.3

1.4

0.66

0.40

g/l

0.44

430

Burn and corrosion of head and neck

1.53

0.63

1.2

1.3

0.39

0.38

g/l

0.02

Open wound of shoulder and upper arm

1.56

0.62

1.2

1.3

0.47

0.34

g/l

—

Viral hepatitis

324

1.24

0.62

1.1

1.3

0.43

0.38

g/l

0.43

226

Alcohol dependence

143

1285

1.11

0.62

1.1

1.4

0.39

0.43

g/l

0.91

934

Persistent delusional disorders

290

0.76

0.61

1.0

1.4

0.31

0.39

g/l

0.82

208

Impacted maxillary canine

1.58

0.61

1.4

1.2

0.51

0.37

g/l

—

Malignant neoplasm of kidney, except renal pelvis

316

1.24

0.60

1.1

1.4

0.38

0.40

g/l

0.14

232

Viral hepatitis, including avohilmo

344

1.22

0.60

1.1

1.3

0.43

0.38

g/l

0.47

238

Pathological resorption of teeth

157

1.34

0.59

1.1

1.2

0.66

0.38

g/l

0.74

115

LSIL lesion of the cervix uteri

593

1.17

0.59

1.3

1.4

0.40

0.36

g/l

0.35

425

Burn and corrosion of trunk

114

1.41

0.59

1.2

1.3

0.47

0.40

g/l

—

Other disorders of breast and lactation associated with childbirth

1.57

0.59

1.3

0.25

0.38

g/l

—

Mental and behavioural disorders due to cannabinoids

123

1.39

0.58

1.2

1.3

0.50

0.32

g/l

—

Tibial collateral bursitis [Pellegrini-Stieda]

1.72

0.58

1.0

1.4

0.41

0.39

g/l

—

Complications of the puerperium, not elsewhere classified

193

1.30

0.57

1.3

1.4

0.30

0.37

g/l

1.17

141

Other chromosome abnormalities, not elsewhere classified

1.69

0.57

1.5

1.3

0.49

0.38

g/l

—

Struck by thrown, projected or falling objec

229

1.27

0.57

1.2

1.3

0.35

0.39

g/l

0.31

158

Malignant neoplasm of breast, HER-negative

857

0.87

0.56

1.3

1.5

0.45

0.39

g/l

0.37

627

Intracerebral haemorrhage

420

1.19

0.56

1.2

1.3

0.44

0.43

g/l

0.09

301

Clear cell adenocarcinoma of kidney

150

1.34

0.56

1.0

1.4

0.44

0.41

g/l

0.14

112

1.59

0.54

1.8

1.3

0.22

0.37

g/l

—

Other and unspecified corneal deformities and disorders

116

1.38

0.54

1.2

1.4

0.45

0.39

g/l

—

Torticollis

1.51

0.54

1.1

1.3

0.43

0.38

g/l

—

Left ventricular outflow tract obstruction, narrow definition

222

1.26

0.54

1.4

1.3

0.30

0.39

g/l

1.10

156

Transient global amnesia

361

0.80

0.53

2.2

1.3

0.56

0.43

g/l

0.25

263

Maternal care for known or suspected fetal abnormality and damage

744

0.88

0.53

1.3

1.4

0.35

0.36

g/l

0.12

554

Type 1 diabetes, strict (exclude DM2)

496

1.17

0.52

1.2

1.4

0.40

0.37

g/l

0.29

363

Type 1 diabetes, definitions combined

496

1.17

0.52

1.2

1.4

0.40

0.37

g/l

0.30

364

Infections of genitourinary tract in pregnancy

442

1.18

0.52

1.4

1.5

0.38

g/l

0.03

320

Combinations of oral blood glucose lowering drugs

142

1291

1.10

0.52

1.3

1.4

0.43

g/l

0.00

928

Sulfonylureas

120

1056

0.90

0.51

1.1

1.4

0.43

g/l

0.01

745

Contact with nonpowered hand tool

170

1.30

0.51

1.4

1.3

0.31

0.39

g/l

0.95

116

Generalized epilepsy

179

1.29

0.51

1.3

0.36

0.40

g/l

0.36

133

Congenital malformations of cardiac septa

331

1.20

0.51

1.3

1.4

0.37

0.38

g/l

0.09

258

Coronary artery bypass grafting

641

1.12

0.50

1.7

1.4

0.44

0.47

g/l

0.21

447

Other abnormal products of conception

199

1206

1.08

0.50

1.5

1.4

0.41

0.36

g/l

1.47

140

901

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

379

0.82

0.50

1.5

1.4

0.31

0.41

g/l

1.58

276

Periapical abscess

286

2684

1.07

0.49

1.4

0.37

0.41

g/l

0.65

206

1952

Obstructed labour due to malposition and malpresentation of fetus

112

1147

0.90

0.48

1.4

0.42

0.35

g/l

1.59

850

Toxic effect of contact with venomous animals

181

1.27

0.48

1.2

1.3

0.28

0.40

g/l

2.75

131

Personal history of malignant neoplasm

355

0.82

0.48

1.2

1.4

0.33

0.42

g/l

0.93

267

Malignant neoplasm of bladder

172

1.28

0.47

1.4

1.2

0.33

0.46

g/l

0.86

133

Ectopic pregnancy

881

1.11

0.47

1.4

0.41

0.37

g/l

0.45

642

Lyme disease

195

1811

1.08

0.46

1.4

0.35

0.41

g/l

2.02

163

1300

Lyme disease, including avohilmo

195

1811

1.08

0.46

1.4

0.35

0.41

g/l

2.02

163

1300

Other viral hepatitis

282

1.21

0.46

1.1

1.3

0.46

0.37

g/l

0.67

200

All dysplastic lesions of the cervix uteri

153

1386

1.09

0.46

1.4

0.39

0.37

g/l

0.26

111

1024

Maternal care for known or suspected malpresentation of fetus

738

0.90

0.45

1.4

0.39

0.36

g/l

0.40

555

Slow fetal growth and fetal malnutrition

1.40

0.45

2.4

1.3

0.49

0.39

g/l

—

Spirochaetal infections, other/unspecified, including avohilmo

196

1825

1.07

0.44

1.4

0.35

0.41

g/l

2.02

164

1305

Malignant neoplasm of breast, ER-negative, including Hilmo

915

0.90

0.44

1.2

1.4

0.45

0.39

g/l

0.41

673

Tarsal tunnel syndrome

1.62

0.43

1.0

1.3

0.66

0.32

g/l

—

Presbyopia

405

1.16

0.43

1.4

0.40

0.37

g/l

0.16

287

Chronic periodontitis, complicated

331

3059

1.05

0.42

1.4

0.42

0.41

g/l

0.17

247

2186

Other osteochondropathies

313

1.18

0.42

1.5

1.3

0.30

0.37

g/l

0.84

218

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.41

0.0

1.1

—

0.55

—

Seminoma of testis, including Hilmo

1.52

0.41

1.0

1.2

0.34

0.37

g/l

—

Other and unspecified vascular occlusions

295

1.19

0.41

1.3

0.35

0.45

g/l

1.83

223

Inflammatory disorders of breast

286

1.19

0.41

1.8

1.4

0.38

0.36

g/l

0.19

207

Malignant neoplasm of hypopharynx

0.00

0.41

0.0

1.1

—

0.38

—

Other viral hepatitis, including avohilmo

305

1.18

0.40

1.1

1.3

0.45

0.37

g/l

0.62

214

Other specified disorders of external ear

132

1.29

0.40

1.6

1.3

0.31

0.45

g/l

1.23

Other blood glucose lowering drugs, excl. Insulins

634

1.12

0.40

1.3

1.4

0.42

g/l

0.00

448

Calculus of lower urinary tract

168

1.25

0.40

1.8

1.2

0.35

0.42

g/l

0.66

123

Malignant neoplasm of rectum, including Hilmo

465

0.86

0.40

1.4

0.33

0.41

g/l

1.08

339

Inflammatory disease of cervix uteri

241

1.21

0.40

1.1

1.3

0.36

0.40

g/l

0.40

177

Retained placenta and membranes, without haemorrhage

587

1.13

0.40

1.3

1.4

0.34

0.35

g/l

0.08

418

Abnormal spermatozoa

493

1.14

0.39

1.3

1.4

0.37

0.46

g/l

1.26

359

Other disorders of iris and ciliary body

1.34

0.39

1.2

1.3

0.37

0.46

g/l

—

Benign leiomyoma with endometriosis

674

1.11

0.38

1.3

1.5

0.40

0.39

g/l

0.06

476

Other mental disorders due to brain damage and dysfunction and to physical disease

419

1.15

0.38

1.4

0.44

0.43

g/l

0.05

303

Cervical polyps

401

1.15

0.38

1.4

0.29

0.41

g/l

2.31

292

HSIL lesion of the cervix uteri

1009

0.91

0.37

1.4

0.41

0.37

g/l

0.44

737

Convergent concomitant strabismus

280

1.18

0.37

1.5

1.4

0.44

0.37

g/l

0.53

205

Frostbite

1.36

0.37

1.4

0.34

g/l

—

Contact with sharp glass

161

1.25

0.37

1.2

1.3

0.39

0.37

g/l

0.11

116

Pre-eclampsia or poor fetal growth

175

1632

1.07

0.36

1.4

0.40

0.38

g/l

0.35

128

1201

Follow-up examination after treatment for malignant neoplasms

281

1.18

0.36

1.2

0.35

0.46

g/l

1.17

166

Right hemicolectomy

180

1.22

0.36

1.2

0.77

0.43

g/l

1.19

132

Pedal cyclist injured in transport accident

108

1172

0.92

0.35

1.5

1.3

0.39

0.41

g/l

0.27

843

Retinal detachment with retinal break

526

1.12

0.35

1.6

1.4

0.33

0.42

g/l

1.33

381

Malignant neoplasm of ovary

179

0.78

0.35

1.3

1.5

0.43

0.35

g/l

—

131

Manic episode

1.32

0.35

1.3

0.31

0.37

g/l

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

363

0.85

0.35

1.5

1.4

0.31

0.41

g/l

1.53

267

Acute and transient psychotic disorders

575

0.89

0.35

1.2

1.4

0.33

0.39

g/l

1.70

407

Malignant neoplasm of urinary organs

348

1.15

0.34

1.1

1.4

0.40

0.41

g/l

0.07

257

Congenital malformations of aortic and mitral valves

181

1.22

0.34

1.4

1.3

0.31

0.39

g/l

0.70

128

Other and unspecified nonorganic psychotic disorders

1033

0.92

0.33

1.2

1.4

0.39

0.38

g/l

0.12

715

Type 1 diabetes, strict definition, subgroup 1

377

1.14

0.33

1.2

1.3

0.33

0.36

g/l

0.28

285

Malignant neoplasm of testis

1.28

0.32

1.2

1.3

0.31

0.37

g/l

—

Supervision of normal pregnancy

111

684

0.92

0.32

1.2

1.4

0.38

0.37

g/l

0.07

514

Bulimia nervosa (incl. atypical)

146

1.24

0.32

1.3

1.4

0.27

0.37

g/l

1.63

Kela-code for severe mental illness

186

1967

0.95

0.31

1.2

1.4

0.39

0.40

g/l

0.15

132

1392

Leiomyoma of uterus

368

1982

1.04

0.31

1.5

1.4

0.38

0.39

g/l

0.15

264

1463

Malignant neoplasm of testis, including Hilmo

1.32

0.31

1.1

1.3

0.30

0.38

g/l

—

Open wound of thorax

1.30

0.30

2.0

1.2

0.39

0.37

g/l

—

Other and unspecified injuries of head

296

1.15

0.30

1.2

1.3

0.36

0.42

g/l

0.59

212

Postpartum haemorrhage due to retained placenta

641

0.90

0.30

1.2

1.4

0.39

0.37

g/l

0.20

458

Carcinoma in situ of cervix uteri

504

0.89

0.29

1.4

1.5

0.39

0.37

g/l

0.14

364

Inguinal or femoral hernia, bilateral

411

1.12

0.29

1.2

1.4

0.54

0.42

g/l

0.44

301

Diabetes mellitus in pregnancy

193

1163

1.05

0.28

1.2

1.4

0.36

0.38

g/l

0.45

141

877

Embolic stroke

130

1.23

0.28

1.3

1.2

0.54

0.46

g/l

0.45

Malignant neoplasm of rectum

365

0.88

0.28

1.5

1.4

0.33

0.41

g/l

0.91

267

Other disorders of amniotic fluid and membranes

716

0.92

0.28

1.8

1.4

0.36

g/l

0.03

531

Nontraumatic intracranial haemmorrhage

786

1.08

0.27

1.3

1.4

0.45

0.41

g/l

0.29

559

Septal defects

321

1.13

0.27

1.2

1.4

0.38

0.37

g/l

0.10

258

Burns and corrosions of external body surface, specified by site

548

1.10

0.26

1.5

1.3

0.44

0.38

g/l

0.54

394

Carcinoma in situ of colon

1.27

0.26

1.3

0.37

0.43

g/l

—

Postpartum care and examination

458

0.92

0.26

1.3

1.4

0.35

0.34

g/l

0.06

340

Pervasive developmental disorders excl. Autism + Asperger

1.30

0.26

1.0

1.2

0.25

0.42

g/l

—

Gestational diabetes (for exclusion)

206

1484

0.95

0.26

1.2

1.4

0.38

0.37

g/l

0.22

152

1112

Parkinson's disease, excluding more controls

411

0.89

0.26

1.7

1.5

0.33

0.47

g/l

2.12

286

Malignant melanoma

626

1.09

0.25

1.3

1.4

0.64

0.40

g/l

0.50

461

Malignant melanoma, including Hilmo

713

1.08

0.25

1.3

1.4

0.62

0.41

g/l

0.49

520

Wide developmental disorders

197

1.16

0.25

1.4

0.27

0.39

g/l

2.94

155

Malignant neoplasm of ovary, including Hilmo

234

0.85

0.24

1.2

1.5

0.51

0.36

g/l

1.08

168

HSIL lesion of the cervix uteri, vagina or vulva

103

1097

0.94

0.24

1.4

0.39

0.37

g/l

0.21

799

Dislocation, sprain and strain of joints and ligaments of elbow

302

1.13

0.24

1.8

1.4

0.43

0.36

g/l

0.60

224

Other sexually transmitted chlamydial diseases

302

1.13

0.24

1.3

1.4

0.41

0.38

g/l

0.15

203

Malignant neoplasm of corpus uteri, including Hilmo

321

1.12

0.24

1.2

1.5

0.50

0.38

g/l

0.47

227

Antenatal screening

119

707

0.94

0.24

1.2

1.4

0.37

g/l

0.00

528

Maternal care related to the fetus and amniotic cavity and possible delivery problems

265

1493

1.04

0.24

1.4

0.37

0.39

g/l

0.54

202

1118

Other assisted single delivery

0.72

0.24

1.2

1.5

0.63

0.34

g/l

—

Other obstructed labour

350

1.12

0.24

1.2

1.4

0.31

0.36

g/l

0.59

253

Use of galantamine

201

0.85

0.23

1.3

0.33

0.48

g/l

1.76

149

Inguinal hernia, bilateral

408

1.10

0.23

1.2

1.4

0.53

0.42

g/l

0.41

300

Parkinson's disease, strict definition, excluding more controls

374

0.90

0.23

1.8

1.4

0.35

0.46

g/l

1.53

256

Otosclerosis

294

1.12

0.23

1.1

1.5

0.50

0.39

g/l

1.26

216

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

1.29

0.23

1.8

1.2

0.26

0.39

g/l

—

Unspecified lump in breast

727

1.07

0.23

1.6

1.4

0.32

0.40

g/l

1.93

512

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

640

1.08

0.23

1.2

1.4

0.40

g/l

0.03

466

Dementia in other diseases classified elsewhere

153

1.18

0.22

1.2

0.42

0.49

g/l

—

113

Ependymoma

0.00

0.21

0.0

1.2

—

0.35

—

1.19

0.21

1.4

1.1

0.24

0.37

g/l

—

Mental and behavioural disorders of puerperium, not classified elsewhere

1.19

0.21

1.8

1.2

0.26

0.32

g/l

—

Chondrosarcoma

0.00

0.21

0.0

1.2

—

0.37

—

Syndactyly, including avohilmo

0.00

0.21

0.0

1.2

—

0.32

—

Schizophrenia or delusion, excluding more controls

148

1396

1.05

0.20

1.1

1.4

0.39

0.41

g/l

0.30

983

Cleft hard palate NOS

0.00

0.20

0.0

1.1

—

0.32

—

Sequelae of transport accidents

0.00

0.20

0.0

1.4

—

0.38

—

Postpartum hemorraghe, parous women as controls

141

1125

1.05

0.20

1.3

0.39

0.38

g/l

0.14

108

816

Maternal care for cervical incompetence

144

0.83

0.20

1.3

1.4

0.41

0.36

g/l

—

111

Colorectal adenocarcinoma

768

0.94

0.19

1.7

1.4

0.39

0.44

g/l

0.72

556

Benign neoplasm: Peripheral nerves and autonomic nervous system

1.18

0.19

1.0

1.4

0.23

0.36

g/l

—

Contact with other sharp object(s)

333

0.90

0.19

1.2

1.3

0.31

0.37

g/l

0.81

236

Other disorders of penis

443

1.08

0.18

1.7

1.4

0.37

0.48

g/l

1.00

320

Chronic viral hepatitis

227

0.88

0.18

1.1

1.3

0.47

0.36

g/l

0.53

156

Abnormalities of forces of labour

538

0.93

0.17

1.2

1.4

0.36

0.35

g/l

0.17

389

Spermatocele

281

1.10

0.17

1.5

1.4

0.39

0.46

g/l

0.59

194

Injury of nerves at wrist and hand level

138

1.16

0.17

1.3

0.30

0.38

g/l

—

Postpartum haemorrhage due to anatomy

517

0.93

0.17

1.3

0.38

0.37

g/l

0.11

371

Serous carcinoma of ovary, including Hilmo

110

1.18

0.17

1.2

1.6

0.45

0.38

g/l

—

Non-small cell lung cancer, squamous

110

1.18

0.17

1.4

1.2

0.53

0.42

g/l

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

1007

0.95

0.17

1.3

1.4

0.44

g/l

0.01

733

Antepartum haemorrhage, not elsewhere classified

454

0.92

0.16

1.4

0.33

0.35

g/l

0.22

339

Pregnancy examination and test

529

1.05

0.16

1.7

1.4

0.31

0.35

g/l

0.78

398

Colorectal cancer

937

0.95

0.16

1.6

1.5

0.43

g/l

0.00

676

Crowding of teeth, including avohilmo

418

1.07

0.16

1.2

1.4

0.43

0.36

g/l

1.14

313

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.16

0.15

1.1

1.2

0.25

0.40

g/l

—

487

1.07

0.15

1.2

1.4

0.36

0.37

g/l

0.04

348

malignant neoplasm of female genital organs

622

0.94

0.15

1.2

1.5

0.49

0.39

g/l

0.60

447

Multiple delivery

420

0.93

0.15

1.6

1.4

0.39

0.35

g/l

0.55

337

Traumatic amputation of wrist and hand

150

1.13

0.14

1.5

1.3

0.24

0.44

g/l

2.74

103

Other and/or unspecified nontoxic goitre

315

0.92

0.13

3.1

1.3

0.34

0.40

g/l

0.78

224

Complications of labour and delivery

362

1970

1.02

0.13

1.4

0.40

0.37

g/l

1.02

261

1445

Failed induction of labour

296

1.08

0.13

1.5

1.4

0.32

0.36

g/l

0.60

219

Colorectal cancer, including Hilmo

106

1026

0.96

0.13

1.5

0.43

0.44

g/l

0.05

751

Colon adenocarcinoma, helper endpoint

458

0.94

0.13

1.9

1.3

0.44

0.43

g/l

0.09

332

Other complications of labour and delivery, not elsewhere classified

565

1.05

0.12

1.2

1.4

0.40

0.35

g/l

0.71

422

Abnormal findings on antenatal screening of mother

427

0.94

0.12

1.5

0.35

0.38

g/l

0.42

324

Carcinoma in situ of other and unspecified digestive organs

152

1.12

0.12

1.2

1.3

0.56

0.43

g/l

0.38

107

Distal bite

218

1.09

0.12

1.6

1.4

0.27

0.37

g/l

1.73

172

Use of levodopa decarboxylase inhibitor

477

0.94

0.12

2.0

1.3

0.33

0.46

g/l

1.76

344

severe traumatic brain injury, does not include concussion

936

1.04

0.11

1.4

0.44

0.46

g/l

0.12

674

Burns and corrosions

720

1.04

0.11

1.4

1.3

0.41

0.39

g/l

0.31

508

Vascular dementia (subcortical)

1.16

0.11

1.4

1.2

0.33

0.52

g/l

—

Unspecified mental disorder

228

2233

1.02

0.10

1.2

1.4

0.37

0.40

g/l

0.59

164

1595

Prominent ears

1.14

0.10

1.4

1.2

0.49

0.37

g/l

—

Mental and behavioural disorders associated with the puerperium

1.06

0.09

1.8

1.4

0.26

0.35

g/l

—

Malignant neoplasm of rectosigmoid junction

1.06

0.09

1.2

1.3

0.20

0.40

g/l

—

Other congenital malformations of male genital organs, including avohilmo

1.04

0.09

1.0

1.5

0.48

0.33

g/l

—

Bicuspidal aortic valve syndrome

145

1.10

0.09

1.4

1.3

0.36

0.40

g/l

—

103

Benign neoplasm of breast

523

0.96

0.09

1.4

0.31

0.40

g/l

1.87

376

Maternal care for known or suspected abnormality of pelvic organs

141

928

1.03

0.09

1.3

1.4

0.38

0.37

g/l

0.18

694

Deep bite that required surgery

1.07

0.08

1.5

1.3

0.36

0.31

g/l

—

Liveborn infants according to place of birth

1.03

0.08

1.0

1.2

0.26

0.33

g/l

—

Polyhydramnios

214

1.08

0.08

1.4

0.42

0.36

g/l

0.23

155

Placenta praevia

224

1.07

0.08

1.4

0.34

0.36

g/l

0.08

163

Type1 diabetes, definitions combined, early onset

350

1.05

0.08

1.2

1.3

0.35

0.37

g/l

0.14

257

LeFortI or BSSO operation

176

1.08

0.07

1.3

1.4

0.39

0.35

g/l

0.32

126

Hypertrichosis

0.86

0.06

1.3

1.4

0.22

0.35

g/l

—

Other disorders of prostate

0.86

0.06

2.0

1.2

0.34

0.47

g/l

—

malignant neoplasm of female genital organs, including Hilmo

714

0.97

0.06

1.2

1.4

0.54

0.39

g/l

1.15

514

Supervision of high-risk pregnancy

114

671

1.02

0.06

1.5

1.4

0.38

0.37

g/l

0.10

502

Use of rivastigmine

465

0.96

0.06

1.4

1.3

0.41

0.46

g/l

0.45

337

Labour and delivery complicated by fetal stress [distress]

137

875

1.02

0.05

1.3

1.4

0.39

0.35

g/l

0.62

101

652

Malignant neoplasm of colon

563

1.03

0.05

1.7

1.4

0.51

0.41

g/l

0.73

409

Single delivery by caesarean section

113

632

1.02

0.05

1.4

1.5

0.37

0.35

g/l

0.34

501

Fall on and from ladder

297

1.04

0.05

1.4

1.2

0.46

0.40

g/l

0.47

220

Deep bite

556

1.03

0.05

1.3

1.4

0.34

0.38

g/l

0.91

416

Pre-eclampsia

106

1041

1.02

0.05

1.6

1.4

0.42

0.37

g/l

0.56

750

Acute appendicitis, with complications

908

0.98

0.05

1.4

0.53

0.43

g/l

0.29

666

Macular hole

189

1.06

0.04

1.4

1.5

0.27

0.43

g/l

1.93

143

Other sexually transmitted chlamydial diseases, including avohilmo

494

0.97

0.04

1.3

1.4

0.42

0.39

g/l

0.18

340

Hydrocephalus

239

1.05

0.04

2.1

1.3

0.36

0.42

g/l

0.34

184

Alcohol withdrawal state with delirium

281

0.96

0.04

1.1

1.3

0.43

0.41

g/l

0.13

205

Malignant neoplasm of corpus uteri

279

1.04

0.04

1.1

1.5

0.54

0.39

g/l

0.49

202

Poor fetal growth

676

1.02

0.04

1.3

1.4

0.39

0.36

g/l

0.45

503

Postpartum haemorrhage

141

1175

0.99

0.03

1.3

1.4

0.39

0.35

g/l

0.82

108

874

Pedal cyclist injured in collision with motor vehicle

122

1.07

0.02

2.1

1.3

0.36

0.38

g/l

—

Gonococcal infection, including avohilmo

132

1.06

0.02

1.4

1.6

0.48

0.35

g/l

—

Type 1 diabetes, strict definition

429

1.02

0.02

1.2

1.3

0.35

0.36

g/l

0.12

316

Family history of malignant neoplasm

540

1.02

0.02

1.2

1.4

0.31

0.40

g/l

1.29

398

Pedal cyclist injured in other and unspecified transport accidents

541

1.02

0.02

1.4

0.35

0.39

g/l

0.38

392

Pre-eclampsia or eclampsia

113

1121

1.01

0.01

1.5

1.4

0.40

0.37

g/l

0.34

811

Myocardial infarction, unclassifiable

659

0.99

0.01

1.3

1.4

0.45

0.46

g/l

0.07

475

Vascular dementia

238

0.97

0.01

1.4

1.2

0.31

0.52

g/l

2.00

178

Memory loss

307

0.98

0.01

1.5

1.4

0.51

0.43

g/l

0.18

227

Divergent concomitant strabismus

337

0.98

0.01

1.8

1.4

0.39

0.37

g/l

0.10

240

Subarachnoid haemorrhage

377

0.98

0.01

1.4

0.46

0.39

g/l

0.33

269

Thyrotoxicosis with toxic multinodular goitre

216

0.97

0.00

2.0

1.5

0.32

0.41

g/l

0.49

159

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

246

0.98

0.00

1.5

1.4

0.54

0.36

g/l

0.78

178

Multiple gestation

464

1.01

0.00

1.5

1.4

0.40

0.35

g/l

0.68

338

Non-small cell lung cancer, squamous, helper endpoint

131

0.99

0.00

1.4

1.2

0.53

0.46

g/l

—

101

Twin gestation

445

1.01

0.00

1.5

1.4

0.39

0.35

g/l

0.62

322

Malignant neoplasm of colon, including Hilmo

706

1.00

0.00

1.6

1.4

0.47

0.42

g/l

0.38

512

Benign neoplasm of other and unspecified female genital organs

153

0.98

0.00

1.7

1.6

0.28

0.38

g/l

—

119

Postpartum hemorraghe, all women as controls

141

1373

1.00

0.00

1.3

1.4

0.39

0.37

g/l

0.46

108

1012

Colon adenocarcinoma

427

1.01

0.00

1.9

1.4

0.44

0.41

g/l

0.22

311

Rubella [German measles], including avohilmo

145

0.97

0.00

2.8

1.4

0.41

0.51

g/l

—

102

Rubella [German measles]

145

0.97

0.00

2.8

1.4

0.41

0.51

g/l

—

102

Birth injury to skeleton

0.00

0.0

1.4

—

0.29

—

Acne varioliformis

0.00

0.0

1.0

—

0.49

—

Carcinoma in situ of oral cavity

0.00

-0.00

0.0

1.6

—

0.26

—

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

0.99

-0.00

1.1

1.2

0.37

0.35

g/l

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

0.99

-0.00

1.1

1.2

0.37

0.35

g/l

—

Atrophy of thyroid (acquired)

0.00

-0.00

0.0

1.0

—

0.25

—

Staphylococcal scalded skin syndrome

0.00

-0.00

0.0

1.2

—

0.49

—

Hirsprung

0.00

-0.00

0.0

1.0

—

0.48

—

Congenital malposition of the kidney

0.00

-0.00

0.0

1.0

—

0.37

—

Phlebitis and thrombophlebitis of other sites, drug-induced

0.00

-0.00

0.0

1.8

—

0.24

—

Malignant neoplasm of palate

0.00

-0.00

0.0

1.2

—

0.47

—

Intentional self-harm by jumping or lying before moving object

0.00

-0.00

0.0

1.0

—

0.41

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.2

—

0.38

—

Renal cell carcinoma of kidney

0.91

-0.00

1.3

1.2

0.36

0.40

g/l

—

Hirsutism in women

0.96

-0.00

1.3

1.4

0.22

0.36

g/l

—

Cellulitis of external ear

1.02

-0.00

1.0

1.3

0.45

0.34

g/l

—

Malignant neoplasm of other and unspecified urinary organs

0.00

-0.00

0.0

1.4

—

0.38

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

IgG subclass 3 [Mass/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS